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Summary
Telomeres are essential nucleoprotein structures located at the ends of chromosomes that 
provide both end protection and avoid recognition through the DNA damage response. 
In humans, telomeres consists of arrays of TTAGGG repeats which associate with, and 
are protected by, shelterin, a complex of telomere binding proteins. Dysfunctional 
telomeres arise by either gradual telomere erosion as a result of the end replication 
problem to critical lengths, or by the removal of telomere binding proteins. It is widely 
accepted that short dysfunctional telomeres are recognised as DNA double strand 
breaks. The aberrant repair of telomeric double strand breaks and the subsequent 
formation of dicentric chromosomes, can initiate cycles of anaphase bridging, breakage 
and fusion that can drive genomic instability. In eukaryotes, double strand breaks are 
repaired by either error-free homologous recombination or error-prone non-homologous 
end joining.
In this thesis, single molecule approaches were used to observe the telomere dynamics 
of DNA repair deficient fibroblast cultures and to characterise possible fusion events in 
cells undergoing crisis following die forced expression of HPV16 E6E7 oncoproteins.
All the DNA repair deficient human fibroblast strains observed in this thesis exhibited a 
similar limited replicative capacity. In contrast to previous reports, the data presented 
here supports the assumption that DNA repair deficiency does not result in accelerated 
telomere erosion and therefore the reduced replicative lifespan of these fibroblast 
cultures appears to be telomere independent.
The main aspect of this diesis was to examine the role that components of the DNA 
repair mechanisms might play in the fusion of short dysfunctional telomeres. The results 
presented here indicate that the fusion of short dysfunctional telomeres is largely 
independent of DNA Ligase I and DNA Ligase IV. These observations lead to the 
assumption that DNA Ligase III might be the predominant ligase involved in the fusion 
of short dysfunctional telomeres.
Furthermore, NBS1 deficiency results in a paucity of sporadic telomere deletion events 
which is consistent with the hypothesis that NBS1 is involved in the resolution of 
Holliday junctions within T-loops creating telomeric deletion events. In contrast, DNA 
Ligase IV deficiency and PARP1 inhibition caused distinct short telomere length 
distributions. Both these phenotypes might be related to problems with telomere 
replication.
Ill
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Chapter 1: Introduction
1.1 History of Telomeres
At the end of the 1930’s, two independent researches made a seminal observation 
(McClintock, 1939, Mueller, 1938). The disruption of the chromosome following X-ray 
treatment resulted in various types of internal rearrangements including translocations, 
inversions and deletions. However, most interestingly, the chromosome ends were 
excluded from these chromosomal alterations. The geneticist Herman Mtiller speculated 
that an unidentified structure protected the end of the chromosomes in Drosophila 
melanogaster which prevented chromosomal modifications and maintained the integrity 
of the chromosome. He named these structures “telomeres” derived from the Greek 
words telos (end) and meros (part) (Fig 1.1a). At the same time, in 1939, Barbara 
McClintock’s observations in maize (Zea Mays) provided evidence that the loss of these 
end structures following X-irradiation induces frequent sister chromatid fusion events. 
These fusion events created dicentric chromosomes which formed a “bridge” between 
the two “daughter” cells during the meiotic anaphase. The cell separation at the end of 
anaphase stretches and breaks the dicentric chromosome inducing an unequal break site 
in the two daughter chromosomes. Mitosis of the “daughter” cell can induced continuous 
cycles of replication, chromatid fusion and unequal breakage which are termed 
“breakage-fusion-bridge” (BFB) events. Consequently several BFB cycles can lead to 
chromosomal abnormalities, gene amplifications and gene loss. Further experiments 
showed that BFB cycles were only maintained in non-embryonic tissue. In embryonic 
cells the continuous BFB events were interrupted and the incipient chromosomal 
breakage were permanently healed (McClintock, 1941).
1.2 Structure of Telomeres
Even though telomeres were identified in the 1930’s, it took another 40 years until the 
first telomeric DNA sequence could be identified in the protozoa Tetrahymena 
thermophilia (Blackburn and Gall, 1978). Telomeric DNA is highly conserved amongst 
eukaryotes despite displaying variability in telomeric sequence and length. The 
TTAGGG repeats sequence is thought to be the oldest telomeric sequence as it is 
observed in the telomeres of protozoa, fungi, plants and mammalians. Even as the 
telomere repeats vary between species, most telomeres are composed of a G-rich strand 
(G-strand) at the chromosomal13bnd and a C -rich strand (C-strand) at the 'Send 
(Meyne et al., 1989). Rather than ending in a blunt end, the G-strand protrudes over the 
C-strand in a single stranded extensions forming a G-rich 3 -overhang (Fig 1.1b). G- 
strand overhangs are present at both chromosome ends (Cervantes and Lundblad, 2002, 
Makarov et al., 1997, McElligott and Wellinger, 1997). It has been suggested that the G- 
rich overhang at the 3' end of the chromosome is a result of the end replication problem. 
In contrast to this, the overhang of the 5' end is generated by either degradation of the C- 
rich strand or elongation of the G-rich strand by telomerase (Dionne and Wellinger, 
1996, Makarov et al., 1997, McElligott and Wellinger, 1997). The overhangs are 
maintained throughout the replicative capacity of the cell (Chai et al., 2005).
The 3 -overhang is thought to fold back into the telomere repeat region forming a 
secondary telomeric DNA structures termed the t-loop. By invading the double stranded 
DNA a single stranded displacement loop (D-loop) is created (Fig 1.1c). The t-loop 
protects telomere ends from degradation, DNA repair activity and regulates telomerase 
activity (Griffith et al., 1999, Palm and de Lange, 2008). The formation of the t-loop is 
supported by members of the shelterin complex (de Lange, 2004). T-loops have been 
observed in protozoan, plants and humans and to some extend in yeasts (Cesare et al., 
2003, Griffith et al., 1999, Munoz-Jordan et al., 2001, Tomaska et al., 2004). However 
very little is known about the dynamics of T-loop assembly and whether each 
chromosome end is capped by a t-loop. Furthermore it is not clear whether the t-loop is
a)
b)
centromere
subtelomeric
region
TVR
region
double stranded 
telomeric repeats
■ ■ ■ ■ ■ ■ ■  3'
5'
G-rich single strand 
overhang
centromere
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stable throughout the cell cycle or the t-loop is displaced during DNA replication 
(Denchi, 2009, Palm et al., 2009).
An exception to the conserved G-rich structure of most eukaryotic telomeres are Diptera. 
The telomeres of Drosophila chromosomes terminate in arrays of telomere-specific non- 
long terminal-repeat (LTR) retrotransposons (Pardue and DeBaryshe, 2003). In D. 
melanogaster chromosome termini consist of up to 12 kb of tandem arrays of telomere- 
specific HeT-A, TART and TAHR LTR retrotransposons (Mason and Biessmann,
1995).
1.2.1 Protozoa
Sequencing of the termini of extrachromosomal ribosomal RNA genes of the protozoa 
Tetrahymena thermophilia revealed 20 to 70 repeats of the repetitive sequence 
TTGGGG (Blackburn and Gall, 1978). The macronuclear DNA of ciliates like 
Oxytricha fallax and Stylanychia pustulata is capped by 20 bp of TTTTGGGG telomeric 
repeats sequence ending in an additional 16 bp 3 -overhang (Oka et al., 1980, Pluta et 
al., 1982). T-loop like structure has been found in ciliates. Trypanosomatid telomeres 
contain the same TTAGGG repeats as found in many eukaryotes. Trypanosoma brucei 
chromosomes terminate in 10 -  20 kb of telomeric repeats and display a 3 -overhang of 
21 -  250 nt of TTAGGG repeats. T-loop formation has been observed at end of T. 
brucei DNA (Munoz-Jordan et al., 2001). T. cruzi telomeres have a similar structure as 
7! brucei and have a G-rich overhang of 9 -  50 nt (Chiurillo et al., 1999).
1.2.2 Fungi
The telomeric sequence found at the chromosome termini of budding yeast 
Saccharomyces cerevisiae consists of 120 to a 150 bp of G2-3(TG)i-6 repeats. An 
additional more distal domain contains varying number of TG1.7 repeats (Shampay et al.,
1984, Wang and Zakian, 1990). In S. cerevisiae, the two telomeric arrays form an 
alternative higher order structure which differs from t-loop observed in other eukaryotes 
(de Bruin et al., 2001). The telomeres of fission yeast Schizosaccharomyces pombe 
contain approximately 300 bp of the degenerated telomeric repeat sequence, 
TTAC(A)(C)G2-8 (Hiraoka et al., 1998). T-loop formation has been observed in S. 
pombe and appears to be dependent on Tazl, a component of the fission yeast shelterin 
complex (Tomaska et al., 2004). Both budding and fission yeast have a G-rich single 
stranded overhang at their chromosome termini. In contrast to mammalian cells where 
the length of the G-rich overhang appears to be constant (Makarov et al., 1997), the 
amount of G-rich overhang of S. cerevisiae and S. pombe increases during S-phase 
(Wellinger etal., 1993).
1.2.3 Plants
In almost all plants, the chromosomal termini are composed of canonical TTTAGGG 
repeats (Fajkus et al., 2005, Riha and Shippen, 2003). However the telomere length 
varies between different plants species. For example, the Arabidopsis telomere spans an 
area of 2 to 5 kb (Riha and Shippen, 2003) whereas the telomere repeat regions in 
tobacco plants reaches 150 kb (Fajkus et al., 1995). Exceptions from the normally 
TTTAGGG repeat observed in plants are the algae Chlamydomonas and member of the 
Asparagles species. In the Chlamydomonas, telomeres contain the repeat sequence 
TTTTAGGG (Petracek et al., 1990). In Asparagales, a single nucleotide change causes a 
switch to the repeat motif TTAGGG which is normally observed in humans (Fajkus et 
al., 2005). In contrast to other plants, members of the Alliaceae family (onions) lack any 
kind of G-rich telomere repeats and display a completely unknown telomere structure 
(Pich et al., 1996). Like the telomere length, the length of G-rich 3'-overhang is highly 
variable in plants ranging from 20 to 30 nt in Arabidopsis (Riha and Shippen, 2003) to 
75 kb in Pisum sativum (common garden pea)(Cesare et al., 2003). Most interestingly, 
not all chromosomal termini in plants end in a G-rich 3'-overhang indicating a so far 
unknown telomere structures in plants (Riha et al., 2000, Watson and Riha, 2010).
1.2.4 Mammalian
The chromosome ends of mammalians are capped by telomeres containing the 
conserved TTAGGG repeat sequence (Meyne et al., 1989). However the telomere length 
varies between different species and subspecies. For instance the wild forms of Mus 
musculus and Mus spretus have telomeres in the range of 5-20 kb whereas the telomere 
length is significantly longer in inbred strains of M. musculus. The mouse strain DBA/2 
displays a telomere length ranging from 20 to 150 kb, whereas the strain C57BL/6 has 
telomeres of 20-65 kb in length (Kipling and Cooke, 1990).
Human telomeres are composed of pure TTAGGG repeat arrays ranging from 5 to 20 
kb. In addition to this highly conserved telomere repeat sequence, human telomeres 
contain 1 to 2 kb of telomere variance repeats (TVR) such as TTGGGG, TGAGGG and 
TCAGGG at the proximal end of the telomere (Baird et al., 1995, Brown et al., 1990, de 
Lange et al., 1990).
1.3 Telomere Associated Proteins
Human telomere repeats arrays interact with a specialised multi-protein complex termed 
shelterin complex. The components of this complex are abundant at the chromosome 
termini throughout the cell cycle. The six core proteins of the shelterin complex are the 
telomere repeat binding factors 1 and 2 (TRF1 and TRF2), the TRF-interacting protein 2 
(TIN2), protection of telomeres 1 (POT1), the POT1-TIN2 organizing protein (TPP1, 
also known as TINT1, PTOP or PIP1) and repressor/activator protein 1 (RAP1) (de 
Lange, 2005, Palm and de Lange, 2008)(Fig 1.2). Only TRF1, TRF2 and POT1 bind 
directly to telomeric DNA, with TRF1 and TRF2-binding to telomeric double stranded 
DNA and POT1 binding to the G-rich single stranded 3 -overhang. The other 
components of the shelterin complex associate with the chromosomal termini via the 
interaction with the 3 telomere binding proteins.
TRF 2
centromere
Figure 1.2 The shelterin complex, a) The six core components o f the shelterin complex, b) the shelterin 
complex interacting with a telomere in t-loop configuration . Since TRF 1 and TRF 2 bind indepentently 
to telomeric repeats and TIN2. the resutling subcomplexes are presented in this scheme (modified from 
Denchi 2009, Martinez 2010)
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1.3.1 The Shelterin complex
1.3.1.1 Telomere Repeat Binding Factors 1 and 2 (TRF1 and TRF2)
TRF1 was first isolated in HeLa cells as a protein binding to TTAGGG repeats (Zhong 
et al., 1992). Further experiments identified TRF2 as a distant homologue of TRF1 
(Broccoli et al., 1997). The structure of TRF 1 and TRF2 displays large similarities. Both 
bind to telomeric DNA via a C-terminal helix-tum-helix SANT/Myb DNA-binding 
motif which displays high specificity for the double stranded sequence 5 - 
YTAGGGTTR-3' (Bianchi et al., 1999, Broccoli et al., 1997). Both proteins form 
homodimers and thus increasing the DNA binding affinity of each protein complex. The 
dimerization of each proteins is mediated by an N-terminal TRF homology (TRFH) 
domain (Bianchi et al., 1997, Broccoli et al., 1997). Despite their similarities in sequence 
and structure, TRF1 and TRF2 do not interact with each other and serve different 
functions at the telomere (Broccoli et al., 1997, Fairall et al., 2001). Notable, TRF1 and 
TRF2 are both extremely abundant and they are suspected to cover each telomere with 
thousands of heterodimers (Palm and de Lange, 2008).
TRF1 has DNA remodelling activity which might stimulate the T-loop formation 
(Bianchi et al., 1997, Griffith et al., 1998). TRF1 has been shown to contribute to 
telomere length regulation (Smogorzewska et al., 2000, van Steensel and de Lange, 
1997). However it role in telomere protection has not been established. TRF1 promotes 
the replication of telomere repeats and prevents the stalling of replication forks (Sfeir et 
al., 2009). TRF1 deletion in mouse is lethal (Iwano et al., 2004, Karlseder et al., 2003). 
TRF1 is a negative regulator of telomere length in telomerase-positive cells, whereas 
TRF2 is important for telomere capping (Kim et al., 2004). The poly(ADP-ribosyl)ation 
of TRF 1 inhibits the binding of TRF 1 to telomeres and therefore leaves the chromosome 
termini accessible for telomerase (Cook et al., 2002, Smith and de Lange, 2000, Smith et 
al., 1998). TRF1 interacts with TIN2, TNKS1, the Ku70/80 heterodimer, Bloom’s
syndrome helicase (BLM), ATM kinase, PinXl (Hsu et al., 2000, Kim et al., 2004, 
Lillard-Wetherell et al., 2004, Smith et al., 1998).
TRF2 can form t-loop like structures in the presence of model telomere substrates. 
(Stansel et al., 2001). The Ku70 subunit of the Ku 70/80 heteromere has been shown to 
interact with TRF2. Ku70/80 also associates with the hTERT component of telomerase, 
indicating an involvement in telomere length maintenance (Chai et al., 2005, Hsu et al., 
2000, O'Connor et al., 2004, Ye et al., 2004a). TRF1 also recruits ERCC1/XPF to the 
telomere, removing the 3' overhang from uncapped telomeres allowing non-homologous 
end joining (NHEJ), The ERCC1/XPF is also implemented to prevent telomere 
recombination with chromosome internal sites (Zhu et al., 2003). Other proteins which 
interact with TRF2 are the MRN complex and Werner syndrome helicase (WRN) 
(Opresko et al., 2002, Zhu et al., 2000, Zhu et al., 2003).
13.1.2 TIN2
TIN2 (TRF1- and TRF2-interacting nuclear factor 2) provides a stabilizing scaffold for 
the shelterin complex as it binds to TRF1, TRF2 and TPP1 (Houghtaling et al., 2004, 
Kim et al., 2004, Ye et al., 2004a, Ye et al., 2004b). The TIN2 protein contains 3 distinct 
binding sites for each binding partner (Chen et al., 2008, Ye et al., 2004a). The binding 
site for TRF1 is located on the C-terminus of TIN2, whereas the N-terminus is 
associated with binding to TRF2. Both binding sites on TIN2 interact with the TRFH 
domain in the corresponding protein. TIN2 recruits TPP1-POT to telomeres using a third 
binding site located in its N-terminus and thereby linking double stranded and single 
stranded telomeric repeats (Chen et al., 2008, Houghtaling et al., 2004, Kim et al., 2004, 
Ye et al., 2004a). Furthermore, TIN2 is an important stabilisation factor for TRF1 and 
TRF2. TIN2 prevents the poly(ADP-ribosyl)ation of TRF1 through tankyrase 1 which 
results in the modification of TRF 1 and consequently in the release of TRF 1 from DNA. 
(Smith et al., 1998, Ye et al., 2004b). In addition, the link, TIN2 forms between TRF1 
and TRF2, further stabilises TRF2’s binding to telomeric DNA (Kim et al., 2004, Ye et 
al., 2004a). In human cells, the expression of TIN2 with a truncated N-terminus leads to
aberrant telomere elongation, whereas the over-expression of TIN2 inhibits telomere 
elongation. This suggests that TIN2 along with TRF1 and TRF2 limits the access of 
telomerase to the chromosome end and therefore acts as a negative telomere length 
regulator (Kim et al., 1999).
1.3.1.3 TPP1
POT1-TIN2 organizing protein (TPP1, also known as TINT1, PTOP or PIP1) was first 
identified by two hybrid screens with TIN2. It acts as a linker protein between POT1 and 
TIN2 (Houghtaling et al., 2004, Liu et al., 2004b, Ye et al., 2004b). The C-terminus of 
TPP1 binds to TIN2 whereas the central domain of the protein interacts with POT1 (Liu 
et al., 2004b, Ye et al., 2004b). Furthermore, a serine rich region is located between the 
two protein binding domains but its function is unknown at the moment (Palm, de Lange 
2008). Recent findings indicate that the N-terminus of TPP1 contains a telomerase- 
interacting domain which implements a role for TPP1 in the telomerase recruitment and 
regulation of telomerase activity at chromosome ends (Xin et al., 2007, Ye et al., 2004a). 
TPP1 is essential for the recruitment of POT1 to telomere. However, several reports 
have claimed that POT1 can localise at chromosome ends in the absence of functional 
TPP1 (Colgin et al., 2003, He et al., 2006). In addition, TPP1 is crucial for proper 
localisation of POT1 in the nucleus (Chen et al., 2007). The expression of a non­
functional TPP1 results in removal of all POT1 from the chromosome end and sub- 
consequently leads to a telomere de-protection and telomere length phenotype which is 
similar to the one observed after POT1 loss (Denchi and de Lange, 2007, Liu et al., 
2004a, Xin et al., 2007).
1.3.1.4 POT1
POT1 (Protection of Telomeres 1) was first identified through its homology to the 
cilicate telomere protein TEBPa (Baumann and Cech, 2001). Human POT1 contains two 
oligonucleotide/oligosaccharide-binding (OB) folds that are highly specific' for 5 -
(T)TAGGGTTAG-3' sequence. Surprisingly, it appears that POT1 only binds to 
telomeric DNA in the presence of TPP1 (Baumann and Cech, 2001, Loayza and De 
Lange, 2003, Loayza et al., 2004). However, several reports have indicated that POT1 
can localise to chromosome ends in the absence of functional TPP1 (Colgin et al., 2003, 
He et al., 2006). In addition, POT1 appears to require TPP1 for nuclear localisation 
(Chen et al., 2007). Knock down of human POT1 caused telomere elongation and only a 
few telomeres fused (34 -37). Moreover, POT1 is thought to stabilise the t-loop 
formation as it binds to the displacement G-strand in the D-loop (Loayza et al., 2004, 
Palm and de Lange, 2008).
13.1.5 Rapl
Human Rapl (Repressor/Activator Protein 1) is recruited to the chromosomal termini by 
TRF2 (Li et al., 2000) and depends on TRF2 to remain stable (Celli and de Lange, 
2005). Rapl contains 3 different domains; a Myb domain to interact with an unknown 
protein partner (Hanaoka et al., 2001), an N-terminal BRACT (BRAC1 C-terminal) 
motif and a C-terminal domain which enables the binding to TRF2 (Palm and de Lange,
2008). In contrast to yeast Rapl, human Rapl does not directly bind to telomeric DNA 
(Li and de Lange, 2003). The exact function of human Rapl has not been established 
yet. Nevertheless based on its structure, human Rapl might be involved in protein- 
protein interactions (Denchi, 2009). However more recent suggest the RAP1 might be 
involved in the inhibition of NHEJ (Bae and Baumann, 2007, Sarthy et al., 2009).
1.3.2 Transient Associated Telomeres Proteins
In contrast to the six shelterin proteins which reside at telomeres throughout the cell 
cycle, several proteins have been reported which transiently associate with chromosome 
ends. Most of these proteins are involved in DNA damage response or DNA damage 
repair. Several components of homologous recombination (HR) have been observed at 
mammalian telomeres. These proteins include the MRN complex (Zhu et al., 2000),
Rad51D (Tarsounas et al., 2004), Blooms syndrome helicase (BLM) (Lillard-Wetherell 
et al., 2004, Opresko et al., 2005, Opresko et al., 2002) and WRN RecQ helicase 
(Crabbe et al., 2004, Opresko et al., 2002). In addition to HR proteins, non-homologous 
end joining (NHEJ) core components associate with telomere (DNA-PKcs (d'Adda di 
Fagagna et al., 2001, Hsu et al., 1999), Ku 70/80 (Hsu et al., 1999, O'Connor et al., 
2004). Other proteins include PinXl (Kim et al., 2004), PARP1 (O'Connor et al., 2004), 
tankyrase 1 and tankyrase 2 (Cook et al., 2002, Smith et al., 1998). Almost all of these 
proteins are recruited to the telomere by TRF1 and TRF2 (Chen et al., 2008, Palm and 
de Lange, 2008).
13.2.1 PinXl
PinXl is a TRF binding protein that directly inhibits telomerase activity. The protein, 
along with its interacting partner MCRS2 (a cell cycle dependant protein that 
accumulates in S-phase), negatively regulates telomeric length, binding directly to 
TERT and TRF 1 (Zhou and Lu, 2001). PinXl binds to the region of TERT that 
associates with TERC RNA subunit with the telomerase complex, thereby preventing it 
association with the RNA telomerase template (Banik and Counter, 2004).
1.3.2.2 Tankyrasel and Tankyrase2
Tankyrase 1 (TNKS) and Tankyrase 2 (TNKS2) are both poly(ADP-ribose) polymerases 
(PARPs) (Cook et al., 2002, Smith et al., 1998). TNKS is a 140 kDA protein which was 
first identified in a yeast two hybrid screen (Smith et al., 1998). TNKS shares 80% of 
overall amino acid content with TNKS2 (Lyons et al., 2001). In humans, TNKS and 
TNKS2 localise to telomeres and are' involved in telomere length maintenance. They 
both interact with and poly(ADP-ribosyl)ated TRF1. The poly(ADP-ribosyl)ation of 
TRF1 inhibits the binding of TRF 1 to telomeres and therefore leaves the chromosome 
termini accessible for telomerase (Cook et al., 2002, Smith and de Lange, 2000, Smith et 
al., 1998). Moreover, TNKS interacts with mitotic apparatus protein NuMA regulating
for mitotic spindle function (Chang et al., 2005). TNKS knockdown cells display defects 
in assembly of bipolar spindles as well as other spindle and microtubule defects (Hsiao 
and Smith, 2008). In addition TNKS is essential for the resolution of sister telomeres 
during mitosis. TNKS deficiency leads to fusion between the two de-protected sister 
chromatids. The sister telomeres are fused by NHEJ (Hsiao and Smith, 2009). TNKS2 
functions are not so clear; it appears it shares similar functions with TNKS however 
further studies are needed to define them (Cook et al., 2002).
1.4 Telomere Repeat Containing RNA (TERRA)
Telomeres establish a heterochromatic state at chromosome ends. Heterochromatin 
states are characterised by the presence of trimethylated lysines at position 9 in histone 
H3 and 20 in histone H4, histone hypoacetylation, the accumulation of several isoforms 
of heterochromation protein 1 and hypermethylation of cytosines in CpG-dinucleotides 
present in subtelomeric regions (Blasco, 2007, Ottaviani et al., 2008). Telomeric 
chromatin states contribute to chromosome positioning and movement within the 
nucleus and also to the regulation of telomerase. Abnormal telomeric chromatin states 
have been linked to severe stochastic telomere loss and thus suggesting a crucial role of 
this structure during telomere replication (Yehezkel et al., 2008, Michishita et al., 2008). 
Recent studies have identified telomeric repeat containing RNA (TERRA) in several 
eukaryotes including yeasts, plants and mammals. TERRA localizes to telomeres 
throughout the entire cell cycle and forms an integral component of telomeric 
heterochromatin. TERRA-associated functions are still mostly a mystery. However, 
several discoveries have been made in TERRA biogenesis (Azzalin et al., 2007, 
Schoeftner and Blasco, 2008, Luke et al., 2008, Luke and Lingner, 2009).
Mammalian TERRA is a heterogeneous non-coding RNA that consists of telomeric 
UUAGGG repeats, and ranges in length from approximately 100 bases up to more than 
9 kb (Azzalin et al., 2007, Schoeftner and Blasco, 2008, Luke and Lingner, 2009). 
TERRA is transcribed in a centromere to telomere direction and contains both telomeric 
and subtelomeric RNA. This may suggest that the transcription site of TERRA lies
-13-
within the subtelomeric sequence. The DNA-dependent RNA polymerase II (RNAPII) is 
thought to be the main polymerase to transcribe TERRA and uses the C-rich telomeric 
strand of the telomere as template. Evidence for this assumption is provided by the fact 
that RNAPII physically associate with mammalian telomeres and with TRF1, a 
sheltering component. Furthermore, a proportion of mammalian and yeast TERRA is 3' 
polyadenylated, a circumstance which is shared with the majority of RNAPII products. 
However, more recent studies indicated that other RNA polymerases like RNAPI and 
RNAPIII may also have a potential function in TERRA transcription (Azzalin et al., 
2007, Schoeftner and Blasco, 2008, Luke and Lingner, 2009, Dejardin and Kingston,
2009).
The non-sense-mediated RNA decay (NMD) machinery, which plays an important role 
in the degradation of mRNAs containing pre-mature termination codons, has been 
implicated in TERRA localisation at human telomeres (Azzaline 2007, Chawla Azzalin 
2008). It has been demonstrated that three of the key players in the NMD pathway 
(UPF1, SMG1 and hESTlA/SMG6) associate directly with telomeres and depletion of 
these proteins results in a significant increase in the amount of TERRA foci at telomeres. 
Furthermore, both TERRA half-life and total TERRA levels were unaffected by the 
depletion of these three proteins (Azzalin et al., 2007, Luke and Lingner, 2009).
1.5 Telomeric Function
1.5.1 Capping the Chromosome termini
Observations in Drosophila melanogaster and in maize (McClintock, 1939, Mueller, 
1938) showed that disrupted chromosomes following X-ray treatments lead to various 
types of chromosomal rearrangements. However the chromosome ends were excluded 
from these alterations. This lead to the hypothesis that chromosomes are capped and this 
“capping” somehow distinguishes the chromosome end from a DNA double strand 
break. Electron microscopy analysis of chromosome ends revealed a large duplex loops
referred to as t-loop which might provide this capping function (Griffith et al., 1999). T- 
loop formation depends on TRF1 and TRF2 which have been proposed to remodel 
telomeric DNA into large loops (Bianchi et al., 1997, Griffith et al., 1999, Stansel et al., 
2001).
In addition to the t-loop, quadruplex (four-stranded) structures might provide a cap for 
the chromosome ends. The quadruplex structures can be formed by sequences of 
telomeric DNA which contain repetitions of the GGTTAG motif. The four individual 
guanines from each strand form planar G.G.G.G tetrad arrangements, consequently 
aligning all four DNA strands parallel, with the three linking trinucleotide loops 
positioned on the exterior of the quadruplex core (Chang et al., 2003, Granotier et al., 
2005, Parkinson et al., 2002, Wang and Patel, 1993). Furthermore, quadruplex 
conformation of telomeric DNA might be able to impair telomerase activity. This 
function depends on small molecules which bind and stabilize quadruplex structures in 
vivo (Gomez et al., 2003, Riou et al., 2003).
1.5.2 Protection from DNA Damage Response (DDR)
One of the key functions of telomeres is protect the chromosome termini from 
inappropriate DNA damage repair and distinguish them from DNA double strand 
breaks. Two members of the shelterin complex, TRF2 and POT1, play a major role in 
the interaction of telomeres with the DNA damage response (DDR). For example, the 
expression of a dominant-negative mutant of TRF2 results in the recognition of 
telomeres as DNA double strand breaks which in turn leads to the activation of the 
ATM/p53 damage response pathway (Karlseder et al., 1999, van Steensel et al., 1998). 
TRF2 is also thought to be capable to directly inhibit the autophosphorylation and self­
activation of ATM and thereby abrogating the ATM signalling pathway (Bradshaw et 
al., 2005, Karlseder et al., 2004). Furthermore, the core shelterin components TRF2 and 
POT1, both repress DNA damage signalling pathways. The two proteins act 
independently from each other. TRF2 prevents the activation of ATM kinase, whereas 
POT1 represses ATR (Denchi and de Lange, 2007). However proteins which are
involved in the detection of DNA damage, DNA damage repair and DDR signalling also 
localise to functional telomeres. Recent studies have shown that functional telomeres 
require the DDR machinery for telomere replication (Denchi, 2009, Dimitrova and de 
Lange, 2009, Verdun et al., 2005, Zhu et al., 2000).
1.5.3 Telomeres in mitosis and meiosis
During meiosis, homologous chromosomes align with each other, recombine and 
synapse. In order to align with each other, chromosomes attach to the nuclear envelop 
(NE) and cluster to form a structure which resembles a bouquet of flowers. The 
“bouquet” formation process has been observed in nearly all eukaryotes except 
Caenorhabditis elegans and Drosophila (Demburg et al., 1995, McKee, 2004, 
Scherthan, 2001). Observations in maize, human and mice indicated that telomeres 
attach randomly to the NE during leptotene and move around the NE until they approach 
each other (Bass et al., 1997, Scherthan et al., 1996). The process appears to be a highly 
active mechanism which is tightly regulated and is switched off in early pachytene. It 
has been assumed that the bouquet formation assists the efficiency of meiotic prophase 
(Harper et al., 2004). In human cells, it appears that that tethering of the chromosome 
termini to the nuclear envelop is dependent on the two TRF proteins (Luderus et al.,
1996).
Meiosis is separated in different stages. In the first stage called lepotene, the de­
condensed clouds of chromatin are organised into long thin fibres. At the end of 
leptotene or the beginning of zygotene, telomeres attach to the NE and cluster together 
forming the bouquet. During the zygotene stage, homologous chromosomes begin to 
associate tightly along their length or synapse when the central element of the 
synatonemal complex is installed. The bouquet formation is perpetuated throughout the 
zygotene phase and into early pachytene. By mid-pachytene, synatonemal complex 
formation is complete and meiotic recombination between homologes is resolved. The 
telomeres are no longer clustered. After the bouquet is dispersed, the cells continue 
through diplotene, when the synatonemal complex disassembles and chiasmata, which
hold the homologous together until anaphase I, become visible. In diakinesis, the 
chromosome under go a final stage of chromosome condensation just before NE 
breakdown and the initiation of metaphase (Harper et al., 2004).
1.6 Telomere dynamics in somatic cells
A majority of eukaryotic somatic cells do not express telomerase and divide only a finite 
number of times (Hayflick limit) before entering a non-dividing nevertheless 
biologically active growth arrest known as replicative senescence (RS) (Allsopp et al., 
1995, Hayflick, 1965). The Hayflick limit is dependent on telomere length and therefore 
cells with longer telomeres have a larger replicative capacity compared to cells with 
shorter telomeres (Allsopp et al., 1992). The telomeric loss of 50 -  200 bp with each cell 
division cycle is progressive and is thought to be a consequence of the end replication 
problem (Baird et al., 2003, Harley et al., 1990, Henderson et al., 1996). This gradual 
attrition of telomeric DNA acts as an intrinsic mechanism to count cell division and is 
therefore thought to be a benchmark for cellular aging. The introduction of active 
telomerase can reverse the end replication problem, avoid the onset of replicative 
senescence and extend the replicative capacity of cells indefinitely (Bodnar et al., 1998). 
In somatic cells, the eroding telomeres gradually loose their telomeric function, until a 
small subset of short telomeres triggers a DNA damage response and replicative 
senescence is induced (Hemann et al., 2001a, Hemann et al., 2001b, Martens et al.,
2000). Replicative senescence is thought to be a potent tumour suppressor mechanism in 
young cells providing a barrier to unlimited cell proliferation. However new evidence 
shows that accumulation of senescent cells in aging tissue can induce cancer progression 
(Campisi and d'Adda di Fagagna, 2007).
1.6.1 The End Replication Problem
Following the discovery of the DNA replication mechanism and the fact that the 
discontinuous or lagging strand requires a RNA-DNA primer to initiate 5 to 3' 
replication, a problem with the semi-conservative replication of linear DNA at the 
chromosomal termini became apparent (Olovnikov, 1971). Whereas the leading strand is 
continuously replicated in a 5' to 3' direction after the firing of the replication origin, the 
delayed synthesis of the lagging strand occurs in short defined Okazaki fragments (50- 
150 nt). A DNA polymerase a/primase complex synthesises a RNA-DNA primer (40 nt, 
including 10 nt of RNA) generating a free 3 -OH group which provides the basis for 5 
to 3' elongation through DNA polymerase 6. The synthesis of a new Okazaki fragment 
is discontinued after pol 5 complex reaches the previous Okazaki fragment. In order to 
produce a continuous DNA strand, two nucleases, RNase HI and FEN1, completely 
remove the initial RNA primer and after filling the small gap between the two 
fragments, the two matured Okazaki fragments are joined by DNA ligase I (Waga and 
Stillman, 1998). However, at the end of the chromosome, the removal of the RNA 
primer from the lagging strand creates an unfilled gap ranging in size from a single RNA 
primer to a complete Okazaki fragment (10 - 150 nt). In consequence the truncated 
lagging strand would drive a gradual shortening of the chromosome end with each 
successive replication cycle. The deliberation was termed the end replication problem 
(Fig 1.3).
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1.6.2 Telomere-dependant Replicative Senescence
With ongoing cell division, the end replication problem results in a progressive loss of 
telomeric DNA, until the short and thus dysfunctional telomeres trigger a DNA damage 
response (DDR). The activated p53 and pl6-pRB tumour suppressor pathway results in 
permanent growth arrest (Gire et al., 2004, Herbig et al., 2004, Takai et al., 2003). 
Similar to DNA double strand breaks, DNA damage sensors such as p53 binding protein 
1 (53BP1), mediator of DNA damage checkpoint 1 (MDC1), Rad 17 and 
Mrell/RAD50/NBS1 complex are recruited to the chromosome termini (d'Adda di 
Fagagna et al., 2003, Takai et al., 2003). The sensor proteins recruit the protein kinases, 
ataxia telangiectasia mutated (ATM) and ATM and RAD3-related (ATR), to the 
chromosome termini (Shiloh, 2006). In a positive feedback loop, ATM and ATR trigger 
the phosphorylation of heterochromatin variant H2AX (yH2AX) (dAdda di Fagagna et 
al., 2003, Takai et al., 2003) The DNA damage signal is amplified by the 
phosphorylation of secondary kinase like Chkl and Chk2 (Jackson et al., 2002) which in 
return activate p53 and cell division cycle 25 (CDC25). DDR primarly induces 
replicative senescence through the p53 pathway. However depending on the cell type or 
species, DDR can also permanently arrest cells through the pl6-pRB pathway (Campisi 
and d'Adda di Fagagna, 2007).
1.6.3 Telomere-independent Replicative Senescence
Telomere erosion is not the sole cause of replicative senescence. Also oxidative stress, 
DNA damaging agents and oncogene over expression can induce premature replicative 
senescence and thereby limit the replicative lifespan of human fibroblasts significantly 
(Dumont et al., 2000, Robles and Adami, 1998, Serrano et al., 1997). Replicative 
senescence caused by the end replication problem can be circumvented by the ectopic 
expression of TERT, the catalytic protein component of human telomerase (Bodnar et 
al., 1998). However telomerase can not prevent replicative senescence caused by other 
senescence inducers (Campisi and d'Adda di Fagagna, 2007, Chen et al., 2001).
Accumulation of DNA damage causes many cell types to undergo senescence (Di 
Leonardo et al., 1994, Parrinello et al., 2003). Like telomere dependent senescence, 
DNA damage induced sensences relies on p53 and are usually accompanied by 
expression of p21 (Di Leonardo et al., 1994, Herbig et al., 2004). This gave rise to the 
hypothesis that DNA damage inducing chemotherapy might cause senescence in tumour 
cells. However, tumour cells with functional p53 are more likely to senesce than the 
ones with mutated p53, at least in cell culture or cancer-prone mouse models (Roberson 
et al., 2005, Schmitt et al., 2002).
The forced over-expression of active oncogenes in normal cell leads to premature 
senescence. The transformation of human primary cells with ras, a cytoplasmic 
transducer of mitogenic signals results in an early onset of cellular senescence (Serrano 
et al., 1997). Similar results were achieved following the over-expression of other 
members of the ras signalling pathway (Lin et al., 1998, Michaloglou et al., 2005, Zhu et 
al., 1998) and the proliferative nuclear proteins like E2F-1 (Dimri et al., 2000). Since 
oncogenes like member of the ras signalling pathway stimulate cell growth and therefore 
can drive uncontrolled cell proliferation, it is assumed that oncogene induced senescence 
evolved as a tumour suppressor mechanism, preventing tumourgenesis (Braig and 
Schmitt, 2006). Similar to telomere-dependent senescence, oncogene-induced 
senescence elicits a DNA damage response (DDR). However, DDR plays a significant 
role in initiation and maintaining oncogene-induced senescence, since down-regulation 
of DDR components results in cell proliferation and oncogenic transformation (Di 
Micco et al., 2006).
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1.7 Telomeric Elongation
1.7.1 Telomerase
Telomerase is a ribonucleoprotein reverse transcriptase (RT) that synthesises telomeric 
repeats in germline cells and cancer cells. Like telomeric repeats, telomerase was first 
identified in Tetrahymena thermophilia (Greider and Blackburn, 1985). Since then 
telomerase activity has been detected in protozoa (Shippen-Lentz and Blackburn, 1989, 
Zahler and Prescott, 1988), in fungi (Cohn and Blackburn, 1995, Lingner et al., 1997) 
and mammals (Morin, 1989, Prowse et al., 1993).
Active human telomerase consist out of 3 core elements, the telomerase RNA 
component (TERC), the reverse transcriptase telomerase (TERT) and the TERC-binding 
protein dyskerin (DKC1) (Fig 1.4). In addition to the core elements, several species- 
specific accessory proteins are associated with active telomerase forming a holoenzyme. 
These species-specific accessory proteins control the biogenesis, cellular localisation 
and function of telomerase (Wyatt et al.). Amongst these proteins in humans are the two 
NTPase proteins NHP2 and NOP 10; the two closely related ATPases potin and reptin; 
and TCAB1 (telomerase Cajal body protein 1) (Cohen et al., 2007, Fu and Collins, 2007, 
Venteicher et al., 2009, Venteicher et al., 2008).
Dyskerin is a putative pseudouridine synthase, which also recognizes the H/ACA 
sequence motif. This motif can be found in TERC (Mitchell et al., 1999). Dyskerin 
functions to support telomerase biogenesis and TERC stability (Mitchell et al., 1999). 
Recent reports indicate that dyskerin, NHP2 and NOP 10 are necessary for the 
accumulation and stabilisation of TERC (Fu and Collins, 2007). Pontin interacts directly 
with both TERT and dyskerin. The amount of TERT bound to pontin and reptin peaks 
in S phase, providing evidence for cell-cycle-dependent regulation of TERT. Depletion 
of pontin and reptin markedly impairs TERT accumulation, indicating an essential role 
in telomerase assembly. These findings suggest an alternative approaches for inhibiting
telomerase in cancer (Venteicher et al., 2008). The depletion of TCAB1 by using RNA 
interference prevents TERC from associating with Cajal bodies, disrupts telomerase- 
telomere association, and abrogates telomere synthesis by telomerase. Thus, TCAB1 
controls telomerase trafficking and is required for telomere synthesis in human cancer 
cells (Venteicher et al., 2009).
Telomerase is stringently repressed in the majority of somatic cells with the exception of 
a low activity level in S-phase, which may participate in the maintenance of the 
telomeric overhang in normal human cells (Dionne and Wellinger, 1998). In contrast to 
normal human cells, 90% of all human cancer display telomerase re-activation (Broccoli 
et al., 1997, Broccoli et al., 1995, Kim et al., 1995). TERC is constitutively expressed in 
all types of tissue, whereas the expression of hTERT is a highly regulated (Kolquist et 
al., 1998, Masutomi and Hahn, 2003). However, the level of telomerase activity and 
telomere length is not related to the expression levels of hTERC and hTERT (Swiggers 
et al., 2004). Telomerase elongates telomeres by catalysing multiple rounds of copying 
its own RNA template. In the first step, the telomere RNA template anneals to the free 3 
end of the DNA substrate. In the second step, new nucleotides are added to the DNA 
substrate until the'5end of the template sequence is reached. In the final step, 
telomerase relocates and realigns to the newly synthesised '3end where the next round 
of telomere synthesis is initiated (Greider and Blackburn, 1996, Wyatt et al.).
Cajal body
b)
Figure 1.4 Telomerase. a) telomerase holoenzyme in a Cajal body outside o f S phase (m odified from 
Venteicher 2009). b)
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1.7.2 Alternative Lengthening of Telomeres (ALT)
Alternative lengthening of telomeres (ALT) has been described in 15% of all human 
cancers, where telomerase activity is un-detectable. Telomere length maintenance in 
these cancers occurs through homologous recombination and the mis-regulation of 
normal telomere homeostasis (Bryan et al., 1997, Dunham et al., 2000, Muntoni and 
Reddel, 2005). Phenotypic characteristics of ALT cell lines and tumours include an 
abundance of extrachromosomal telomeric DNA which might presents itself as double­
stranded telomeric circles (t-circles) (Cesare and Griffith, 2004, Wang et al., 2004). 
Telomeric DNA (either extrachromosomal or chromosomal) and associated proteins can 
be found in promyelocytic leukaemia nuclear bodies (PML nuclear bodies). PML bodies 
which contain telomeric chromatin are highly characteristic for ALT cells and are 
therefore also referred to as ALT-associated PML bodies (APBs) (Yeager et al., 1999). 
APBs are large nuclear structures which co-localises with telomeric DNA and telomere 
binding proteins TRF1 and TRF2. Promyelocytic leukaemia proteins are essential for the 
accumulation of p53 in response to DNA damage. These proteins display a neutralizing 
effect on the negative p53 regulator Mdm2 (Louria-Hayon et al., 2003). APBs also 
contain replicative factor A, RAD51, RAD52 and the MRN complex, all proteins 
involved in DNA synthesis and recombination (Wu et al., 2000, Yeager et al., 1999, Zhu 
et al., 2000). APBs might drive the homologous recombination resulting in ALT, 
although there is still a debate of APBs exact function.
1.8 Telomeres and Disease
Telomere dysfunction can lead to genomic instability. Direct evidence has been 
observed in telomerase deficient p53 mutant mice. Telomere erosion in ageing 
telomerase-deficient p53 mutant mice results in repetitive cycles of fusion-bridge 
breakage and consequently leads to the formation of complex non-reciprocal 
translocations. This process facilitates the progression of epithelial cancers (Artandi et 
al., 2000). Furthermore, severe chromosomal instability, as a result of non-functional
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telomeres, promotes secondary genetic changes which in turn promote carcinogenesis 
(Artandi and DePinho, 2000b). Some genomic instability syndromes are caused by 
mutated genes which directly interfere with telomere dynamics. The resulting telomere 
instability has a major effect upon the integrity of the chromosome. However, in most 
cases, it is not entirely clear how the mutated gene interferes with telomere biology.
1.8.1 Cancer
A cancer cell is described as a cell which grows out of control, ignoring signals to stop 
dividing and is unable to recognize its own natural boundaries. Cancer progression is 
thought to be a somatic evolution, in which certain mutagens give rise to a cell which 
has selective proliferative advantages (Cahill et al., 1999). Current opinion states that 
most cancers derive from rare stem cells that are able to proliferate indefinitely. These 
stem cells promote carcinogenesis through improper homeostatic mechanisms that 
govern tissue repair and stem cell self-renewal (Beachy et al., 2004, Reya et al., 2001). 
Telomerase negative cells lose their telomeric function due to the gradual attrition of 
their telomeres which results in non-reciprocal translocations and chromosomal fusion 
events. These cells may evade replicative senescence by circumventing the p53 and pRB 
checkpoints and therefore driving the formation of cancer (Artandi and DePinho, 2000a, 
Chin et al., 1999, Hara et al., 1991).
Most cancer cells and tumours maintain their telomere length through re-activation of 
telomerase (Holt and Shay, 1999, Kim et al., 1994, Shay and Bacchetti, 1997). The 
expression of the hTERC and hTERT telomerase subunits is up regulated in almost all 
human malignant tumours. Therefore, telomerase activity is a significant indicator of 
outcome and progression of cancer (Hiyama and Hiyama, 2002, Hiyama et al., 2004, 
Keith, 2003). Subsequently telomerase is a prime target for developing anti-cancer 
therapies (Keith et al., 2004).
In contrast to the cancers types which avoid senescence via activation of telomerase,
15% of all human cancers maintain their telomere length by one or more mechanisms
named alternative lengthening of telomeres (ALT) (Bryan et al., 1997, Dunham et al., 
2000, Muntoni and Reddel, 2005). ALT is predominant in tumours of mesenchymal 
origin indicating a tendency of mesenchymal stem cells to activate ALT (Lafferty- 
Whyte et al., 2009). Other tumours types display ALT include glioblastoma multiform 
(most common form of malignant brain tumour in adults), osteosarcoma and some type 
of soft tissue sarcoma (Cesare and Reddel, 2010).
Telomerase activity alone does not always immortalise cells (Kiyono et al., 1998). For 
many cancers, telomerase re-activation is a late stage event. The exact contribution of 
telomerase to cancer development and progression, apart from telomere maintenance, is 
not clearly defined (Blasco and Hahn, 2003).
1.8.2 Telomere Dysfunction in Disease
1.8.2.1 Dyskeratosis Congenita
Dyskeratosis Congenita (DC) is an inherited disease which is characterised by abnormal 
skin pigmentation, bone marrow failure, nail dystrophy and leucoplakia (Marrone and 
Mason, 2003, Mason, 2003). Two distinct types of dyskeratosis congenita have been 
observed; X-linked recessive DC and autosome dominant DC. The X-linked form is 
linked to mutations in the DKC1 gene at Xq28. The encoded protein, dyskerin, is 
associated with a sub group of both small nucleolar RNAs and the RNA component of 
the telomerase complex (TERC) (Mitchell et al., 1999). The autosomal dominant form 
of the disease is caused by mutations in TERC itself (Vulliamy et al., 2001), in the 
catalytic subunit of telomerase TERT (Vulliamy et al., 2005) and in the member of the 
shelterin complex TIN2 (Savage et al., 2008). Both dyskeratosis congenital forms 
feature short dysfunctional telomeres.
1.8.1.2 Bloom’s Syndrome
Bloom’s syndrome (BS) is an autosomal recessive disorder and is characterized by 
stunted growth, sun sensitive telangiectasia skin, severe impaired immune response and 
a predisposition to cancer (Bloom, 1954). Cellular key features of BS patients are very 
high levels of sister chromatide exchange (SCE) after treatment with DNA damaging 
agents (German et al., 1977) and symmetrical quadriradials, chromosomal re­
arrangements between homologous chromosomes at homologous sites (German et al., 
1965). The affected protein in BS is a RecQ ATP-dependent DNA helicase (Ellis et al., 
1995, Karow et al., 1997). The BLM helicase is involved in homologous recombination, 
Holliday branch migration and is essential for genome stability (Karow et al., 2000, Wu 
et al., 2001). POT1 stimulates WRN and BLM to unwind long telomeric duplexes and 
D-loop structures. This suggests that the two helicases are involved in resolving of 
telomeres and possibly protecting the free 3' overhang during the DNA unwinding 
(Opresko et al., 2005). BLM co-localises with TRF2 in ALT. cells suggesting a possible 
role for BLM in ALT telomere maintenance (Lillard-Wetherell et al., 2004).
1.8.2.3 Ataxia Telangiectasia
Ataxia Telangiectasia (AT) is a rare recessive disease caused by mutations in the ataxia 
telangiectasia mutated (ATM) gene on chromosome llq22 (Savitsky et al., 1995). The 
clinical symptoms include progressive neurodegenerative dysfunction, 
immunodeficiency, radiation sensitivity, ocular telangiectasia, hypogonadism, genome 
instability and a predisposition to cancer (Kastan and Lim, 2000, Lavin and Shiloh, 
1997, Meyn, 1999, Savitsky et al., 1995). Furthermore, patients with AT have a short 
stature and display signs of premature aging such as grey hair, wrinkled skin, skin 
atrophy and sclerosis (Lavin and Shiloh, 1997, Savitsky et al., 1995). The ATM kinase is 
involved in mitogenic signal transduction, cell cycle control and DNA damage response 
(Hoekstra, 1997, Kastan and Lim, 2000). AT patients appear to have accelerated 
telomere attrition as well as an elevated number of chromosomal fusion events (Metcalfe
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et al., 1996). Fibroblasts derived from patients with AT undergo early senescence and 
are sensitive to oxidative stress (Tchirkov and Lansdorp, 2003).
1.8.1.4 Werner Syndrome
«r*
Wemer Syndrome (WS) is an autosomal recessive disease caused by mutations in the 
WRN gene located on chromosome 8p (Yu et al., 1996). Clinical features of WS include 
cataract skin atrophy, soft tissue calcifications, type II diabetes, atherosclerosis and 
osteoporosis, all indicators of old age (Martin, 1982). In addition, WS is associated with 
genomic instability and an early onset of cancer (Davis and Kipling, 2009). In line with 
the premature aging, 90% of all WS cells prematurely senescence (Tollefsbol and 
Cohen, 1984). Initially this was thought to be a consequence of accelerated telomere 
attrition (Faragher et al., 1993, Schulz et al., 1996), However STELA analysis of clonal 
WS cultures disproved this hypothesis, showing that WS fibroblast erode at similar rates 
then normal fibroblasts (Baird et al., 2004). The reason why WS fibroblasts display an 
attenuated replicative capacity is not understood so far, but may involve replicative 
stress (Davis et al., 2005). WS cells tend to develop chromosomal rearrangements 
including translocations, inversions, and deletion (Salk, 1982). Furthermore, the cells 
display an increased frequency of chromosomal deletions (Fukuchi et al., 1989).
1.8.1.5 Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a normally fatal lung disorder with a so far 
unknown pathogenetic mechanism. Its main symptom is progressive scarring (fibrosis) 
of the supporting framework of both lungs, which results in an irreversible destruction of 
the lung’s architecture (Selman and Pardo, 2002). The disease appears to be age related, 
with most cases diagnosed in patients older than 50. IPF is caused by heterozygous 
mutations in TERT or TERC which result in short telomeres (Alder et al., 2008, 
Armanios et al., 2007).
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1.9 DNA Repair Mechanism
DNA double strand breaks (DBSs) and single-strand breaks (SSBs) are an every day 
occurrence in primary human fibroblasts caused by ionising radiation, ultraviolet light, 
reactive oxygen species, errors during DNA replication, enzymes during meiosis and 
V(D)J recombination. The repair of these DSBs and SSBs is essential to maintain 
genomic fidelity and stability. In order to combat DBSs and SSBs, cells have developed 
multiple distinct DNA repair mechanisms which detect damaged DNA, signal its 
presence and promote the repair of the damage (Jackson and Bartek, 2009, Weterings 
and Chen, 2008). One of these mechanisms is base excision repair (BER). BER is a 
multi-step process that corrects non-bulky damage to bases resulting from oxidation, 
methylation, deamination, or spontaneous loss of the DNA base itself. In BER, DNA 
glycosylase recognises the damaged base and mediates base removal before proliferating 
cell nuclear antigen (PCNA), polymerase (3 and DNA ligase I or DNA Ligase III 
complete the repair process (Jackson and Bartek, 2009, David et al., 2007, Hoeijmakers,
2001). Nucleotide excision repair (NER) is perhaps the most flexible of the DNA repair 
pathways. NER recognises and repairs lesions which are caused by helical distortion of 
the DNA duplex and pyrimidine dimers (cyclobutane pyrimidine dimers and 6-4 
photoproducts) which are caused by the UV component of sunlight. Other NER 
substrates include bulky chemical adducts, DNA intrastrand crosslinks, and some forms 
of oxidative damage. Two distinct NER pathways exist: transcription-coupled NER 
which focuses on lesion blocking transcriptions and global genome NER which surveys 
the entire genome for distorting damage (Jackson and Bartek, 2009, David et al., 2007, 
Hoeijmakers, 2001, Loeb and Monnat, 2008). DNA mismatch repair (MMR) pathway 
plays an essential role in the correction of replication mistakes such as base-base 
mismatches resulting from errors of DNA polymerases which escaped the proof reading 
function and insertion/deletion loops caused by template slippage. Mutations in several 
human MMR genes can cause a predisposition to hereditary nonpolyposis colorectal 
carcinoma (HNPCC), as well as a variety of sporadic tumours that display microsatellite 
instability (Jackson and Bartek, 2009, David et al., 2007, Hoeijmakers, 2001, Loeb and 
Monnat, 2008, Jiricny, 2006).
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In eukaryotes, DSBs are repaired by either homologous recombination (HR) or non- 
homologous end joining (NHEJ). Both pathways require the MRN complex to bind to 
unprocessed DNA breaks, tethering the ends and aligning them for DSB repair 
(Williams et al., 2008). The error-free HR is limited to late S and G2 phase and utilises 
homologous repeat sequences like the sister chromatids to repair DNA damage. NHEJ- 
mediated DNA repair is relatively error-prone and is composed of two distinct pathways 
termed classic NHEJ (C-NHEJ) and alternative NHEJ (A-NHEJ). C-NHEJ can be 
observed throughout the cell cycle and is dependent on Ku70/80 and DNA Ligase 
IV/XRCC4. In contrast, A-NHEJ is associated with G2 phase and requires PARP1 and 
DNA ligase III/XRCC1 or DNA ligase I (San Filippo et al., 2008, Weterings and Chen,
2008)(Fig 1.5).
1.9.1 Homologous Recombination
Homologous recombination (HR) is a very accurate DNA repair mechanism and is 
restricted to the S and G2 phase of the cell cycle (Hartlerode and Scully, 2009). HR is 
initiated after a DSB has appeared. After the DSB formation, the DNA ends are 
processed by nucleolytic resection to give single-strand tails with free 3'-OH ends. These 
ends become the substrate for the HR protein machinery in order to form the 
recombinase filament on the single stranded DNA end. After a successful homology 
search, strand invasion occurs to form a nascent D-loop intermediate. DNA polymerase 
synthesizes new DNA and thereby extents from the 3 end of the invading strand. The 
second DSB is captured to form a D-loop intermediate, which contains two crossed 
strands or Holliday junctions. The reaction is completed by gap-filling DNA synthesis 
and ligation. Finally Holliday junctions are resolved to give a crossover and non­
crossover product (Fig. 1.5 A) (Weterings and Chen, 2008, Rass et al., 2010).
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1.9.1.1 MRN Complex
The three members of the MRN complex were first observed in S. cerevisiae via screens 
for genes involved in meiotic recombination and resistance to DNA damage (Ogawa et 
al., 1995). The first member of MRN complex is Mrel 1, a highly conserved 70-90 kDA 
protein which is composed of an N-terminal phosphoesterase domain and two C- 
terminal DNA-binding domains (D'Amours and Jackson, 2002, Williams et al., 2007). 
Mrell possess an intrinsic DNA binding activity and endo- and exonuclease activities 
against single-stranded and double stranded DNA (Pauli and Gellert, 1999). Mrell 
forms homodimers and binds specifically to open ends of DSBs (Williams et al., 2008). 
The endonuclease activity of the Mrel 1 has been observed in HR and NHEj-dependent 
DNA repair (Milman et al., 2009, Zhuang et al., 2009). The second member, Rad50, is a 
150 kDA protein which also binds to double stranded DNA ends. The protein partially 
unwinds the double stranded DNA via its ATP-binding cassette (ABC)-type ATPase 
domain which is formed by the stable association of the N-terminal Walker A and C- 
terminal Walker B nucleotide binding motifs of RAD50 (de Jager et al., 2001, Hopfher 
et al., 2001, Hopfher et al., 2000). NBS1 is the third member of the MRN complex. The 
protein contains a N-terminal fork head associated domain (FHD) and two breast cancer 
C-terminal (BRCT) domains. The FHD domain binds DNA damage proteins Mdcl and 
Ctpl whereas the BRCT domains are involved in the recruitment of repair and 
checkpoint proteins to DSBs (Lloyd et al., 2009, Williams et al., 2009). NBS1 also 
contains an ATM binding domain which recruits ATM to DSBs. Moreover, several 
conserved sequences in the central region are phosphorylated by ATM as part of the 
DNA damage response (Falck et al., 2005, You and Bailis, 2010). Mrell, RAD50 and 
NBS1/Xrs2 were shown to interact physically with each other (Trujillo et al., 1998). 
Each subunit of the Mrel 1 dimer binds one Rad50 molecule creating the Mrel l2Rad502 
core of the MRN complex (de Jager et al., 2001, Hopfher et al., 2001). The 
Mrell2Rad502 core complex is recruited to the end of double stranded DNA and its 
coiled-coil arms tether the DNA termini together. This function depends on the protein 
concentration. It is believed that the Mrell dimer facilitates short-range interaction 
while Rad50 enables long-range tethering of DNA ends (Hopfher et al., 2002, Williams
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et al., 2008). NBS1 interacts with Mrel 1 and is responsible for the translocation of the 
Mrell2Rad502 complex from the cytoplasm into the nucleus (Desai-Mehta et al., 2001, 
Williams et al., 2009).
The MRN complex has multiple roles in DNA damage repair, checkpoint activation, 
telomere maintenance, meiosis and DNA replication. Firstly, MRN acts as an early 
sensor on DSBs in the DNA damage response activating the signal transduction 
cascades that lead to cell cycle checkpoints (Petrini and Stracker, 2003). Furthermore the 
MRN complex in association with other proteins like CtIP shifts the DNA damage 
sensing to DNA repair (You and Bailis, 2010). In addition, the MRN complex plays a 
pivotal role in telomere maintenance. Both Mrell and NBS1 sequester at telomeres in 
meiotic human fibroblasts. The MRN complex associates with TRF2 though out the cell 
cycle, where as NBS1 only accumulates at telomeres in S-phase (Lombard and 
Guarente, 2000, Verdun et al., 2005, Zhu et al., 2000). Further investigation showed that 
knockdown of Mrell or NBS1 reduces the length of the 3' G-overhangs of telomeres, 
demonstrating that MRN can promote telomere function by recruiting telomerase to 
fully capped telomeres (Verdun et al., 2005, Zhu et al., 2000). On the other hand, several 
report showed that the MRN complex can prevent the fusion of newly replicated 
telomeres by activating the ATM signalling in order to induce a DNA damage response 
(Attwooll et al., 2009, Dimitrova and de Lange, 2009, Deng et al., 2009). Moreover, 
studies of dysfunctional telomeres following the abolishment of TRF2 have revealed that 
depending on the stage of the cell cycle, MRN can either promote or suppress NHEJ- 
mediated fusion of short dysfunctional telomeres (Deng et al., 2009, Dimitrova and de 
Lange, 2009).
1.9.2 Classic Non-homologous End Joining (C-NHEJ)
The core elements in mammalian classic NHEJ are the heterodimer Ku70/80, the 
catalytic subunit of DNA-dependent protein kinase (DNA-PkcS), and the DNA Ligase IV 
-  XRCC4 complex. The mechanism for C-NHEJ is presented in Fig 1.5 B. C-NHEJ is 
initiated by the binding of the Ku70/80 heterodimer to two broken ends of the DSB. The 
two Ku heterodimers are presumed to provide a scaffold for the members of C-NHEJ
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and thereby allowing the modification of both DNA ends in preparation for joining. The 
two Ku proteins in turn recruit DNA-PKcs, thus linking the two DNA ends and thereby 
forming the active DNA-PK complex. Active DNA-PK interacts with different 
nucleases and polymerases and starts DNA processing by phosphorylating several 
proteins like Ku and itself. In a final step, the DNA ligase IV/XRCC4 complex is 
recruited, further stabilising the broken DNA ends and finally mediating the rejoining of 
the modified break side. The recently discovered XLF/Cemunnos protein is thought to 
enhance the ligation process (Lieber, 2010, Lieber, 2008, Weterings and Chen, 2008).
1.9.2.1 Ku 70/80 Heterodimer
The Ku 70/80 heterodimer was first identified in patients suffering from polymyositis- 
scleroderma overlap syndrome, The Ku complex is one of the most abundant nuclear 
proteins and is formed by Ku70 and Ku 80 subunits (Ma et al., 2005, Mimori et al., 
1981). The Ku heterodimer has roles in DNA replication, transcription regulation and 
telomere maintenance (Cohen et al., 2004, Sawada et al., 2003). Ku70/80 is one of the 
core components of the C-NHEJ repair pathway. The protein complex displays a strong 
binding affinity to double stranded DNA. It binds to blunt ends, toarfd 3' single 
stranded overhangs or to hairpin structures (Arosio et al., 2002, Dynan and Yoo, 1998).
Ku70 and Ku80 proteins share a similar structure. Both contain a N-terminal a/p 
domain, a central P-barrel domain and a helical C-terminus arm. The central p-barrel 
domains of the two proteins form a double ring which encircles the DNA molecule. The 
N-terminal and C-terminal domains of Ku70 and Ku80 for binding of other DNA repair 
proteins (Walker et al., 2001).
In classic NHEJ, Ku70/80 is implicated to be involved in strand alignment and synapsis, 
suppression of exonuclease resection, end ligation and the recruitment of further DNA 
processing factors. The Ku complex initiates C-NHEJ by the binding to two broken ends 
of the DSB (Lieber et al., 2003, Ma et al., 2005). Furthermore, the Ku70/80 heteromer 
contributes to protecting DSBs from nucleolytic processing. Several reports have shown
that the absence of functional Ku70/80 leads to excessive end processing resulting in the 
deletion of large segments of DNA (Boulton and Jackson, 1996, Feldmann et al., 2000, 
Li and Comai, 2002). Besides, it has been reported, the Ku complex might also 
encourage break ligation by on the one hand sterically aligning the two DNA ends 
(Kysela et al., 2003, Ramsden and Gellert, 1998) and on the other hand recruiting the 
DNA Ligase IV/XRCC4 complex (Chen et al., 2000, Nick McElhinny et al., 2000). In 
addition the Ku complex stimulates the association of polymerase p and 8 with DNA 
fragments. Both polymerases are implicated in gap filling during the alignment of DNA 
ends (Ma et al., 2004).
1.9.2.2 DNA-PKcs
The DNA-dependent protein kinase catalytic subunit (DNA-PKcS) is a member of the 
phosphoinositide-3-kinase-related family, which includes ATM and ATR DNA damage 
signalling proteins. The large protein kinase, consisting of 4128 amino acids (aa), has a 
molecular weight of 469 kDA (33, 85-87). DNA-PKcs associates with the Ku70/80 
heterodimer and forms a catalytic active DNA-PK holoenzyme (Falck et al., 2005). The 
kinase activity of DNA-PKcs is activated upon interaction with a free DNA. The protein 
can bind to DNA fragments in absence of the Ku complex. However its kinase activity 
appears to be much lower (Hammarsten and Chu, 1998). DNA-PKcs mediates the 
synapsis and ligation of the two DNA fragments (Block et al., 2004, DeFazio et al., 
2002, Kysela et al., 2005). The auto-phosphorylation of DNA-PKcs results in the 
remodelling of DNA-Pk (Block et al., 2004). Moreover, DNA-PK phosphorylates the 
histons H2AX and HI.This might indicate that DNA-PK modifies chromatin structure to 
facilitate the access of other DNA repair complexes to DSBs (Kysela et al., 2005).
1.9.2.3 Artemis
The endonuclease Artemis was first recognised as an essential factor in V(D)J 
recombination, stimulating the opening of hairpin structures (Moshous et al., 2001,
Rooney et al., 2002). However following the observation that Artemis deficiency leads 
to ionizing radiation (IR) sensitivity, it became apparent that Artemis might play a role 
in DSB repair (Ma et al., 2002). Purified Artemis protein displays single-strand-specific 
5' to 3' exonuclease activity. Following the recruitment of Artemis to the DSB by DNA- 
PKcs, Artemis acquires endonuclease activity on 5 and 3' overhangs, as well as hairpin 
structures (Ma et al., 2002). Furthermore, Artemis is phosphorylated by both the ATM 
kinase and to a minor extent by DNA-PK^ kinase (Dahm, 2007). However it is not 
clear, if this phosphorylation of Artemis is essential for the activation of the 
endonuclease activity as observations are contradictory (Weterings and Chen, 2008).
1.9.2.4 DNA Ligase IV/XRCC4 complex
DNA Ligase IV and XRCC4 form a complex which is essential for C-NHEJ. The 
complex mediates the final ligation of the processed DNA ends (Lieber, 2010, Lieber, 
2008, Weterings and Chen, 2008). DNA Ligase IV and XRCC4 deficiency is lethal in 
mice (Barnes 1998, Gao 1998). Crystallographic analysis of the DNA Ligase IV/XRCC4 
complex revealed that one DNA Ligase IV protein binds to two XRCC4 proteins 
(Sibanda et al., 2001). XRCC4 is crucial for DNA Ligase IV activity as it stabilises the 
localisation of DNA Ligase IV at DSBs (Bryans et al., 1999, Chen et al., 2000, 
Costantini et al., 2007). Interaction between Ku70/80 and the DNA Ligase IV/XRCC4 
complex is important for efficient NHEJ (Nick McElhinny et al., 2000). DNA-PKcs also 
interacts with XRCC4, providing further stability to the ligation process (Chen et al., 
2000, Costantini et al., 2007).
1.9.2.5 XLF/Cernunnos
XRCC4-like factor (XLF) or Cemunnos is the most recently identified component of C- 
NHEJ (Ahnesorg et al., 2006, Buck et al., 2006).The 33 kDa protein displays sequence 
and structural homology to XRCC4 (Andres et al., 2007). It is assumed that 
XLF/Cernunnos is recruited by the Ligase IV/XRCC4 complex to the DSB where it 
either enhances or modulates the efficiency of the ligation reaction (Ahnesorg et al.,
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2006). Furthermore, the presence of XLF/Cemunnos facilitates the joining of mis­
matched and non-cohesive DNA ends, thereby limiting the nucleotide loss through C- 
NHEJ (Ahnesorg et al., 2006, Tsai et al., 2007, Weterings and Chen, 2008).
1.9.3 Alternative Non-homologous End Joining (A-NHEJ)
Recent studies described an alternative non-homologous end-joining (NHEJ) pathway 
which is independent of DNA-PKcs and Ku70/80. Instead the pathway relies on 
poly(ADP-ribose) polymerase 1 (PARP-1) and XRCC1/DNA Ligase III complex 
(Audebert et al., 2004, Audebert et al., 2006, Wang et al., 2005). This slower back-up 
process (A-NHEJ) can be observed in wild-type cells and cells with defects in DNA-PK 
dependent NHEJ (C-NHEJ). The pathway utilizes microhomologies and is prone to 
missjoining (Roth and Wilson, 1986, Verkaik et al., 2002). In addition, the joining 
process is biased to a high G:C content at the joining point (Audebert et al., 2008).
1.9.3.1 PARP
Poly(ADP-ribose) polymerase 1 (PARP1) generates large chains of poly(ADP-ribose) 
(pADPr or PAR), a polymer composed of two ribose moieties and two phosphates. 
Poly(ADP-ribosyl)ation through PARP1 transfers ADP-ribose subunits from 
nicotinamide adenine dinucleotide (NAD+) to target proteins forming long pADPr 
polymers (Kameshita et al., 1984, Rouleau et al., 2010).
The nuclear protein PARP1 is comprised of three functional domains. The N-terminal 
end contains a DNA-binding domain consisting of three zinc fingers of which two are 
essential for single stranded and double stranded DNA binding (Gradwohl et al., 1990, 
Hassa and Hottiger, 2008). The third one plays an important role in linking damage 
induced alterations in the DNA binding domain to changes in the PARP catalytic 
activity (Langelier et al., 2008, Tao et al., 2008). The central domain allows the auto- 
poly(ADP-ribosyl)ation of PARP 1 (Altmeyer et al., 2009, Tao et al., 2009). It contains a
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BRCA1 carboxy-terminal (BRCT) domain which can be found in many members of the 
DNA damage response pathway (Rouleau et al., 2010). The catalytic domain of PARP 1 
is located at the C-terminus, executing the poly(ADP-ribosyl)ation of target proteins 
(Kameshita et al., 1984).
Following the induction of DNA damage, PARP1 is rapidly recruited and starts 
immediately to transfer ADP-ribose subunits from NAD+ to the receptor, thereby 
creating large pADPr chains (Haince et al., 2008, Hassa and Hottiger, 2008), However, 
most of the pADPr ribbons are attached to PARP1 itself. The pADPr polymers initiate 
the recruitment of other proteins to the DSB (Ahel et al., 2009, Kraus, 2009, Timinszky 
et al., 2009). Some of these proteins like XRCC1 bind directly to pADPr (Masson et al., 
1998). Furthermore, the auto-poly(ADP-ribosyl)ation of PARP1 creates an auto- 
regulatory feedback loop as the synthesis of pADPr diminished the binding affinity of 
PARP for DNA. pADPr polymers provide a mechanism to remove PARP1 from the 
DSB allowing access of other DNA repair proteins and consequently inhibiting further 
poly(ADP-ribosyl)ation (Kraus, 2009, Satoh and Lindahl, 1992, Timinszky et al., 2009).
In addition to recognising DNA damage, PARP1 is involved in the rapid recruitment of 
MRN and ATM (Haince et al., 2007, Haince et al., 2008), indicating PARP1 is involved 
in HR, in NHEJ (Audebert et al., 2004, Veuger et al., 2004, Wang et al., 2004), in 
BER(Masson et al., 1998), and in the restarting of the replication fork (Bryant et al., 
2009).
1.9.3.2 XRCC1
X-ray cross-complementing group 1 (XRCC1) is a 70 kDA protein which contains 3 
domains: a C-terminal BRCT II domain, a central BRCT I domain and an N-terminal 
DNA binding domain. XRCC1 has no known enzymatic activity (Mani et al., 2004, 
Marintchev et al., 1999). The protein associates easily with nicked and gapped DNA, 
implying a role as a strand-break sensor (Mortusewicz and Leonhardt, 2007). These 
reports suggest that XRCC1 functions as a scaffold protein which is able to coordinate
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and facilitate the steps of various DNA repair pathways (Mani et al., 2004, Mortusewicz 
and Leonhardt, 2007). XRCG1 binds to PNK and enhances its capacity for damage 
discrimination (Mani et al., 2007). Furthermore, the stabilization of DNA ligase Ilia is 
dependent on its interaction with the BRCT II domain of XRCC1 (Taylor et al., 1998). 
XRCC1 interacts with automodified PARP-1 (Masson et al., 1998) as does DNA ligase 
Ilia. This might provide another mechanism to recruit the XRCC1-ligase Ilia complex 
to sites of DNA damage (Thompson et al., 1982).
1.9.3.3 DNA Ligase in
Human DNA Ligase III functions in several different DNA repair pathways, including 
single-strand repair, base excision repair and nucleotide excision repair. More recent 
studies report that DNA Ligase III is also involve in an alternative NHEJ pathway 
(Moser et al., 2007, Wang et al., 2005, Wang et al., 2006). DNA Ligase III is the only 
DNA Ligase present in human mitochondria and provides all DNA repair and 
replication activities in this organelle (Bogenhagen et al., 2001, Lakshmipathy and 
Campbell, 2001). Moreover, DNA Ligase III contains a PARP-like zinc finger (ZnF) 
that increases the extent of DNA nick joining and intermolecular DNA ligation. This 
type of zinc finger is only present in DNA Ligase III and therefore distinguishes Ligase 
III from the other two mammalian DNA Ligases (Cotner-Gohara et al., 2008, Kulczyk et 
al., 2004, Mackey et al., 1999). DNA Ligase III deficiency in mice leads to early 
embryonic lethality (Puebla-Osorio et al., 2006).
1.9.3.5 DNA Ligase I
Members of the DNA Ligase I family can be found in all eukaryotes. In Saccharomyes 
cerevisiae, cell division cycle mutant cdc9 is defective in DNA Ligase I (Nasmyth, 
1978). The temperature sensitive strain is both impaired for DNA replication and DNA 
damage repair (Johnson et al., 1979, Nasmyth, 1978). Human Ligase I and S. cerevisiae 
cdc9 only share 40% of homology; however both have similar functional domains. Both
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contain a N-terminal DNA binding domain (DBD) and a conserved carboxyl-terminal 
catalytic core composed of a oligonucleotide binding (OB) fold and an adenylation 
domain (AdD). All three domains interact together to allow the flexible enzyme 
structure to completely engulf the DNA substrate (Barnes et al., 1990, Pascal et al., 
2004). The N-terminal DBD contains a proliferating cell nuclear antigen (PCNA) 
binding site allowing the recruitment of DNA Ligase I to nicked DNA to initiate the 
final ligation step, thus sealing breaks in the phosphodiester bonds formation (Levin et 
al., 1997, Levin et al., 2000). Like all eukaryotic DNA ligases, DNA Ligase I is a 
nucleotidyltransferase (NTase) reviewed in (Martin and MacNeill, 2002). The ATP- 
dependent ligase interacts with members of the replication complex (Li et al., 1994) and 
catalyzes the joining of Okazaki fragments during lagging strands synthesis (Waga et al., 
1994). In addition, DNA Ligase I ligates DNA nicks during base pair excision repair 
(BER) (Prasad et al, 1996).
1.10 This Work
Previous studies in our group have shown that short telomeres have the potential to 
undergo fusion with other short telomeres and thus increase the risk of genomic 
instability, a hallmark of cancer (Capper et al, 2007). Sequence analysis of fusions 
between short telomeres have identified a distinct mutational profile comprising large 
deletions into the telomere-adjacent DNA, short patches of microhomologies at the 
fusion point and low amount of TTAGGG repeats (Capper et al, 2007, Letsolo et al, 
2009). This profile is consistent with MMEJ first described in S. cerevisiae (Ma et al, 
2003) and an alternative NHEJ pathway in humans (Feldmann et al, 2000) which are 
both Ku independent. In contrast to fusion of critical short telomeres, the TRF2 knock 
down in embryonic mouse fibroblasts creates chromosomal fusion events which display 
several kilo bases of telomeric repeats at the fusion point and are dependent on DNA 
Ligase IV, Ku 70/80 and DNA PKcs, all components of C-NHEJ (Smogorzewska et al, 
2002, van Steensel et al, 1998).
Since both mutational profiles indicate an aberrant DNA damage repair pathway driving 
chromosomal fusion events, the main focus of this study will be examine the possible 
pathways involved in the fusion of short dysfunctional telomeres. This will be done by 
generating short dysfunctional telomeres in patient derived cells which are deficient in 
DNA repair mechanisms. Furthermore, the direct sequencing of possible fusion events 
should clarify the role of different DNA repair proteins in the mechanistic basis of 
telomere fusion. The forced expression of human papillomavirus HPV16 E6E7 
oncoproteins results in the abrogation of functional RB and p53 and thus allows cells to 
bypass senescence and continue to grow until crisis (Bond et al., 1999, Shay et al., 
1993). By taking advantage of this fact and the unaltered telomere dynamics of the 
transformed cells, our group has previously shown that telomeres eroding beyond a 
certain threshold length undergo fusion (Capper et al., 2007).
Moreover, as STELA is a chromosome specific method to analyse telomeres, telomere 
dynamics of DNA repair deficient patient derived fibroblast cultures will be observed. In 
order to compare and consequently exclude the influence of oxidative stress from 
telomere dynamics, the fibroblast cultures are going to be cultured under physiological 
and normal oxygen culture conditions.
Chapter 2: Material and Methods
2.1 Tissue Culture
2.1.1 Cells
Ligase IV syndrome cells (GM17523 and GM16088), Ligase I deficient cells 
(GM16096), Nijmegen Breakage Syndrome (GM07166) were received from Coriell - 
Institute for Medical Research, Camden, New Jersey, USA. Fibroblast strains GM17523, 
GM16088, GM 16096 and GM07166 were maintained in monolayer culture at 20% and 
3% oxygen, re-fed once a week and re-seeded at a confluence of -90%. For further 
details see table 2.1.
Human embryonic kidney cells HEK293 and the clonal derivative of MRC-5 E6E7 
human diploid fibroblasts were described previously (Capper et al., 2007, Letsolo et al.,
2009). Both cell lines were cultured in monolayer at 20% oxygen. The medium of MRC- 
5 E6E7 clone 1 and HEK293 cells was changed every 3-4 days and cells were passaged 
at a confluence of -75%. For further details see table 2.1.
2.1.2 Medium and Inhibitors
All cells, except MRC-5 E6E7 and HEK293, were cultured in Eagle’s minimum 
essential medium (EMEM, Invitrogen) supplemented with Earle’s salts containing 
Sodium Bicarbonate (7.5% solution, Gibco), 2x nonessential amino acids (Sigma), 2x 
essential amino acids (Sigma), 2x vitamins (Sigma), 10% (v/v) fetal calf serum 
(Autogenbioclear), lx 105 U/l penicillin, 100 mg/1 streptomycin and 2mM glutamine (all 
Sigma). MRC-5 E6E7 clone 1 fibroblasts were cultured in EMEM (Invitrogen) 
supplemented with Earle’s salts containing Sodium Bicarbonate (7.5% solution, Gibco), 
2x nonessential amino acids (Sigma), 10% (v/v) fetal calf serum (Autogenbioclear),
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Table 2.1 Cell lines
Name/ID GM 17523 GM 16088 GM 16096 GM07166 MRC-5 E6E7 HEK293
Description LIG4
Syndrome
LIG4
Syndrome
Ligase I, DNA, 
ATP-dependent 
LIG1
Nijmegen
breakage
syndrome
Cell Type fibroblast fibroblast fibroblast fibroblast fibroblast epithelial
Tissue Type Skin Skin Skin / Lung Kidney
Species Homo sapiens Homo sapiens Homo sapiens Homo sapiens Homo sapiens Homo
sapiens
Transformant Untransformed Untransformed Untransformed Untransformed HPV 16E6E7 
Transformed
Transformed 
With adenovirus 5 
DNA
Age 10 years 15 years 18 years 20 years 14 weeks fetus
Sex female male female female male
Race Caucasian Caucasian Caucasian Caucasian Caucasian
Telomerase no no no no no yes
Clinically
affected
yes yes yes yes no no
Mutated Gene LIG4 LIG4 LIG1 NBS1
Chromosomal 
location 
of mutated 
gene
13q22-q34 13q22-q34 19ql3.2-ql3.3 8q21
Identified
Mutations
GLY469GLU
ARG814TER
ARG278HIS GLU566LYS;
ARG771TRP
5-BP DEL, 
NT657-661;
none der(l)t(l;15)
(q42;ql3),
der(19)t(3;19)
(ql2;ql3),
der(12)t(8;12)
(q22;pl3),
Reference (O’Driscoll
2001)
(O'Driscoll,
2001)
(Webster, 1992) (Varon, 1998) (Capper 2007, 
Letsolo 2009)
(Capper 2007, 
Letsolo 2009)
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25mM HEPES Buffer, lx 105 U/l penicillin, 100 mg/1 streptomycin and 2 mM L- 
glutamine (all Sigma). The fibroblasts were continuously treated with PARP inhibitor
1,5 -  Dihydroxyisoquinoline (DIQ, Sigma). The inhibitor was dissolved in dimethyl- 
sulfoxide (DMSO, Sigma) and was added to the cell culture medium at 10 |JM and 100 
pM. The inhibitor was replenished with each medium exchange.
HEK293 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, 
Invitrogen) supplemented with 10% (v/v) fetal calf serum (Autogenbioclear), lx 105 U/l 
penicillin, 100 mg/1 streptomycin and 2 mM L-glutamine (all Sigma).
2.1.3 Typsinising and passaging cells
After aspirating used medium, cells were washed with pre-warmed lx tiypsin (0.05% 
trypsin and 0.2% EDTA (Gibco)) to remove all remaining serum. An appropriate 
volume of fresh lx trypsin was added to the flask and the cells were incubated for up to 
40 minutes at 37°C until the cells were rounded. Fresh medium was added to deactivate 
tryspin. The cell suspension was transferred to a 15 ml tube. For re-plating, sufficient 
numbers of cells (Ni) and fresh medium was added to a new flask or well. For further 
details see table 2.2.
2.1.4 Counting cells and PD calculations
To monitor population doubling (PD) of the cell lines, cells were counted at every 
passage. After trypsinizing, 10 pL of cell suspension were counted in a haemocytometer 
(Improved Neubauer, Hawksley). Total cell number N2 was determined as follows:
N2 = number of counted cells x 104x volume of cell suspension (in mL)
The population doublings (PDs) for each culture were recorded during every 
experiment. PDs were calculated with following formula:
PD = [log N2 (total cell number) -  log Ni (seeded cell number)]/log2 cm2
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Table 2.2 Trypsinising and plating cells
Surface
areas
(cm2)
Media
Volume
(ml)
Trypsin
(ml)
Medium
to
deactivate
trypsin
(ml)
NI
(Untransformed 
cells lines)
NI (MRC-5 
HPV 16 
E6E7 
transformed)
NI
(HEK293,
transformed
with
andenovirus)
T175 176.71 25 3 12 4 -6 x 105 / /
T75/100 
mm dish
78.54 10 2 8 0.5 - 2 x 105 4-6 x 10* 4-6 x 105
T25/60mm
dish
28.27 5 1 4 2 -8 x 104 0.5-1 x 105 0.5-1 x 105
6 well 9.62 2 0.5 2 < 2 x  104 / /
24 well 1.76 1 0.1 0.5 < 1x1 0" / /
2.1.5 Cell freezing
Cells were frequently frozen to serve as a back-up for further experiments or in case of a 
contamination of the culture. For freezing, the cells were trysinized as usual and were 
pelleted by centrifugation at 1000 rpm for 5 min in a Centaur-2 centrifuge. The cells 
were re-suspended in 0.5 mL of culture medium and an equal amount of freezing mix 
(20% dimethyl-sulfoxide (DMSO, Sigma) in culture medium). The suspension then was 
transferred to a freezing ampoule which was placed in a freezing box containing iso­
propanol. The freezing mix and iso-propanol allows a gentle gradual freezing procedure 
preventing ice crystal formation in the cells. Cells were frozen at -80°C and were kept at 
this temperature for short term storage. For long term storage, cells were transferred into 
liquid nitrogen at -196°C.
2.1.6 Thawing cells
Cells were removed from -80° or liquid nitrogen and thawed rapidly in a water bath 
(Grant) at 37°C. To remove all traces of DMSO, 9 mL of fresh culture medium were 
added drop wise. The slow dilution minimised the damage through osmotic shock and
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increased the survival rate of the cells. The cell suspension was centrifuged at 1000 rpm 
for 5 min in a Centaur-2 centrifuge at room temperature (RT). After aspirating the 
supernatant, the pellet was re-suspended in an appropriate volume of fresh culture 
medium and re-plated. See Table 2.2 for seeding densities.
2.1.7 Measurement of DNA Synthesis of Senescent Cells by BrdU labelling
The onset of replicative senescence was defined as at least 4 weeks of no cell growth 
and bromodeoxyuridine (BrdU) labelling indices of < 3% (Bond et al., 1999). BrdU 
incorporation enables the detection of dividing cells in a cell population. For the assay, 
cells were seeded onto coverslips at a concentration of 2.0 -  5.0 x 104 cells per 35 mm 
dish. Cells were re-fed with fresh medium 2 days prior to the BrdU labelling. The cells 
were incubated with BrdU (50jJmol/l, Boehringer) for 1 hour at 37 °C. To remove 
excess BrdU, cells were washed three times in lx PBS and afterwards fixed for 30 
minutes in pre-cooled 70% ethanol (Fisher Scientific) at 4°C. The coverslips were then 
extensively washed in lx PBS and left to re-hydrate for 10 minutes in lx PBS. In order 
to depurinate the DNA, the coverslips were incubated in 4 M HC1 (Fisher Scientific) for 
10 minutes at RT. Afterwards the coverslips were rinsed once in lx PBS and then 
incubated with 0.1 M Borax, ph 8.5 (Sigma) for 5 minutes at RT. After washing the 
coverslips three times in 1 x PBS, coverslips were transferred into a humidified chamber 
and were incubated with an anti-BrdU monoclonal antibody (Dako M0744, Dako 
Cytomation), diluted to 1:100 in 0.6% bovine serum albumin (BSA, Roche) in lx PBS, 
for 50 minutes at 37°C. Again, the cells were washed 3 times in lx PBS and then 
incubated with rabbit anti-mouse antibody (Dako P0260 Dako Cytomation), diluted 
1:100 in 0.6% BSA in lx PBS, for a further 50 minutes at 37°C. The coverslips were 
washed in lx PBS and developed with diaminobenzidine (DAB) solution for less than 5 
minutes. The DAB solution was prepared immediately before use by adding 1 ml of 
DAB stock solution to 9 ml of lx PBS and then adding 3.4 ml of hydrogen peroxide to 
the solution. DAB was washed off with three lx PBS washes, followed by a wash with 
tap water. To finish the BrdU labelling, coverslips were stained with Meyers
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hematoxylin for 30 to 60 seconds, followed by 3 washes with tap water. The 
hematoxylin staining was monitored under the microscope. As a final step, coverslips 
were dehydrated by quickly washing them in H2O, followed by two quick washes in 
100% ethanol and two quick washes in Xylene. Coverslips were mounted on glass slide 
and left to dry overnight. BrdU labelling index (%) was determined by counting dividing 
cells (stained brown) and comparing them with the total amount of fixed cells.
BrdU labelling index (%) = (number of stained cells / total number of cells)* 100
2.1.8 Retroviral Infection
The recombinant retrovirus expressing HPV16E6E7 from a pLXNS construct, packaged 
in amphotropic PA317 cells was described previously (Halbert et al., 1991). As an 
empty vector control, a pBABEneo vector, packed in ipCRIP producer cells was used 
(Wyllie et al., 1993). Retroviral gene transfer was carried out as described previously 
(Bond et al., 1999, Capper et al., 2007).
Ligase IV syndrome cells (GM 17523 and GM16088), Ligase I deficient cells 
(GM16096), Nijmegen Breakage Syndrome (GM07166) were infected individually with 
both the pLXNS-E6E7 and pBABE-NEO control retrovirus supernatants. All cells were 
plated at a concentration of 2.0 -2.5 x 105 cells per 60 mm dish on the day prior to 
infection. Cells were incubated with fresh medium containing 8 pg/ml polyprene 
(Aldrich) for at least one hour before the infection. 2 - 4  mL of virus-containing harvest 
medium were taken from storage at -80°C and thawed in a 37°C water bath (Grant). 
Supernatants were filtered with a 0.45 pm filter (Pall corporation) using a 5 mL syringe 
(Tyco Heatlhcare Kendall) and a kwill (Avon) and were transfered into a bijou (Sterilin). 
Polyprene was added to the retroviral suspension so that the final polyprene 
concentration was 8 pg/mL. After removing the medium from the cells, 2- 4 mL of 
medium containing the retroviral vector were added to each 60 mm dish and were left to
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incubate for 4 -  6 hours at 37°C. After the incubation, the harvest medium was filled up 
with fresh culture medium to 5 mL. 48 hours after infection, the cells were re-plated in 
100 mm dishes with normal culture medium at 1/2, 1/10, 1/50, 1/100 1/250 fold 
dilutions (Fig. 2.1). By using a non-selective medium, cells were giving time to reattach 
to the dish surface increasing the infection rate. The next day, cells were re-fed with 
selective medium containing 0.4 mg/ml geneticin (G-418, Invitrogen). The selection 
process took approximately 14 days, in which the cells were fed once a week with 
selective medium. The 1/2 and 1/10 fold dilution were used for bulk populations 
whereas 1/50, 1/100 1/250 fold dilution yielded individual clones. Clones were isolated 
using cloning rings. They were trypsinised and passed into 24 well plates after reaching 
a local densitiy of 90%. Both bulk populations and single clones were trypsinised and re­
seeded like non-infected cells but were re-fed only with selective medium containing 
G418 every week.
2.1.9 Preparations of cell samples for further experiments
Cells were alternatively either frozen or sampled for single telomere length analysis 
(STELA) and fusion assays to obtain a complete overview of the telomere dynamics 
before senescence and/or crisis. The cells were pelleted by centrifugation at 1000 rpm 
for 5 minutes at RT. The supernatant was aspirated and the cell pellet was washed with 
lx PBS to remove residue culture medium. After centrifuging at the same conditions and 
removing the supernatant again, the cell pellet was frozen and stored at -20°C for up to 
12 months.
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Figure 2.1 Retroviral Infection
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2.2 Molecular Biology
2.2.1 DNA extraction
High molecular weight DNA was isolated from the cell samples using either a Phenol/ 
Chloroform DNA extraction protocol or QIAamp DNA Micro Kit.
2.2.1.1 Phenol/Chloroform DNA extraction
Genomic DNA was extracted from the cell pellets (more than lx 105 cells per sample) 
following a standard proteinase K / Phenol/ Chloroform DNA extraction protocol. To 
lyse the cells, 300pl of lysis puffer (lOOmM NaCl, lOOmM Tris-HCL ph 8.0, 5mM 
EDTA ph 8.0, 0.5% SDS) containing O.lmg/ml RNase (Sigma) and 0.2 mg/ml 
Proteinase K (Sigma), were added to the cell pellet and then gently mixed. Lysis was in 
general carried out overnight at 45 °C. After a quick spin to remove all condensation 
from the tube lid, lx volume of high purity phenol/chloroform (Sigma) was added to the 
sample. The samples were placed on a tube rotator (Stuart Scientific) for 30 minutes to 
enhance the digestion of DNA contaminations like proteins. To separate the phases, the 
samples were centrifuged for 5 minutes at 13000x g in a Heraeus centrifuge. Afterwards 
the aqueous and interphase were transferred into a fresh tube containing lx volume of 
phenol/chloroform. Depending of the amount of lysed cells, this step was repeated 2-4 
times until the aqueous phase was clear. As a last step only the aqueous phase was 
transferred into a fresh tube, DNA was precipitated by adding 30pl of 3M sodium 
acetate (NaAc) ph 5.2 and 900pl of ice cold 100% Ethanol (Fisher Scientific). To 
support DNA precipitation, the tubes were left at -20°C overnight. The DNA pellet was 
recovered by centrifuging 18000xg at 4°C for 30 minutes in a Camlab centrifuge. The 
pellet was washed in 70% ethanol and after removing the ethanol, was dried at room 
temperature for up to 2 hours. The dried pellet was re-suspended in corresponding 
amount of lx EcoRI buffer or lOmM Tris-HCl ph 8.0 (50pl for large, 25pi for medium 
and 15pl for small pellets). DNA samples were stored at 4°C allowing the DNA to
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solubilize again. Large pellets were further solubilized by restriction enzyme digestion 
with 12 units of EcoRl (New England Biolabs) for 6 hours at 37°C, followed by heat 
inactivation at 65°C for 10 minutes.
2.2.1.2 DNA extraction using QIAamp DNA Micro Kit
For cell samples which contained less then lx 105 cells, genomic DNA was extracted 
using QIAamp DNA Micro Kit. The kit enables the purification of genomic DNA from 
small samples sizes by binding the DNA to a silica-based membrane. DNA was 
extracted from the cell pellets by adding lOOpl of the provided ATL buffer (tissue lysis 
buffer) and lOpl of the provided Proteinase K solution. After adding IOOjliI of the 
provided AL buffer (containing guanidinium chloride to denature proteins), the samples 
were pulse-vortexed for 15s. The lysis of the samples was carried out at 45°C for 10 
min. After a quick spin to remove all condensation from the tube lid, 50pl 100% ethanol 
was added to the sample. Afterward the sample was pulse-vortexed for 15s and 
incubated at RT for 3 min. The entire lysate was transferred to the QIAamp MinElute 
Column. The samples were centrifuged for 1 min at 6000x g in a Heraeus centrifuge to 
bind the DNA to the silica-based membrane. Residual contaminations were removed by 
washing twice with the provided buffers AW1 (containing guanidinium chloride to 
denature proteins) and AW2 (70% ethanol to remove salt). The DNA was eluted from 
the column with 30pl lOmM Tris-HCl pH 8.0.
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2.2.2 Single Telomere Length Analysis (STELA) and Fusion Assay
The solubilised genomic DNA was quantified in triplicate using Hoechst 33358 
fluorometry (BioRad). Hoechst 33358 is a fluorescent dye which binds to DNA in high 
salt concentrations and allows quantitative DNA measurements by comparing the 
fluorescence emission of the unknown DNA sample against the emission of a known 
DNA sample. The dye was diluted in TEN buffer (10 mM Tris/HCL pH 8.0, ImM 
EDTA, lOOmM NaCl) to a final concentration of lpl/mL. lpl of each DNA sample was 
added to 1ml of freshly prepared TEN buffer containing Hoechst 33358 and the 
fluorescence emission is measured with the fluorometer (BioRad). Later on genomic 
DNA was quantified in triplicate using NanoDrop (Thermo Scientific). NanoDrop is a 
micro-volume UV to visible light Spectrophotometer. After pipetting lpl of the DNA 
sample on the pedestal, the machine automatically adjusts the path length for 
measurement and gives a concentration reading.
Each DNA sample was diluted in 10 mM Tris-HCL pH 8 (Sigma) to 10 ng/p.1. In case 
the sample contained less than 10 ng/pl of DNA, undiluted DNA was used for the 
STELA working dilution or the fusion assay. The single telomere length analysis 
(STELA) and the single molecule fusion PCR were performed according to the existing 
protocols (Baird et al., 2003, Britt-Compton and Baird, 2006, Capper et al., 2007, 
Letsolo et al., 2009).
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Figure 2.2 Single Telomere Length Analysis and Fusion Assay, a) Principle o f  STELA, b) principle 
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2.2.2.1 PCR for STELA
Single telomere length anlaysis (STELA) is a long range single-molecule PCR technique 
determining the telomere length of specific chromosomes. The principle of STELA is 
shown in Figure 2.2 a) (Baird et al., 2003, Britt-Compton et al., 2006). For STELA, 40 
pi of working dilution (250 pg/pl DNA, 10 mM Tris-HCL pH 8 (Sigma) and 1 pM 
telorette2 primer) was prepared enabling the binding of the telorette linker to the G-rich 
3' overhang. The mechanism which allows the binding of the telorette linker to the 3' 
overhang is not known so far. Multiple 10 pi PCR reactions (normally 4-6 reactions per 
sample) were carried out containing 250 pg telorette2-linked DNA, 75mM Tris-HCL pH 
8.8, 20mM (NH2)S04, 0.01% Tween-20, 2mM MgCl2, 1.2 mM dNTP’s, 0.5 pM teltail 
primer, 0.5 pM of telomere-adjacent primer (table 2.3) and 0.5 U Taq/Pwo mixture at a 
unit ratio of 10:1 (Promega/Roche). The reactions were cycled in a MJ PTC-225 
thermocycler (MJ Research) or Tetrad Peltier Thermal Cycler (BioRad) using the 
following program: 22 cycles of denaturation at 94°C for 20 seconds, annealing at 59°C 
or 65°C for 17pseqrevl and XpYpE2 respectively for 30 seconds and elongation at 68°C 
for 8 minutes.
2.2.2.2 PCR for Fusion Assay
Like STELA PCR, the fusion assay is a long range single-molecule PCR technique. The 
assay uses chromosome-specific primers, located up to 3 kb from the telomere in the 
subtelomeric DNA, to detect unique telomere-telomere fusion events. The principle of 
fusion assay is shown in Figure 2.2 b) (Capper et al., 2007, Letsolo et al., 2009). The 
primers of the 21 q group bind within the sub-telomeric repeat regions which are shared 
among the chromosome ends 21q, lq, 2q, 5q, 6q, 6p, 8p, lOq, 13q, 17q, 19p, 19q, 22q 
and the 2ql3 interstitial telomeric locus. This allows the assay to detect fusion events 
between at least 35% of telomeres in the human genome. In addition to fusions between 
Xp, Yp, 17p and the above mentioned chromosome ends, the assay can detect sister 
chromatid-type fusion events as long as there has been a deletion of at least one of the 
telomeric repeat arrays. However, fusion events which contain perfect inverted repeat
55
sequences present a problem as a perfect sequence match can not be separated during 
sequencing. Furthermore, observations in our group have shown that the 21 q group 
primers can generate additional non-specific products which can not be re-amplified. 
This artifical product is dependent on the DNA sample and the amount of DNA used in 
the fusion assay. Therefore the fusions detected with the 21q primer were not used to 
determine the fusion frequency of the analysed samples (Letsolo et al., 2009, Capper et 
al., 2007).
Multiple 10 pi PCR reactions (normally 9 or 18 reactions per sample) were carried out 
containing 10 ng DNA, 75mM Tris-HCL pH 8.8, 20mM (NH2)SC>4 , 0.01% Tween-20, 
2mM MgCh, 1.2 mM NTP’s, 0.5 pM XpYpM primer, 0.5 pM 17p6 primer, 0.5 pM 
21ql primer and 0.5 U Taq/Pwo mixture at a unit ratio of 10:1 (Promega/Roche). The 
reactions were cycled in a MJ PTC-225 thermocycler (MJ Research) or Tetrad Peltier 
Thermal Cycler (BioRad) using following program: 25 cycles of denaturation at 94°C 
for 20 seconds, annealing at 59°C or 65°C for 17p and XpYp respectively for 30 seconds 
and elongation at 68°C for 8 minutes.
2.2.23 Gel Electrophoresis for STELA and Fusion Assay
The amplified DNA fragments created by STELA or fusion PCR were resolved by 
horizontal submarine gel electrophoresis. After adding 2 pi of a 6x Ficol based gel 
loading dye (5% bromophenol blue, 5% xylene and 15% ficol) to the PCR reactions, 5 
pi of each reaction was loaded on a 0.5% Tris-acetat-EDTA (TAE) agarose gel (Roche) 
containing 0.1% ethidium bromide (EtBr, Fisher Scientific). To track the molecular 
weight of the PCR products, a DNA ladder containing 0.5 pi of 1 kb DNA ladder 
(Stratagene) and 0.5 pi of 2.5 kb DNA ladder (Stratagene) was loaded onto the gel. Gels 
were run overnight at 110 Volt for at least 15 hours. The gel tanks and power packs used 
were from Bio-Rad.
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2.2.2.4 Southern B lot
Gels were trimmed to size by visualising the DNA ladder on a UV tansilliuminator 
(FOTODYNE Incorporated) and removing excess gel. After DNA depurination for 2x 6 
minutes in 0.25M HCL, the DNA fragments were denaturated in 1.5M NaCl, 0.5M  
NaOH for 15 minutes. The separated fragments were then transferred to a positively 
charged membrane (Hybond XL, GE Healthcare) by alkaline southern blotting. The 
denaturation buffer was used as transfer buffer. Southern blot construction is shown in 
Figure 2.3. The transfer was stopped after 4 - 6  hours, afterwards the membrane was 
quickly washed in H2O and allow to dry at room temperature.
Glassplate
Membrane
Gel
Papertowels 
Filterpaper 
Filter paperwick
Figure 2.3 Southern Blot (m odified from Cornel Mulhardt. The Experiment alor. 
Spektrum Akademischer Verlag; 6 edition (2008). Print)
2.2.2.5 Southern Hybridisation Probes for STELA and Fusion Assay
Telomere adjacent probes and the probe binding telomere repeats for the detection o f  
STELA products by southern hybridisation were generated by PCR (2.2.4.1) using the 
following oligonucleotides (table 2.3): For 17p STELA: 17p2 and 17p7; for XpYp 
STELA: XpYpE2 and XpYpB2.
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Hybridisation probes for the detection of fusion assay products by southern hybridisation 
were generated by PCR (2.2.4.1) using the following oligonucleotides (table 2.3): For 
17p: 17p7 and 17pseq3; for XpYp: XpYpE and XpYpB; for 21q group members: 21ql 
and 21qseqrevl.
2.2.2.6 Southern Hybridisation
The hybridisation probes for STELA and fusion assay were labelled by using the 
rediprime random hexamer labelling kit (GE Healthcare). 25 ng of the probe template 
was denatured at 96 °C for 5 minutes and snap chilled on ice for 5 minutes. The 
denaturated DNA and [a-33P] dCTP was added to the ready-made labelling mix 
containing random sequence hexamers, dNTPs and the klenow fragment of DNA 
polymerase I. The mix was incubated at 37 °C for 15 minutes starting DNA synthesis 
and the incorporation of the radioactive 33P into the probe. To enable the detection of 
molecular weight markers on the blot, lpl of [a-33P] labelled 1 kb and 2.5 kb DNA 
markers was added to the telomere specific probe. The labelled probe was again 
denatured at 96 °C for 5 minutes and half the probe was add to the hybridisation tubes 
containing 15 ml of Church’s buffer (7% SDS, 1% bovine serum albumin, 1 mM EDTA, 
0.5 M sodium phosphate, pH 7.0) and the southern blot. Hybridisation was carried out 
overnight at 60 °C in a hybridisation oven (ThermoHybaid).
2.12.1 Hybridisation Washes and Fragment Analysis
After hybridisation overnight, the blots were washed with 0.1 x SSC/0.1% SDS at 60 °C 
for 1-2 h. The wash solution was exchanged several times to maximize the removal of 
all non-specific bound hybridisation probe. The blots were dried and the hybridized 
fragments were detected by phosphoimaging with a Molecular Dynamics Storm 860 
Phoshorlmager (GE Healthcare). Prior to re-hybridisation with additional probes, blots 
were stripped with boiling 0.1% SDS for at least 6 hours. The molecular weights of the 
DNA fragments were enumerated and sized by using the software package Phoretic ID
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quantifier (Nonlinear Dynamics). Each data set was transferred into a separate Microsoft 
Excel Spread sheet (Microsoft, Seattle, USA). All mean values, standard deviations 
(SD), standard errors (SE) and median values were calculated with Microsoft Excel. 
Modal telomere distributions of each sample were determined as peaks in the histogram 
depicting the calculated individual and cumulative frequencies of the different telomere 
lengths. The frequency of occurrences of a value in the data set was generated by the 
histogram analysis tool of Microsoft Exel (Microsoft, Seattle, USA).
2.2.3 Oligonucleotides
Primers were synthesised by MWG. All used primers were designed previously in the 
group and were based on telomere adjacent sequences (Baird et al., 2003, Britt-Compton 
and Baird, 2006, Capper et al., 2007, Letsolo et al., 2009). All used primers are detailed 
in Table 2.3.
Table 2.3 Oligonucleotides
STELA primers Tm (°C) Reference
Telorette2
(Tel2)
5 -TGCTCCGTGCATCTGGCATCTAACCCT-3' (Baird 2003)
Teltail 5'-TGCTCCGTGCATCTGGCATC-3' various (Baird 2003)
XpYpE2 5 '-TTGTCTCAGGGTCCTAGTG-3' (406 bp) 65 (Baird 2003)
17pseqrevl 5'-GAATCCACGGATTGCTTTGTGTAC-3' (31 lbp) 59 (Britt-Compton 2006)
Fussion assay primer Tm (°C) Reference
XpYpM 5'-ACCAGGTTTTCCAGTGTGTT-3' 59 (Capper 2007)
17p6 5 '-GGCTGAACT AT AGCCTCTG-3' 59 (Britt-Compton 2006)
21ql 5'-CTTGGTGTCGAGAGAGGTAG-3' 59 (Letsolo 2009)
Probe generation Tm (°C) Reference
XpYpB2 5'-TCTGAAAGTGGACC(A/T)ATCAG-3' (Baird 2003)
17p2 5 '-GAGTC AATGATTCC ATTCCT AGC-3' (Britt-Compton 2006)
17p7 5-CCTGGCATGGTATTGACATG-3' (Capper 2007)
17pseq3 5'-AGAATCCTGTCCTCAACAAGT-3' (Britt-Compton 2006)
21qseqlrev 5 AGCT AGCT ATCTACTCTAAC AG AGC-3' (Letsolo 2009)
21qseql 5-TGGTCTTATACACTGTGTTC-3' (Letsolo 2009)
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Reamplification primers Tm (°C) Reference
XpYpO 5 '-CCTGT AACGCTGTT AGGT AC-3' (Capper 2007)
21qlB 5'-TTGGTGTCGAGAGAGGTAGC-3' Baird unpublished
Sequencing primers Tm (°C) Reference
17p-33G 5 ' -GCACCCGGGCTCATACCTG-3' 50 (Capper 2007)
21q2ct 5 AGT AGC ATCTC YAGTGCTGGAG-3' 50 (Letsolo 2009)
21q3 5-CTGCAGTTGTCCTAGTCGC-3' 50 (Letsolo 2009)
lOql 5-AGGTTCCACTCGTCTCTGCG-3' 50 (Letsolo 2009)
10q2 5-TGCAATGTCCCTAGCTGCCAG-3' 50 (Letsolo 2009)
8pl 5 '-TGC AC AGGACTCTT AGGCTG-3' 50 (Letsolo 2009)
• Subtel2 5'-GAATCCTGCGCACCGAGATTCTC-3' 50 (Letsolo 2009)
21qseq2 5 '-TGCCCC AATC ATC ATTC ACT CT GC-3' 50 (Letsolo 2009)
6pl 5 '-CTGC AC AGG ACTCCT AGG ATG-3' 50 (Letsolo 2009)
2.2.4 Polymerase Chain Reaction (PCR) and Gel Electrophoresis
2.2.4.1 PCR for generating probes
To generate probes for Southern Hybridisation, the template DNA was diluted in lOmM 
Tris-HCl (ph 8.8) to 50 ng/pl. The PCR reaction volume of 10|Jl contained 100 ng/pl 
DNA , 75mM Tris-HCL pH 8.8, 20mM (NH2)S04, 0.01% Tween-20, 2mM MgCl2, 1.2 
mM NTP’s, 1 pM primer 1, 1 pM primer 2 and 1 U of 10:1 ratio of Taq (Promega) and 
Pwo polymerase (Roche). The reactions were cycled in a MJ PTC-225 thermocycler (MJ 
Research) or Tetrad 2 Peltier Thermal Cycler (Bio Rad) using following program: 32 
cycles of denaturation at 96°C for 20 seconds, annealing temperature Tm (table 2.3) for 
30 seconds and elongation at 68°C for 8 minutes.
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2.2.4.2 Reamplification PCR
Fusion products were reamplified as described previously (Capper et al., 2007, Letsolo 
et al., 2009). First-round PCR reactions containing fusion events were diluted 1:20 in 
H2O. A second PCR reaction (end vol. 30pl) with nested primers (XpYpO, 17p7, 
21qseql or 21qlB, Table 2.3) was carried out containing 3|Jl diluted PCR reaction, 
75mM Tris-HCL pH 8.8, 20mM (NH2)SC>4 , 0.01% Tween-20, 2mM MgCl2 , 1.2 mM of 
dNTPs, 0.5 pM primer 1, 0.5 pM primer 2 and 0.5 U of 10:1 ratio of Taq (Promega) 
and Pwo polymerase (Roche). The reactions were cycled in a MJ PTC-225 thermocycler 
(MJ Research) or Tetrad 2 Peltier Thermal Cycler (Bio Rad) using following program: 
32 cycles of denaturation at 94°C for 20 seconds, annealing at 59°C for 30 seconds and 
elongation at 68°C for 8 minutes.
2.2.43 Agarose Gel Electrophoresis
DNA fragments were resolved using horizontal submarine gel electrophoresis. After 
adding 6 pi of a 6x Ficol based gel loading dye to the PCR reactions, the complete 
reaction was loaded on a lx TAE or lx TBE (45mM Tris-borate, 1 mM EDTA) agarose 
gel (Fisher Scientific) containing 0.1% ethidium bromide (EtBr, (Fisher Scientific). To 
estimate the molecular weight of the PCR products, a DNA ladder containing 0.5 pi of 1 
kb DNA ladder (Stratagene) and 0.5 pi of 2.5 kb DNA ladder (Stratagene) was loaded 
onto the gel. Gels were run either overnight at 45 Volt or at 120 Volts for 1-2 hours. The 
used gel tanks and power packs were Bio-Rad.
2.2.4.4 DNA Gel Extraction
The resolved DNA fragments were visualised with a UV tansiluminator (FOTODYNE 
Incorporated) and appropriate fragments were cut from the gel using a clean scalpel. The 
DNA was extracted from the agarose block using QIAamp Gel extraction Kit. The kit
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enables the separation of DNA and agarose by binding the DNA to a silica-based 
membrane. After several washing steps, the DNA was eluted from the column with 30pl 
lOmM Tris-Cl, ph 8.5.
2.2.5 Sequencing Analysis of Fusion events
Sequencing was carried out using Big Dye 3.1 or Big Dye 3.0 GTP. The lOpl reaction 
contained 4.4 pi of reamplified fusion product, 1.6 pi lpM primer and 4.0 pi of Big 
Dye mix (PE applied Biosystems). The sequencing reaction was then cycled in a MJ 
PTC-225 thermocycler (MJ Research) or Tetrad 2 Peltier Thermal Cycler (Bio Rad) 
using following program: 25 cycles of denaturation at 96°C for 30 seconds, annealing at 
50°C for 15 seconds and elongation at 60°C for 4 minutes. Unincorporated dye 
terminators were removed from the sequencing reaction using gel-filtration technology 
(DyeEx Spin 2.0 Kit, Qiagen). The purified reactions were resolved and sequences were 
generated using an Applied Biosystems Genetic Analyzers (3130x1), Data Collection 
software version 3.0 and Sequencing Analysis software version 5.2.
2.3 Statistical Analysis
All tissue culture and sequence analysis data was entered into Microsoft Excel Spread 
sheets (Microsoft, Seattle, USA). All mean values, standard derivations (SD), standard 
errors (SE) and median values were calculated with Microsoft Excel. All presented 
diagrams were generated in Microsoft Excel.
2.3.1 Determination of erosion rates
To establish the erosion rate in the exponential growth phase of the cells, the telomere 
length determined by STELA was plotted against the corresponding PD. The slope of 
the regression line of the data points gave the erosion rate in base pairs (bp) per PD. R2 
values were used to assess correlations between telomere length and PDs. In order to
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decide whether the telomere erosion rates at the two oxygen concentrations are 
significantly different, or whether the differences might just be due to chance standard 
errors (also standard error of the mean, SE) was chosen as error bars. SE is defined as 
SE = SD/Vn. (Cumming et al., 2007)
2.3.2 Frequency of fusion events
In order to calculate the frequency of fusion events, the number of bands generated by 
each fusion reaction was counted and divided by the estimated number of input 
molecules into the reaction. The number of input molecules was estimated from the 
amount of DNA analysed in each reaction divided by the size of a diploid human 
genome of 6pg.
Frequency = number of fusion events/[amount of DNA used in analysis (pg) / 6 pg]
2.3.3 T-test
A paired t-test was used to determine of one sample measured at two conditions differed 
from each other. It was assumed that the data sets were approximately normally 
distributed and the variances of the two sets were homogenous. No differences between 
the two data set and the implication that both could be from the same source was 
postulated to be the null hypothesis Ho. The t-test was calculated in Microsoft Excel 
using a 2-tailed, 2 sample equal variance t-test. The calculated p-value is the probability 
of the null hypothesis Ho being true. At a p-value below 0.05 the null hypothesis Ho was 
rejected.
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2.3.4 Chi-Square test
A Chi-Square test (x2) was used to determine if the observed frequencies conformed to 
the expected frequencies of the category. In this thesis the expected frequencies were 
derived from previous observations in the group, For the null hypothesis Ho , it was 
assumed that the observed and the expected frequencies did not differ from each other. 
The x2 -test was calculated in GraphPAD Prism V.4.01 (GraphPAD Inc., San Diego, 
USA). At a p-value below 0.05 the null hypothesis Ho was rejected.
2.3.5 Repeat Measure ANOVA
A repeat measure ANOVA (analysis of variance) was used to determine if there was a 
significant difference between one sample subjected to three or more different 
treatments. No difference between the different treatments was stated as the null 
hypothesis Ho. The repeat measure ANOVA was calculated in GraphPAD Prism V.4.01 
(GraphPAD Inc., San Diego, USA). At a p-value below 0.05 the null hypothesis Ho was 
rejected.
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Chapter 3: DNA Ligase I Deficiency
3.1 Abstract
The human fibroblasts strain GM16096 is derived from a patient with DNA ligase I 
syndrome. The cells are characterised by a reduction of Ligase I activity levels to less 
than 5 % and the delayed joining of Okazaki fragments. The aim of this work was to 
investigate if DNA Ligase I modulates telomere dynamics and the role that DNA Ligase 
I may play in the mechanism that underlies the fusion of short dysfunctional telomeres.
The telomere dynamics were investigated using STELA. The telomere dynamics in 
DNA Ligase I deficient human fibroblasts were not significantly different from those 
observed in normal human fibroblasts. This suggests that the limited replicative capacity 
is not a result of accelerated telomere attrition and that impaired Okazaki fragment 
joining does not modulate telomere dynamics.
In order to investigate whether DNA Ligase I deficiency plays a role in the mechanisms 
behind chromosomal fusion events, cells were forced to divide beyond senescence to 
“crisis” by the expression of HPV16 E6E7 abrogating the function of p53 and RB. The 
resulting fusion events found in E6E7 expressing DNA Ligase I deficient cells were 
investigated on a molecular level and a distinct mutational profile for telomere-telomere 
fusion events was observed. Telomere fusion involving the 17p telomere and members 
of the 21 q group of related telomeres were detected. This was consistent with the 
observed loss of the 17p telomere. In contrast, the XpYp telomere remained intact and 
was not subjected to fusion. No clear differences in the fusion profile (sub-telomeric 
deletion and microhomology at the fusion point) compared to the profile of normal 
human fibroblast strains could be observed. However, due to the limited data set, no 
statistically significant conclusion about the requirement of DNA Ligase I in the fusion 
of short dysfunctional telomeres could be drawn.
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3.2 Introduction
3.2.1 DNA Ligase I
DNA Ligase I is one of three DNA ligases in human cells which perform a vital role in 
DNA replication and repair (Martin and MacNeill, 2002). Like all eukaryotic DNA 
Ligases, DNA Ligase I is a nucleotidyltransferase (NTase). The ATP-dependent ligase 
interacts with members of the replication complex (Li et al., 1994) and catalyzes the 
joining of Okazaki fragments during lagging strands synthesis (Waga and Stillman, 
1994). In addition, DNA Ligase I ligates DNA nicks during base pair excision repair 
(BER) (Prasad et al., 1996).
3.2.2 DNA Ligase I Deficiency
Only one human being has been diagnosed with DNA Ligase I deficiency. A female 
patient (46BR) showed symptoms of growth retardation, sun sensitivity, severe immune 
deficiency and chromosomal instability, symptoms similar to those of Bloom’s 
syndrome and ataxia telangiectasia (AT). The patient developed lymphoma and died 
shortly after from pneumonia at the age of nineteen (Webster et al., 1992). A fibroblast 
cell line (46BR cell line or GM16096) was established from a skin sample of the patient. 
Early biochemical studies showed that double strand breaks (DBS) induced by the 
treatment with ultraviolet (UV) radiation or DMS persist longer in the 46BR cell line 
than in normal cells (Teo et al., 1983). Furthermore, the cells display retarded joining of 
Okazaki fragment and are lethally affected by 3-aminobenzamid (3’-AB), an inhibitor of 
poly(ADP-ribose) polymerase (PARP) (Creissen and Shall, 1982, Henderson et al., 
1985). All these studies supported the hypothesis that 46BR cells have a basic defect in 
DNA Ligase activity. Following the identification of the human gene encoding DNA 
Ligase I (LIG1) located on chromosome 19 (ql3.2 -  13.3) (Barnes et al., 1990), two 
different missense mutations in both alleles of DNA Ligase I were identified in the 
patient derived cell line, 46BR (Barnes et al., 1992). The first mutation, an arginine-771 
to tryptophan transition within the OB fold domain was inherited from the mother of the 
patient and can also be found in the patient’s siblings. The second mutation, two amino
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acids away from the key active-site lysine on the other allele, replacing glutamic acid- 
566 with lysine was either inherited from the father or occurred spontaneously. Both 
mutations retain the Ligase I enzyme with less than 5% activity (Barnes et al., 1992, 
Lehmann et al., 1988, Prigent et al., 1994).
The fibroblast cell line is highly sensitive to DNA damaging agents and shows a slightly 
increased level of sister chromatid exchange (SCE) after treatment with UV irradiation 
and methylating agents. Most interestingly, DNA Ligase I deficient fibroblasts have a 
defect in Okazaki fragment joining and single strand nick sealing during DNA damage 
repair (Prasad et al., 1996, Prigent et al., 1994). Several studies have shown that the 
ligation kinetics of 46BR are affected. In contrast to an unaffected ligation reaction, the 
reaction is retarded due to an accumulation of the two normally transient intermediate 
products, Ligase I-AMP and nicked DNA-AMP (Henderson et al., 1985, Lonn et al., 
1989, Prigent et al., 1994).
Cytotoxic DNA lesions caused by oxidative damage are normally repaired by base 
excision repair (BER) (Laval et al., 1998). Two sub-pathways have been identified 
which are distinguished by the nucleotide replacement size and proliferating cell nuclear 
antigen (PCNA) dependency (Fortini et al., 1999, Frosina et al., 1996). The short patch 
BER pathway is dependent on polymerase-p and results in the removal and replacement 
of a single nucleotide. The strand re-ligation is carried out by either DNA Ligase I or III. 
In contrast to short patch BER, long-patch BER is dependent on PCNA and involves the 
removal of an oligonucleotide (2-11 nts) from the DNA lesion. The nicked DNA is 
sealed by DNA Ligase I. Not surprisingly, DNA Ligase I deficiency results in the 
favouring of the short patch BER in 46BR cells (Levin et al., 2000). Western Blot 
analysis of GM16096 fibroblasts showed that DNA Ligase I levels are significantly 
lower (Liang et al., 2008) whereas DNA Ligase III levels are enhanced compared to 
normal cells (Moser et al., 2007) and therefore are thought to compensate for DNA 
Ligase I deficiency. In conjunction with the PARP inhibitor lethality (Lonn et al., 1989), 
these observations suggest that the survival of GM 16096 fibroblasts depends on PARP1 
and DNA Ligase III. The DNA damage response (DDR) in 46BR.1G1 cells, the human
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simian virus 40-transformed form of 46BR (GM16096) is altered. However there is only 
a moderate delay in cell cycle progression as the cells do not activate the S-phase 
specific ATR/Chkl checkpoint (execution of mitosis). In contrast, the ATM-mediated 
DNA damage checkpoint appears to be chronically activated (Soza et al., 2009).
Surprisingly, there is no defect in V(D)J recombination to explain the immune 
deficiency instead it appears to result from a defect in B and T cells proliferation after 
stimulation (Hsieh et al., 1993, Petrini et al., 1994).
The absence of functional DNA Ligase I in mice is developmentally lethal due to 
insufficient foetal liver erythropoiesis. However, in early stages of embryogenesis 
another ligase compensates for the lack of DNA Ligase I in other foetal tissues (Bentley 
et al., 1996). DNA Ligase I null mice primary fibroblasts also fail to convert the ligation 
reaction intermediates resulting in a delayed DNA joining process. In contrast to human 
patient derived primary fibroblasts; mouse cells display no lethal sensitivity to DNA 
damaging agents and to the PARP inhibitor 3'- AB. They also show normal level of SCE 
(Bentley et al., 2002). A mouse model (46BR mice) mimicking the mutation observed in 
the patient with DNA Ligase I deficiency was created by introducing Arg-771 to Trp 
replacement mutation into mice. The 46BR mice are challenged in their foetal 
erythropoiesis but evolve into mature animals though at the slower pace than wild type 
mice. Primary fibroblasts from 46BR mice have a significantly increased level of 
genomic instability due to the same abnormal DNA ligation mechanism as seen in 
human 46BR primary fibroblasts. Old 46BR mice display an increased risk of cancer 
and develop rare epithelial tumours (Harrison et al., 2002).
3.2.3 Oxidative Stress and Telomeres
The proliferative capacity of normal fibroblast populations is dependent on seeding 
densities and oxygen concentration (Balin et al., 1984). Lowering the oxygen 
concentration or supplementing the growth media with antioxidants reduces the level of 
oxidative stress on the cells and therefore facilitates an increase in replicative lifespan of
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the cells (Chen et al., 1995). The same effect has been observed in cultures from human 
colorectal mucosa, mouse leukaemia cells and primary melanoma cells (Gupta and 
Eberle, 1984, Pritchett et al., 1985, Joyce and Vincent, 1983). Several more recent 
studies have demonstrated that IMR90 human fibroblast enter premature senescence 
following the treatment with hydrogen peroxide (H2O2). This reactive oxygen species 
induces oxidative stress which has been attributed to induce varying levels of DNA 
damage resulting in the damaged cell exiting the cell cycle within the first 24 hours after 
treatment (Chen et al., 1998, Chen et al., 1995, Chen et al., 2001). H2O2 treatment 
initiates a DNA damage response via p53, p21 and p i6 activation resulting in the cell 
cycle arrest in S-phase (Cheng et al., 2004). Further data suggest a link between 
oxidative damage and telomere biology. Observation in WI38 cell showed that high 
oxygen levels (40%) lead to premature senescence. Interestingly, the telomere lengths at 
senescence were similar to those observed at 20% oxygen. This lead to the hypothesis 
that the elevated telomere erosion rate in WI38 cells cultured at high oxygen levels were 
due to oxidative stress (von Zglinicki, 2002). Similar results were achieved when 
culturing IMR90 at 20% oxygen compared to cells cultured at 5% oxygen (von 
Zglinicki, 2002). Furthermore, IMR90 fibroblasts cultured at 20% oxygen failed to 
immortalise with the forced expression of telomerase (Wright and Shay, 2001). However 
the cells easily immortalise when cultured in 3% oxygen (Britt-Compton et al., 2009, 
Forsyth et al., 2003). In contrast to IMR90 cells, MRC5 and HCA3 fibroblast strains 
show no differences in cell proliferation and telomere erosion at varying oxygen tension 
(Lorenz 2001, Britt-Compton 2009). The controversy concerning oxidative stress as a 
direct cause of telomere loss is further helped with observation in G6PD deficient 
primary foreskin fibroblasts HFF1 and HFF3 which both prematurely senesce after H2O2 
treatment, but none of these cells display elevated telomere erosion rates (Cheng et al., 
2004).
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3.2.4 Aims
The aim of this work was to investigate if DNA Ligase I modulates telomere dynamics 
and the role that DNA Ligase I may play in the mechanism that underlies the fusion of 
short dysfunction telomere.
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3.3 Results
3.3.1 Optimising the replicative lifespan of DNA Ligase I deficient cells
Previous studies have shown that oxidative stress can reduce the replicative lifespan o f  
primary human fibroblasts (Forsyth et al., 2003). It is conjectured that radical oxygen 
species induce varying levels o f  DNA damage leading to premature cell cycle arrest. 
Large quantities o f non-proliferating cells can imply a raised telomere erosion rate 
(Chen et al., 1995). Furthermore, other studies indicate that the telomere erosion rate is 
directly influenced by DNA damage in the telomeric region resulting from oxygen 
tension (von Zglinicki, 2002). DNA damage caused by oxygen radials is normally 
repaired by BER (Laval et al., 1998). DNA Ligase I deficient fibroblasts are impaired in 
BER and favour the short patch BER pathway (Levin et al., 2000). Consequently 
oxidative stress may impede the replicative capacity o f the Ligase I deficient fibroblast 
and thus influence the telomere dynamics observed in the cells. Therefore parental 
Ligase I deficient cells at PD 7.99 were either cultured under normal culture conditions 
(20% O2) or under physiological oxygen levels o f 3% to reduce oxidative stress. The 
fibroblasts were passaged serially in culture and the accumulated PDs were documented 
as a function o f time (Fig. 3.1). After 20 passages the replicative capacity o f GM 16096 
was exhausted at both oxygen concentrations and the cell numbers drop significantly.
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Figure 3.1 Growth curves o f  DNA Ligase I deficient cells cultured in 3% and 20% Oxygen. Plotting 
growth curves as function o f  population doublings (PD) versus time in days. Filled markers represent 
cells cultured at 20%  oxygen and open markers represent those cultured in 3% oxygen.
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Growth curves for both cultures conditions are similar except for a clonal outgrowth of 
the 20% O2 culture close to senescence (indicated with *). Compared to the cultures at 
20% O2, culturing DNA Ligase I deficient fibroblasts at 3% O2 increased the 
proliferating lifespan of the cells by 6.7 PDs. The mean growth rate during the 
exponential growth phase of the two cultures at 3% and 20% O2 was determined to be 
0.244 PD/day ± 0.199 and 0.152 PD/day ± 0.099 respectively. The slight increase in 
growth rate resulting from the lower oxygen concentration accounted for the extended 
lifespan of the cells at 3% oxygen.
Although the GM16096 was derived from a relative young individual (age 18), the 
fibroblasts had a limited replicative capacity of 26 and 28 PD at 20 and 3% O2 
respectively. This is in contrast to normal human fibroblast which undergo 40 to 70 PDs 
before they enter a stable proliferative arrest termed replicative senescence (Hayflick, 
1965). Replicative senescence is defined by a characteristic morphology of high 
endogenous senescence-associated mammalian 0-galactosidase activity index (>90%), a 
very low (<3%) BrdU labelling index and very low death rates (Bond et al., 1999). 
After 4 weeks of no apparent growth in both cultures, cell proliferation was tested by 
BrdU labelling. The cells at 20% O2 presented a BrdU index of 23% in PD 21.74. For 
the cells at 3% O2, a BrdU index of 1.8% in PD 26.36 was determined indicating that the 
cells had reached senescence.
3.3.2 Telomere dynamics of DNA Ligase I deficient fibroblasts
In order to investigate whether low DNA Ligase I activity (< 5%) influences telomere 
dynamics, the XpYp and 17p telomere length distribution of the cells under both culture 
conditions were determined by using single telomere length analysis (STELA) (Baird et 
al., 2003). Only the XpYp and 17p telomeres were analysed since previous studies in our 
group have shown the XpYp telomere length conforms with average chromosomal 
telomere length (Baird and Farr, 2006, Baird et al., 2003). In addition, the telomere 
erosion rates resulting from the end-replication problem are similar at most chromosome 
ends (Britt-Compton et al., 2006). Several samples were taken during the course of the 
experiment and were analysed.
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with STELA. The telomere length profiles for the DNA Ligase I deficient fibroblast 
strain GM 16096 are shown in figures 3.2 and 3.3.
It was evident from the more homogenous telomere length distribution that a clonal 
outgrowth had occurred in the culture at 20% oxygen (Figure 3.2a, PD 23.1 and 25.8), 
overtaking the whole culture and resulting in an apparent increase in XpYp telomere 
length in the last PDs of the culture. Therefore the culture obtained the minimal telomere 
length in 20% oxygen at PD 21.71. Senescence for the culture in 3% oxygen was 
determined at 28.4 PDs. Comparing the two cultures at these two PD points, STELA 
revealed a significantly longer XpYp telomere length under 3% oxygen at the point of 
senescence (p-value <0.01, two tailed t test). In contrast, 17p telomere length appears to 
be similar for both culture conditions at senescence (p-value 0.569, two tailed t test).
From the growth curve (Fig. 3.1) the culture at 20% O2 exited the exponential growth 
phase after 77 days. The lower oxygen level of 3% O2 increased the exponential growth 
phase of the cells for 17 days. In the 20% O2 culture, mean telomere length decreased by 
2.61 kb at the XpYp telomere and by 1.54 kb at the 17p telomere at senescence over
13.9 PDs. The culture at 3% displayed a loss in mean telomere length of 2.01 kb at 
XpYp telomere and of 0.55 kb at 17p telomere at senescence over 16.7 PDs. The erosion 
rates for the XpYp and 17p telomere at each oxygen concentration were calculated 
separately and are shown in Fig. 3.4. The mean rates of erosion of the two chromosome 
ends were determined to be 180.1 ± 27.5 at 20% O2 and 99.6 ± 47.5 at 3% O2 (bp/PD ± 
SE).
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a)
20% Ch 3% Oa
telomere Erosion rate 20% O2  Number of Erosion rate 3% O2  Number of 
bp/PD R2 Data points bp/PD R2 Data points
XpYp 213 0.81 7 135 0.76 10
17p 146 0.92 7 29 0.23 10
overall mean 180.1 overall mean 99.6
overall SE 27.5 overall SE 47.5
Figure 3.4 Summarising the telomere erosion rate data from DNA Ligase I deficient fibroblasts in 
3% and 20% oxygen, a) Telomere erosion rate is calculated as the slope of the regression line after 
plotting the mean telomere length against the corresponding PD. Individual Telomeres are detailed 
on the right, oxygen concentration is displayed above; error bars are ± standard error; y-axis presents 
mean telomere length; x-axis represents PD. b) Erosion rates, accompanying R2 and the number 
of data points for each chromosome are displayed.Overall mean and corresponding standard errors 
are also detailed.
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3.3.3 Telomere dynamics of DNA Ligase I deficient fibroblasts expressing 
HPV16 E6E7 oncoproteins
Given the overlapping function of DNA Ligase I in base excision repair and Okazaki 
fragment joining, the key objective for investigating DNA Ligase I deficient cells was to 
examine the role that DNA Ligase I could play in telomere fusion events. In order to do 
so, telomere length of Ligase I deficient cells was pushed into the range in which 
telomeres become unprotected and undergo fusion (Capper et al., 2007). This was 
achieved by the forced expression of the human papillomavirus HPV16 E6E7. These 
oncoproteins abrogate the function of p53 and Rb allowing the cells to bypass 
senescence and continue to divide to crisis. The expression of E6E7 did not extend the 
replicative life span of the DNA Ligase I deficient cells to the same extend as normal 
human fibroblasts, where typically 26 -  28 PDs can be achieved (Capper et al., 2007). 
Instead the Ligase I deficient cells reached crisis 5-10 PDs after senescence making it 
difficult to obtain sufficient amounts of cells for STELA and fusion assay samples. The 
problem was avoided by altering the existing protocol and transfecting the cells with 
HPV16 E6E7 in PD 12 instead of 3-4 PDs before reaching senescence. Since abrogation 
of p53 and Rb does not influence growth rate and phenotype of the cells (Capper et al., 
2007), only four clones expressing E6E7 (clones 7, 8, 9 and 17) and two clones 
expressing empty vector (Neo clones 1 and 5) achieved sufficient cell numbers (average 
for E6E7 clones: 5 x 104 cells, for Neo clones: 2.5 x 104 cells) for STELA and fusion 
assay samples.
STELA was used to track the telomere dynamics as the cells divide through to crisis. As 
the E6E7 clones approached crisis, the cell cultures ceased to expand resulting in a 
decline in the calculated PDs. This decline is completely artificial and a result of the 
methodology (see chapter 2.1.4). In order to indicate that the cells were still proliferating 
the number of days, the cells were kept in culture after infection, are displayed below the 
calculated PDs in figure 3.5. As expected, following the expression of HPV16 E6E7, the 
XpYp telomere of the E6E7 clones continued to erode beyond the length of the 
senescent control cells (NEO clones 1 and 5) (Fig. 3.5 a). The 17p telomere of the E6E7 
clones eroded beyond a threshold length where it was no longer detectable with STELA
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(Fig 3.5 b). The number of 17p telomere bands decreased with ongoing cells division, so 
that on average less then 4 % of cells retained a detectable 17p telomere at crisis. This 
indicated that this telomere had been lost from the cell population (Figure 3.5 b). Both 
Neo clones show no loss of detectable 17p telomere; the amounts of XpYp and 17p 
bands are similar at senescence (Fig. 3.5).
3.3.4 Fusion assay of DNA Ligase I deficient fibroblasts expressing HPV16 
E6E7 oncoproteins
A previous study has shown that short telomeres in normal MRC5 fibroblasts 
approaching crisis, which are no longer detectable by STELA, have become de­
protected and can undergo fusion (Capper et al., 2007). The presence and quantity of 
telomere-telomere fusion events in DNA Ligase I deficient fibroblasts was determined 
using long-range single-molecules PCR amplifications with 3 primers for 17p, XpYp 
and 21q group telomeres (21q, lq, 2q, 5q, 6q, 6p, 8p, lOq, 13q, 17q, 19p, 19q, 22q and 
the 2ql3 interstitial telomeric locus) (Letsolo et al., 2009) (Fig. 3.6). It was not possible 
to detect fusion between XpYp and the chromosome ends of 17p or members of the 21q 
group. This is consistent with the observation that both XpYp alleles are relatively long 
and are probably still fully capped compared to the 17 p telomere where complete 
telomere loss was observed (Fig. 3.5, 3.6). The fusion frequency was calculated for the 
17p chromosome since most fusions include the 17p chromosome (Fig. 3.6, 3.7). In line 
with previous work in our group (Letsolo et al., 2009, Capper et al., 2007), the fusion 
frequency increased near crisis. The average fusion frequency of all 4 analysed clones at 
crisis is 1.7 x 10'3 ± 1.1 x 10'3. Notably, this frequency is approximately 4 to 5 times 
higher than fusion frequency previously observed in similar manipulated E6E7 
transformed MRC5 fibroblasts analysed using the same fusion assay. With an estimated
3.9 x 10"4 fusions events per analysed DNA molecule this fusion frequency was the 
highest frequency observed thus far (Letsolo et al., 2009).
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3.3.5 Internal Structure of Fusions in Ligase I deficient fibroblasts 
expressing HPV16 E6E7 oncoproteins
In order to gain insight in the mechanistic basis of telomere-telomere fusion events, 25 
telomere-telomere fusion events in DNA Ligase I deficient cells expressing E6E7 were 
re-amplified and sequenced (Fig. 3.7). Because of the nature of fusion events between 
two members of the 21q group, it was not possible to separate the double sequence data 
of 10 fusions (data not shown). Only in one case (Fig. 3.7 d), the location of the fusion 
point allowed the separation of a fusion event between two members of the 21q group. 
The 15 analysed fusion events involved the deletion of one or both telomeres (Fig. 3.7). 
Interestingly, 87% of analysed fusion events involved the 17p telomere (Fig. 3.6, 3.9) 
which was consistent with the loss of this telomere in the crisis cells (Fig. 3.5). 
However, only one of these included a deletion into telomere-adjacent DNA sequence of 
17p (Fig. 3.7 c). The deletion events only occur in members of the 21q group (mean 
1916 bp ± 764 bp) (Fig. 3.7 and 3.8). The deletions include the TVR region of the 
telomere and extend into the telomere-adjacent DNA up to the limit of the fusion assay 
for the 21q group at 3.2 kb. This is in contrast to previous observations in MRC5 cells 
where all investigated chromosome ends displayed varying degrees of telomere repeat 
sequence and several kb of the telomere-adjacent DNA deletions (Letsolo et al., 2009, 
Capper et al., 2007). The distribution of fusion points within the TVR region of the 17p 
telomere (Fig. 3.9) appeared to be random; indicating no clear hot spot for fusion points.
3.3.6 Microhomology at Fusion point
Out of the 15 fusions analysed, 10 of the fusion points (66.6%) contained nucleotide (nt) 
homologies at the fusion point (Fig. 3.7 and 3.8 a). On average 1.0 nt ± 0.22 nt (mean ± 
SE) of 100% sequence homology were observed, with additional homologies in the 20 
bp left and right of the fusion point. The additional homologies were found on both sides 
of the fusion point, with no clear tendency to one side (left: 22.3%, right 18.6%, overall 
mean 20.5%). Previous analysis of normal fibroblasts revealed a bias in the G:C content 
of the sequence of the microhomology regions (Letsolo et al., 2009). A G:C bias was not
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observed in the fusion molecules derived from the Ligase I deficient cells. However this 
may be accounted simply by the small sample size.
3.3.7 TTAGGG repeat content at fusion point
Only 37.5 % of the analysed fusion events contained telomeric TTAGGG repeats at the 
fusion point (Fig 3.8 b) with a mean of 1.1 ± 0.38 nt (mean ± SE) and a maximum 5 
repeats. All the observed repeats could be allocated in the TVR region of the 17p 
telomere (Fig 3.9). All fusion events had only TTAGGG repeats on one side of the 
fusion. This is consistent with the hypothesis, that telomere have to erode into TVR 
region to loose the protection through the shelterin complex and undergo fusion (Capper 
et al., 2007).
3.3.8 Complex fusion events
Most of the analysed fusion events involve only the 17p telomere and a member of the 
21q group. However two of the fusion events are more complex including large patches 
of non-telomere sequences in the fusion. One of these fusion events is depicted in Fig. 
3.7 e. The fusion event between a member of the 21q group and the lip  chromosome 
contains an insert derived from a sequence located near 3p24. It is noteworthy that the 
3p24 sequence is within the vicinity of the FRA3A fragile site and the fusion point with 
the 1 lp chromosome is close to the FRA11C site (Debacker and Kooy, 2007, Debacker 
et al., 2007). Both sites are common fragile sites which are present in nearly all 
individuals and are thought to be part of the chromosomal structure (Debacker et al., 
2007, Durkin et al., 2008). Previous data has indicated that telomere fusion with non- 
telomeric loci may preferentially occur adjacent to fragile sites (Letsolo et al., 2009). 
The second fusion event containing non-telomeric DNA was only partly sequenced due 
to the limited amount of DNA. Nevertheless it was possible to identify an insert derived 
from 15pl3 nested between the involved lOq telomere and 17p telomere. From the 
limited size of the analysed data set, it was apparent that no statistical significant 
conclusion can be drawn.
82
3.3.9 Increased Frequency of Single Nucleotide Mutations in DNA Ligase I
Deficient cells
While analysing the sequence of the observed fusion events in DNA Ligase I deficient 
human fibroblast expressing HPV E6E7, an increased frequency of single nucleotide 
mutations has been observed in the sub-telomeric sequence of the 17p telomere and 
members of the 21q group (data not shown). The sequence variances made it difficult to 
differentiate between the individual chromosomes in the 21q group. Due to the limited 
amount of DNA used for the sequence analysis of the fusion events, it was not possible 
to gain a re-presentable overview of the frequency and position of these single 
nucleotide mutations (data not shown).
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Figure 3.7 DNA sequences data o f fusion events in DNA Ligase I deficient fibroblasts expressing E6E7.
a) 13q:17p fusion b) 13q:17p fusion c) 19q:17p. the only fusion with a subtelomeric deletion o f  17p. 
d)13q:21q group, an example for a fusion between two members o f the 21 q group e) 21q group:3p:l lp, 
fusion with an insertion. Telomere-adjacent DNA is shown in multicolor, TTAGGG repeats (T)in black, 
variant reparts (V) in red and inserts in brown. Fusion points, deletions size in bp. microhomoloy (bold 
and underlined) and number o f  T and V repeats are indicated below.
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Figure 3.8 Histograms summarizing the telomere fusion data in DNA Ligase 1 deficient fibroblasts 
expressing E6E7. a) size of 100% sequence homology at the fusion point, b) the number of TTAGGG 
repeats ajacent to the fusion point c) the deletion size from the start of the telomeres of the 2 Iq group.
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Figure 3.9 Fusion point in the 17p telomere. Fusion points highlighted in yellow.
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3.4 Discussion
3.4.1 Replicative Lifespan, Oxidative Stress and Telomere Erosion in Ligase
I deficient cells
The replicative lifespan of GM 16096 is limited with a maximum of 26-27 PDs obtained 
prior to replicative senescence. Cells were obtained from the Corriel Cell Repository, no 
further information of the proliferative history of the cells was available prior to this 
study. Other studies (Cabuy et al., 2005, Soza et al., 2009) indicate that the proliferative 
capacity of DNA ligase I deficient cells GM16096 is significantly reduced compared to 
normal fibroblast where 40 to 70 PDs at the points of replicative senescence are 
expected (Hayflick, 1965). The replicative capacity of Ligase I deficient fibroblasts is in 
line with that observed in other DNA repair deficient fibroblasts cultures such as Werner 
(Tollefsbol and Cohen, 1984, Martin et al., 1970), DNA Ligase IV syndrome (chapter 4 
in this thesis) and NBS1 deficient fibroblast (chapter 5 in this thesis).
Soza et al 2009 demonstrated that DNA Ligase I deficiency leads to an increased 
number of single-stranded and double-stranded DNA breaks in 46BR.1G1 cells, the 
human simian virus 40-transformed form of 46BR (GM16096). It was also apparent that 
Ligase I deficiency results in moderate delays to cell cycle progression as Okazaki 
fragments remain in the intermediate form (DNA Ligase I-AMP and nicked DNA-AMP) 
for a prolonged time (Prigent et al., 1994, Levin et al., 2000). The resulting DNA 
damage in the newly synthesised DNA strand does not activate the S-phase specific 
ATR/Chkl checkpoint which takes care of problems encountered by replication fork 
(Lukas and Bartek, 2004). The presence of a persistent DNA damage response is likely 
to result in an increase of quantity of cells exiting the cell cycle, thus creating a 
discrepancy between the actual cell divisions of the cultures and the calculated 
population doublings (PDs). In this situation the majority of growth in the culture will 
be driven by the proliferation of a smaller number of cells. This will have the effect of 
both attenuating the replicative lifespan of the culture and will exacerbate the apparent 
rate of erosion as a function of PD. This may account for the attenuated replicative 
capacity of the Ligase I cell culture, and how lower oxygen tensions, that are considered 
to reduce the extent of oxidative stress (Forsyth et al., 2003) and DNA damage, result in
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an increase in the replicative capacity. Consistent with this hypothesis, Cabuy et al 2005 
also reported elevated levels of telomere erosion in GM16096, ranging from 120 bp/PD 
to 200 bp/PD depending on the method used to determine telomere length (Southern blot 
and Flow-FISH). Furthermore this may provide an explanation for the increased rate of 
telomere erosion that was apparent in these cells at 20% O2 that was reduced in lower 
oxygen tensions.
An alternative explanation for the increased rates of telomere erosion, observed at 20% 
oxygen, might be that the absence of Ligase I changes the biochemistry of the end- 
replication problem, for example by increasing the size for Okazaki fragment and thus 
increasing the amount of DNA lost from the terminus with each cell division. However, 
there is no evidence that Ligase I deficient cell exhibit an increase in Okazaki fragment 
size. Furthermore if changes in Okazaki fragments size accounted for this difference, 
culturing the cells in different oxygen tension would not be predicted to decrease the 
rates of erosion, as was observed in this study. A further explanation may also be that 
Ligase I deficient cells exhibit an impaired repair ability to repair double-stranded DNA 
breaks, double-strand breaks within the telomere would have the effect of increasing the 
rates of erosion. However this also appears unlikely as no evidence of any increases in 
telomere length heterogeneity could be observed in these cells, indeed the telomere 
length distributions of these was in distinguishable for that observed in normal fibroblast 
cell cultures (Baird et al., 2003, Britt-Compton et al., 2006, Capper et al., 2007).
3.4.2 Telomere Fusion in DNA Ligase I Deficient human fibroblasts
The expression of HPV E6E7 yielded 4 clonal cell populations, whilst there was no 
apparent proliferative lifespan extension as determined by estimating the population 
doublings by cell counting, the fact that the telomeres were considerably shorter when 
these cells entered ‘crisis’ compared the control clones, suggest that there was indeed a 
lifespan extension. These cell populations exhibited homogenous telomere length 
distributions that were consistent with clonal growth, there were no apparent differences 
in these distributions compared to clonal populations of normal human fibroblasts (Baird 
et al., 2003, Capper et al., 2007). Bimodal distributions were observed at the XpYp
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telomere that were consistent with allelic telomere length variation. At the point of 
crisis the bimodal distributions at XpYp were intact, however 96% of cell had 
completely lost the 17p telomere. Telomere fusion was readily detected in these cells, 
consistent with the telomere length data, telomere fusion could not be detect involving 
the intact XpYp telomere, and the majority (84%) of fusion involved the 17p telomere 
that showed complete loss. Interestingly the maximum telomere fusion frequency 
(4.6x1 O'3) was 10 fold higher than that detected in normal MRC5 cells expressing 
HPVE6E7 (3.9x1 O'4) (Capper et al., 2007, Letsolo et al., 2009) which had lost the 17p 
and XpYp telomeres and were analysed using the same fusion technology. An 
explanation for this is not immediately apparent. However it is of interest to note that 
Ligase I deficient cells exhibit an up-regulation of Ligase III (Moser et al., 2007) and 
favour short patch base excision repair which is Ligase III dependent and involves the 
removal of a single nucleotide (Levin 2000). Long patch base excision repair, in 
contrast, requires Ligase I and involves the removal of larger patches of DNA 
surrounding the lesion (2-12 nt). Ligase III is considered to play a key role in Ku 
independent error prone end joining process alternative NHEJ (Zhu et al., 2000, Wang et 
al., 2005, Audebert et al., 2006, Audebert et al., 2004). It may also be pertinent to note 
that in this study a reduction, of borderline statistical significance, in the amount of 
microhomology at the fusion point was observed.
A further aspect of the telomere fusion data in Ligase I deficient cells was that in a 
sample of 15 fusion events involving the 17p only one displayed a sub-telomeric 
deletion event. Again the explanation for this is unclear. However, the increase in the 
fusion frequency (x5) suggests the possibility that the fusion process is more efficient 
and thus short dysfunctional telomere may be subjected to fusion prior to substantive 
end-processing creating large deletion events. This observation may also provide an 
alternative explanation of the apparent increased frequency of fusion, the lack of sub- 
telomeric deletions at 17p may render the fusion assay more efficient as the paucity of 
sub-telomeric deletion preserves the 17p telomere-adjacent primer sites.
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3.5 Conclusion
DNA Ligase I deficient fibroblasts display an attenuated replicative lifespan. However, 
only the cells cultured at 20% oxygen present an elevated telomere erosion rate 
compared to normal fibroblast. Thus it could be speculated that premature senescence in 
these cells is not the result of increased telomere attrition as telomere erosion rates at 3% 
oxygen are in the range observed in normal fibroblasts. Instead it might be possible that 
DNA Ligase I deficient fibroblasts are sensitive to oxidative stress. Telomere fusion can 
be readily detected in Ligase I deficient cell undergoing crisis. The elevated rates of 
fusion may be related to the bias in the use of short patch base excision repair.
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Chapter 4: DNA Ligase IV syndrome
4.1 Abstract
DNA Ligase IV is a core component of classic non-homologous end joining (C-NHEJ). 
Two patient derived Ligase IV syndrome fibroblast cultures were analysed in this study. 
Both fibroblast strains contain hypomorphic mutations in LiglV gene resulting in 
residual DNA ligase IV activity and impaired C-NHEJ.
The telomere dynamics in Ligase IV deficient fibroblast were investigated using 
STELA. An accumulation of critically short telomeres could be detected in the parental 
fibroblast cultures. It appears that premature senescence of DNA Ligase IV syndrome 
cells is not a result of elevated telomere attrition as telomere erosion rates are in the 
range observed in normal human fibroblasts. However the distribution of short telomeres 
could trigger a DNA damage response inducing premature senescence.
Another aspect of this study was to examine the role of Ligase IV in telomere fusion. 
However the expression of HPV16 E6E7 in DNA Ligase IV syndrome strains failed to 
drive average telomere length of DNA Ligase IV deficient fibroblasts into the length 
range at which telomeres become unprotected and undergo fusion. Nevertheless the 
investigation of the parental cultures displayed a low but significantly elevated fusion 
frequency. This is in contrast to telomere fusion following the experimental abrogation 
of TRF2 which are dependent on DNA Ligase IV. These data are consistent with the 
view that classical NHEJ is not the predominant mechanism underlying the fusion of 
telomeres.
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4.2 Introduction
4.2.1 DNA Ligase IV
As with DNA ligase I, DNA ligase IV is an ATP-dependent nucleotidyltransferase 
(NTase) (Martin and MacNeill, 2002). DNA Ligase IV functions in non-homologous 
end joining (NHEJ) and V(D)J recombination. The Ligase forms a complex with 
XRCC4 and is unstable in the absence of XRCC4 (Critchlow et al., 1997). Interestingly, 
DNA Ligase IV has the ability to join DNA ends which are non-complementary because 
of mismatches and small gaps (Gu et al., 2007).
4.2.2 DNA Ligase IV Syndrome
14 individuals with DNA Ligase IV Syndrome have been reported, each with a 
hypomorphic mutation in the DNA Ligase IV gene (O'Driscoll et al., 2004, Rucci et al., 
2010). The first case with DNA Ligase IV deficiency was discovered in a 14 year old 
acute lymphoblastic leukaemia patient (180BR) who displayed an extreme sensitivity to 
radiation therapy and died following radiation morbidity (Plowman et al., 1990). 
Previously to the diagnosis with leukaemia, the patient was clinically normal and did not 
share the more severe symptoms of the other individuals with DNA Ligase IV 
syndrome. The symptoms include “bird-like” features, microcephaly, pancytopenia, skin 
abnormalities, growth retardation, neurological abnormalities, occurrences of 
malignancy and varying degrees of immune deficiencies (O'Driscoll et al., 2001, 
O'Driscoll et al., 2004). All these symptoms are reminiscent of Nijmegen Breakage 
Syndrome (NBS) and Ataxia Telangiectasia (AT)(Girard et al., 2000).
Two patient derived fibroblast strains were analysed in this study. GM16088 were 
derived from a forearm skin biopsy of the radiation sensitive leukaemia patient 180BR 
(Arlett and Priestley, 1984); GM 17523 were derived from a 9 year old individual 
(99P0149) displaying the clinically more severe characteristics of DNA Ligase IV 
syndrome (O'Driscoll et al., 2001).
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Both fibroblast cultures are viable due to residual Ligase IV activity (Girard et al., 2004, 
O'Driscoll et al., 2001, Riballo et al., 2001). In mice Lig4 null mutations result in 
embryonic lethality (Barnes et al., 1998, Gao et al., 1998). In order to create a Ligase IV 
syndrome model in mice, two mice strains with hypomorphic mutations in the Lig4 gene 
have been established. The ligase IV activity in both strains is reduced 10 fold and 
similar symptoms to humans with Ligase IV syndrome are observed (Nijnik et al., 2009, 
Rucci et al., 2010).
4.2.3 GM16088 or 180BR
Radiation sensitivity is a characteristic of AT (Davis and Kipling, 2009). However, in 
contrast to AT, normal levels of DNA synthesis inhibition were observed in cells from 
thel80BR patient following radiation (Plowman et al., 1990). Further studies revealed 
that even low levels of radiation and consequently low quantities of induced DSBs are 
lethal for cells derived from patient 180BR. This suggested a pre-existing defect in DNA 
double strand repair and an increased sensitivity to chromosomal breakage (Badie et al., 
1995a, Badie et al., 1995b). However members of the DNA-PK complex (Ku70, Ku80 
and DNA-PKcs) are expressed at normal levels in these cells. Furthermore, the DNA 
end binding activity of Ku and DNA-PK activity are indistinguishable from normal cells 
(Badie et al., 1997). Interestingly, in contrast to AT and NBS, 180BR cells are not 
compromised in their ability to arrest at cell cycle checkpoints (Badie et al., 1997). The 
sequencing of the DNA Ligase IV cDNA revealed a homozygous G to A missense 
mutation at position 833. The substitution of arginine with a histidine (R278H) results in 
the remodelling of a highly conserved motif close to the active lysine site of the ligase 
(Riballo et al., 1999). The structural change reduces the ability of DNA Ligase IV to 
form a stable enzyme-adenylation complex retaining the adenlylation activity in 180BR 
below 5% of wild type activity (Riballo et al., 1999). In addition to the low adenylation 
activity, the R278H mutation impairs the double strand and nick ligation ability of 
Ligase IV in 180BR leaving the Ligase with less then 10% of wild type ligation ability 
(Girard et al., 2004, Riballo et al., 2001). The mutation also impacts on the V(D)J 
recombination by inducing imprecise signal end joining (Riballo et al., 2001). V(D)J
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joining in 180BR fibroblasts is carried out at a lower frequency than wild type 
comprising large deletions (2-40 nt) and fewer microhomologies at the joining point 
(Riballo et al., 2001). Taking this together, the R278H mutation leaves the DNA Ligase 
IV conformationally unstable and with a ligase activity of less than 10%. In contrast to 
patient 99P0149, the residual activity of DNA Ligase IV in 180BR is enough to ensure 
normal development explaining why the patient did not display the more severe 
symptoms of DNA Ligase IV syndrome (Girard et al., 2004).
4.2.4 GM17523 or 99P0149
Patient 99P0146 displayed characteristic symptoms of NBS but did not have a mutation 
in NBS1 and produced normal levels of nibrin protein (Cerosaletti et al., 1998, Hiel et 
al., 2001). Further analysis revealed the patient to be a compound heterozygote for two 
mutations in the DNA Ligase IV gene (O'Driscoll et al., 2001). The first mutation, a C to 
T substitution at position 2440 (R814X) results in a truncation of the DNA Ligase IV 
protein between the two C-terminal BRCT domains present in Lig4. The mutation 
interferes with the XRCC4 binding ability of Ligase IV leaving the protein complex 
unstable (Girard et al., 2004, O'Driscoll et al., 2001). The R814X mutation leaves DNA 
Ligase IV with a barely detectable adenylation activity and a residual double strand 
ligation activity of 10 -  15% compared to wild type activity (Girard et al., 2004). The 
second mutation, 1406G>A, converts the amino acid glycine at position 469 in the ligase 
domain to glutamic acid (G469E), impairing ligase IV function without interfering with 
the XRCC4 interaction (O'Driscoll et al., 2001). The G469E mutation yields protein 
with no detectable adenylation and double strand ligation activity. Additionally, only 
residual nick ligation activity could be detected (Girard et al., 2004). Summing up, both 
mutations leave GM 17523 with less then 1% of DNA Ligase IV activity accounting for 
the more severe phenotype of patient 99P0146 (Girard et al., 2004).
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4.2.5 Aims
The aim of this work was to determine if DNA Ligase IV deficiency influences telomere 
dynamics and most interestingly, if DNA Ligase IV is involved in the mechanistic 
pathway fusing short dysfunctional telomeres.
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4.3 Results
4.3.1 Optimising the replicative lifespan of DNA Ligase IV syndrome cells
Radical oxygen species like superoxides, hydrogen peroxide and hydroxyl radicals 
(Halliwell, 1996) can induce different levels of DNA damage in primary human 
fibroblast cultures resulting in premature cell cycle arrest and a significant reduction of 
the replicative lifespan of the cells (Forsyth et al., 2003). Large quantities of non­
proliferating cells in a culture can create an artificial increase in the telomere erosion 
rate (Chen et al., 1995). Furthermore, other studies suggest that oxygen tension directly 
influences the telomere erosion rate by inducing DNA damage in the telomeric regions 
(von Zglinicki, 2002). Both DNA Ligase IV deficient cell lines are impaired in their 
ability to repair DNA damage (Badie et al., 1995b). Therefore oxidative stress may 
aggravate the cells phenotype and consequently attenuate the cultures replicative 
lifespan and influence the telomere dynamics observed in these cells.
In order to determine the influence of oxidative tension on the DNA Ligase IV 
syndrome cells strains GM16088 and 17523, both fibroblast lines were either cultured 
under physiological oxygen levels of 3% O2 or normal culture conditions of 20% 
oxygen. The cells were passaged serially and the accumulated PDs were plotted as a 
function of time (Fig. 4.1). In line with a previous study (Badie et al., 1997), the 
replicative lifespan of both DNA ligase IV syndrome cultures was limited and the cells 
ceased to grow after 20 -  25 passages.
For the cells derived from the DNA ligase IV syndrome patient 180BR (GM 16088), the 
growth curves for both culture conditions are similar (Fig. 4.1a) No increase in 
replicative lifespan could be achieved by culturing the cells at physiological oxygen 
concentrations (3% O2 ). The cells at 20% and 3% oxygen reached their replicative limit 
PD 25 and PD 27, respectively. The growth rates of both cultures, calculated for the 
exponential growth phase of the cells, were determined to be 0.195 PD/day ± 0.115 
PD/day at 20% 0 2 and 0.206 PD/day ±0.127 PD/day at 3% 0 2.
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Figure 4.1 Growth curves o f  DNA Ligase IV syndrome firoblast strains GM 16088 and GM 17523 
cultured in 3 and 20%  oxy gen. Growth curves were plotted as a function o f  population doublings (PD) 
versus tim e in days, a) cells derived from patient 180BR (GM 16088) b) fibroblast derived from patient 
99P0146 (GM 17523). Filled markers represent Fibroblast cultured at 20% oxygen and open markers 
represent those cultured in 3% oxygen.
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In contrast to GM16088, culturing the fibroblast from patient 99P0146 (GM 17523) at 
3% oxygen increased the replicative lifespan of the cells by 5.5 PDs (an increase of 20 
%). The reduction of oxidative tension arising from the low oxygen concentration 
resulted in a slight increase (27%) in the growth rate during the exponential growth 
phase of the cells which accounted for the extended replicative life span of the cells by
5.5 PDs. The growth rates during the exponential growth phase of cells was determined 
to be 0.173 PD/day ± 0.089 PD/day at 20% 0 2 and 0.239 PD/day ± 0.088 PD/day at 3% 
0 2 (mean ± SD).
Both primary cell strains were derived from individuals of similar ages (9 and 14 years) 
exhibited a similar replicative capacity (~ 25PDs). However this was considerably 
shorter than the replicative lifespan normally observed in fibroblast cultures where 60 or 
more PDs would typically be expected (Forsyth et al., 2003, Hayflick, 1965). 
Replicative senescence is defined by a characteristic morphology of high endogenous 
senescence-associated mammalian (3-galactosidase activity index (>90%), a very low 
(<3%) BrdU labelling index and very low death rates (Bond et al., 1999). After 4 weeks 
of no apparent increase in cell numbers in the different cultures, cell proliferation was 
tested by BrdU labelling. The Ligase IV syndrome cells GM16088 at 20% 0 2 presented 
a BrdU index of 7.8 % in PD 25.6. For the cells at 3% 0 2, a BrdU index of 4.9 % in PD
25.3 was determined. Both cultures display a similar BrdU index at a similar PD, 
supporting the assumption that lower oxygen levels do not extend the replicative 
capacity of these cells.
The second fibroblast strain GM17523, a BrdU index of 3.4 % at PD 19.0 in 20% 0 2 
and a BrdU index of 38 % at PD 24.5 at 3% 0 2 were established. All 4 cultures were 
allowed to proliferate for an additional 3 weeks. However after this time, the average 
cell number in both fibroblast cultures at both oxygen concentrations had diminished to 
less then 7 * 104 cells. In order to gain sufficient amount of DNA for STELA and Fusion 
assay, no BrdU labelling was carried out for the last sample of the cultures. It was 
assumed that all cultures except GM 17523 at 3% 0 2 had reached senescence.
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4.3.2 Telomere dynamics of the DNA Ligase IV syndrome cells
In order to investigate whether residual DNA Ligase IV activity influences telomere 
dynamics, the XpYp and 17p telomere length distribution of GM16088 and GM17523 
under both culture conditions were determined by using single telomere length analysis 
(STELA)(Baird et al., 2003). In line with previous studies in the group (Baird and Farr, 
2006, Baird et al., 2003, Britt-Compton et al., 2006), only the XpYp and 17p telomere 
were analysed, as average telomere length conforms to the mean XpYp telomere length 
and telomere erosion resulting from the end replication problem is similar at most 
chromosome ends. Multiple samples were taken during the proliferative lifespan of the 
cultures and subjected to STELA.
The STELA profiles for DNA ligase IV deficient fibroblast derived from patient 180BR 
(GM16088) cultured at 20 and 3% oxygen are displayed in figure 4.2 to 4.4. It was 
apparent that the telomere distributions were complex with bimodal distributions 
observed at the XpYp telomere in both culture conditions (Fig. 4.2 a and 4.4 a). These 
distributions changed as the cells reached the end of their replicative capacity and the 
loss of the lower distribution could be observed. Although less obvious, bimodal 
distributions were also observed at the 17p telomere in both oxygen concentration (Fig.
4.2 b and 4.4 b). Again it was apparent that the lower distribution was lost as the cells in 
3% oxygen reached the end of their replicative lifespan. The same loss could not be 
observed in the cells at 20% oxygen. Comparing the STELA analysis of GM16088 at 
both oxygen concentration with the growth curves (Fig. 4.1 a), it was evident that both 
cultures of GM 16088 exited the exponential growth phase after approximately 77 days 
in culture. The loss of the lower distributions in XpYp and 17p STELA at 20 and 3% 
oxygen in the last PDs of the cultures resulted in an artificial increase in telomere length 
(for 20% 0 2: PD 25.5 and 27.5 in Fig. 4.2 and 4.5; for 3% 0 2: PD 23.7 and PD 25.3 in 
Fig. 4.4 and 4.5). Therefore the minimal telomere length in senescent non-proliferating 
GM16088 cells at both oxygen concentrations was determined at PD 20.5 prior to the 
loss of the lower distribution. Examining both cultures of GM16088 at this PD point 
showed that the bimodal XpYp telomere length
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distribution obtained similar minimal values at senescence in both culture conditions (it 
was not possible to calculate a p-value for the bimodal distributions).
The upper and lower XpYp modal distribution reached a telomere length at senescence 
of 5.2 kb and 1.9 kb respectively (Figure 4.2 a and 4.4 a). Moreover the 17p median 
telomere length of both cultures obtained similar values of 5.0 kb at senescence (Fig. 4.2 
b and 4.4 b) (p-value: 0.441, two tailed t-test). This was consistent with the similar 
replicative histories of the cells in the two oxygen concentrations.
The fastest growth rates were observed in the first 15 PDs of the culture, with a gradual 
slowing of the growth rate as the cells entered the end of their replicative capacity. 
During the first 15 PDs at 20% O2 , the bimodal XpYp telomere length distribution 
decreased by 2.6 kb at the upper modal length whereas the lower distributions decreased 
by 0.5 kb. For the 17p telomere, the culture at 20% O2 displayed a loss of 0.9 kb in the 
median 17p length whereas at 3% O2 a decrease of 1.5 kb at the mean 17p length could 
be observed. The telomere erosion rate data for DNA ligase IV deficient fibroblasts 
GM16088 for 20% and 3% oxygen is summarised in Fig. 4.5. XpYp and 17p telomere 
erosion rates were calculated separately. The erosion rate of both GM 16088 cultures the 
combined average erosion rate of both telomere ends was determined to be 125.4 ± 43.9 
in 20% O2 compared to 112.4 ± 41.5 in 3% O2 (bp/PD ± SE).
STELA requires the sequential hybridisation of the blots with two hybridisation probes; 
a telomere-adjacent probe and then the telomere-repeat containing probe. This allows 
the detection of shorter molecules that do not contain many TTAGGG repeats with the 
telomere-adjacent probe. Interestingly, the telomere adjacent probe for XpYp and 17 
(Fig 4.3) revealed the presence of an additional distribution of very short telomeres in 
cells cultured at 20% oxygen (red box). These short telomeres are in a length range at 
which fusion has been detected (< 252 bp) (Capper et al., 2007, Letsolo et al., 2009). 
The frequency of these short XpYp telomeres (on average < 1% of the analysed 
molecules, Fig 4.3 a) did not appear to be different than those observed in normal 
fibroblasts (Baird et al., 2003, Britt-Compton et al., 2006). However in these previous
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studies, the calculated frequencies refer to the presence of stochastically significantly 
shorter telomeres in unimodal distribution. Due to the bimodal distribution of the XpYp 
telomere in Ligase IV deficient cells GM 16088, it was not possible to determine whether 
these short telomeres are either significantly shorter than the normal distribution of 
telomeres or just a distribution of accumulating short telomeres. The frequency for the 
17p telomere (Fig. 4.3 b) was only calculated for PD 11.3 and 13.1, since it was not 
feasible to exclude that the recurring band in PD 15.3 to PD 21.9 was not a 
contamination of the STELA reaction or a hybridisation artefact. On average 3.8 % of 
the 17p telomere in GM 16088 are shorter than 450 bp (it was not possible to determine 
if this is significant due to the bimodal distribution of the 17p telomere).
The telomere length profiles for the second DNA Ligase IV syndrome culture GM 17523 
at 20% and 3% oxygen are shown in figure 4.6 and 4.7. Again, these displayed complex 
telomere length profiles. At 20% O2 bimodal distributions were evident at both the 
XpYp and the 17p telomere. However a clear tri-modal distribution occurred as the cells 
progressed to the end of their replicative capacity. The appearance of the additional 
distribution appeared to coincide with a substantial decrease in the upper distribution 
between PDs 16.5 and 17.8. As the BrdU index is less than 3.4 % for the cells at 20% 
O2 , it was not possible to determine the minimal telomere length at senescence due to 
the unusual telomere distribution. At 3% O2 , the cells displayed a telomere length 
distribution that was markedly shorter at the 17p telomere (Fig. 4.7 b). This is distinct 
from any other telomere length distribution recorded by STELA (Baird and Farr, 2006, 
Baird et al., 2003, Britt-Compton et al., 2006). The distribution remained constant 
through out the first 23 PDs of the culture and represents on average 14.4 % (ranging 
from 10.3 % to 20.3 %) of the total number of telomeres. The distribution disappeared in 
later samples.
In order to define the rates of telomere erosion in GM 17523 fibroblast at both oxygen 
concentrations, the growth curves were compared with the STELA analysis of the cells. 
Like GM 16088, both cultures exit exponential growth approximate 77 days in
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culture (Fig. 4.1b). During this phase of growth the loss of telomere length at 20% O2 for 
XpYp was 0.46 kb and 0.61 kb for the 17p telomere, over 9.57 PDs. At 3% O2 the loss 
for XpYp was 0.66 kb and 0.84 kb at the 17p telomere over 15 PDs. The erosion rates 
were calculated for the exponential growth phase for XpYp and 17p at each oxygen 
concentration and are shown in Fig. 4.8. The overall mean rates of erosion of GM17523 
were determinded to be 43.85 ± 13.05 bp/PD at 20% 0 2 and 41.50 ± 14.09 bp/PD at 3% 
O2 (mean ± SD).
4.3.3 Telomere dynamics of DNA Ligase IV syndrome fibroblast expressing 
HPV E6E7 oncoproteins
In order to examine the role of Ligase IV in telomere fusion, the cells were forced to 
proliferate beyond the point of senescence. To do this both Ligase IV deficient 
fibroblasts cultures GM 16088 and GM 17523 were transfected with HPV16 E6E7. The 
HPV 16 E6E7 oncoproteins abrogate the function of p53 and Rb and therefore can 
extend the replicative lifespan of normal cells by typically 26 -  28 PDs (Bond et al., 
1999, Capper et al., 2007). Thus, allowing cells to continue to divide and consequently 
the telomeres to erode within the length range where they become de-protected and can 
undergo fusion.
Initial experiments in Ligase IV deficient cells showed that transfection of HPV 16 E6E7 
approximately 3 PDs before the point of senescence was lethal, with no extension of 
proliferate lifespan. Transfection was therefore repeated at an earlier PD point (PD 9). 
This was carried out for both DNA Ligase IV syndrome strains at both 20 and 3% 
oxygen. However it was clear that these cells do not tolerate the presence of HPV16 
E6E7, or they were sensitive to transfection, as they displayed low transfection 
efficiencies compared to similar experiments in normal cells. The cells grew poorly in 
highly diluted cultures and clones could only be established in 20% O2 with GM 16088 
and in 3% O2 with GM 17523, with the other two conditions yielding no viable cell 
clones. The presence of E6E7 did not yield any obvious extension in the replicative 
lifespan (Fig. 4.9). Indeed the control clones of GM 17523 expressing neomycin exhibit a
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longer replicative capacity than the clones expressing E6E7. However the presence of 
E6E7 resulted in large quantity of non-viable floating cells in the cultures at both 20% 
and 3% oxygen.
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A total of 7 GM 16088 clones expressing E6E7 were obtained. However after 130 days 
post transfection, only an average cell count of 1 x 104 cells for E6E7 clones could be 
achieved in 20% O2 . None of the clones expressing empty vector accomplished viable 
cell numbers (Fig. 4.10). At 3% O2 no clones either E6E7 or neomycin attained usable 
cell numbers. For GM 17523 a total of 10 E6E7 clones were obtained in 3% O2 with less 
than 1 x 1 0 4 cells per clone after 104 days in culture, no clones were obtained in 20% 
O2 . 3 clones with the neomycin expressing empty vector (clones 2, 7 and 17) were also 
obtained (Fig 4.11).
Given the small number of cells obtained from the HPV 16 E6E7 and control clones, 
DNA was extracted using the special Qiagen micro kit designed for the analysis of 
forensic DNA samples. STELA was undertaken to examine the telomere length profiles 
of all the clones (Fig 4.10 and 4.11). The GM16088 E6E7 clones at 20% O2 and the 
GM 17523 E6E7 clones at 3% O2 display similar modal distribution like the parental 
populations (Fig. 4.2 and 4.7). In line with previous observations of clonal growth (Baird 
and Farr, 2006, Baird et al., 2003, Britt-Compton et al., 2006, Capper et al., 2007), the 
telomere length distribution were much more homogenous than the parental bulk 
populations despite the long period in culture. However, comparing the telomere length 
of the isolated clones to the parental cultures undergoing replicative senescence (Fig. 
4.2), it was apparent that no obvious difference in telomere length could be observed. 
This is in contrast to the STELA profiles from similar experiments in the normal human 
MRC5 fibroblasts where E6E7 expression extends the lifespan for 26 -  28 PDs and 
consequently telomeres continued to loose another 2 kb resulting in the complete loss of 
one or more telomeric alleles (Capper et al., 2007) (chapter 3 in this thesis).
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4.3.4 Fusion Assay of DNA Ligase IV deficient fibroblasts expressing HPV16 
E6E7
The expression of HPV16 E6E7 in DNA Ligase IV syndrome cells lines GM16088 and 
GM17523 failed to push average telomere length distribution of DNA Ligase IV 
deficient fibroblasts into the length range at which telomeres become unprotected and 
undergo fusion (Figures 4.10 and 4.11). Nevertheless an accumulation of critically short 
telomeres could be detected in both fibroblast cultures (Figures 4.2b, 4.3b, 4.6 b, 4.7 and
4.11). Previous work in the group has shown that even sporadic stochastically deleted 
telomeres can lead to fusion events in normal human cells (Capper et al., 2007). The 
presence and quantity of telomere-telomere fusion events in DNA Ligase IV syndrome 
cells was determined by using long-range single molecule PCR amplifications with 3 
primers for XpYp, 17p and 21q group telomeres (21q, lq, 2q, 5q, 6q, 6p, 8p, lOq, 13q, 
17q, 19p, 19q, 22q and the 2ql3 interstitial telomeric locus) (Letsolo et al., 2009) (Fig.
4.12). However due to the limited number of cells that could be obtained from both the 
bulk parental populations (max. 5 x 105 cells; min. 2 x 104 cells) or the HPV16 E6E7 
expressing fibroblast cultures (average 1 x 104 cells), there was a limited amount of 
DNA that could be analysed. The fusion assay detects a limited number of possible 
fusion events in the human genome and thus large number of input cells equivalents are 
required to detect single fusions (Capper et al., 2007, Letsolo et al., 2009). Nine fusion 
reactions were undertaken containing lOng of DNA (20-40 times less that typically is 
used for this type of analysis). Despite this limitation it was possible to detect fusions in 
the Ligase IV syndrome fibroblast. Interestingly these were detected in the bulk parental 
populations, whilst rare, the frequency of fusion in GM16088 involving XpYp and 17p 
was 1.3 x lO"4, 30 times higher than the frequency of 4 x 10'6 observed in normal 
fibroblasts with a similar relatively long telomere distribution (Capper et al., 2007). In 
the second Ligase IV syndrome fibroblast culture GM 17523, only one fusion involving 
the 17p telomere was observed giving a fusion frequency of 6.7 x 10'5. Even being very 
low, the frequency is still 16 times higher than the frequency observed in normal 
fibroblasts. In addition, it was apparent that more fusions could be detected in the 21q 
group of telomeres. However the specificity of the probe used to detect the 21q group is 
not good enough to allow any meaningful estimation of fusion frequency.
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4.4 Discussion
4.4.1 Replicative lifespan and telomere erosion in DNA Ligase IV deficient
cells
The DNA ligase IV syndrome cell lines, GM 16088 and GM 17523, exhibit a similar 
replicative capacity of approximately 25 PDs. Both fibroblast strains were derived from 
relatively young patients (9 and 14 years of age). GM 16088 and GM 17523 were both 
obtained from the Coriell Cell Repository and no information on the replicative history 
of the cells prior to this study was available. However two other studies of these 
fibroblast cultures indicated that they exhibit a reduced replicative lifespan compared to 
normal diploid fibroblasts strains (Badie et al., 1997, Cabuy et al., 2005). This is typical 
of many cell strains derived from individuals with mutated members of DNA damage 
repair mechanisms like DNA Ligase I (chapter 3), NBS1 (chapter 5) and WRN (Martin 
et al., 1970, Tollefsbol and Cohen, 1984). Classical NHEJ is disrupted in patient derived 
DNA Ligase IV syndrome cultures (Badie et al., 1995a, Badie et al., 1995b, Girard et al., 
2004, O'Driscoll et al., 2001) however the hypomorphic mutation in Lig4 gene does not 
impair the DNA damage response in these cells (Badie et al., 1997, O'Driscoll et al.,
2001). This raises the possibility that these cells may suffer high levels of genomic stress 
that signals a cell cycle arrest. This may lead to a telomere independent reduction in the 
proliferative capacity. Alternatively, the deficit in NHEJ may directly influence telomere 
dynamics increasing the rate of telomere erosion and thus undergo telomere-driven 
premature replicative senescence. However in this study the erosion rate in DNA Ligase 
IV deficient cells was not obviously different from that observed in normal fibroblast 
cultures, 113 bp/PD in GM16088 and 43 bp/PD in GM17523 compared to 60 to 120 bp 
per cell division in normal fibroblasts (Baird et al., 2003, Harley et al., 1990). This 
argues against the hypothesis that the Ligase IV deficiency impacts directly upon 
telomere dynamics. However these data are in contrast to a previous study (Cabuy et al.,
2005) were elevated rates of erosion was observed in GM 16088 (>200 bp/PD) and 
signal free ends were detected. The Cabuy et al study was undertaken using TRF 
Southern blot analysis, Flow-FISH and Q-FISH and rates of erosion varied between the 
different techniques used. These techniques are hybridisation based and thus suffer from
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a lower telomere length threshold below which telomeres cannot be detected. STELA 
does not suffer in this regard as it is capable of determining the length of the shortest 
telomeres. Therefore the distinction between the apparent rates of erosion may be a 
function of the difference in the technologies used to determine telomere length. The 
rate of erosion documented with STELA in the Ligase deficient cell strain GM17523 is 
just 43 bp/PD, we conclude that Ligase IV deficient cells exhibit no change in the rates 
of erosion of the bulk of the telomere length distribution.
4.4.2 Influence of Oxidative Stress on the Replicative Capacity and Telomere 
Dynamics of DNA Ligase IV syndrome fibroblasts
One aspect of this study was to test if the replicative lifespan of Ligase IV syndrome 
fibroblast cultures was sensitive to oxidative stress. The less severely affected fibroblast 
culture GM 16088 displayed no increase in replicative capacity at low oxygen 
concentrations. This is mirrored in the similar growth rates and telomere erosion rates at 
both oxygen concentrations. The more severe phenotype of the second Ligase IV 
syndrome strain was reflected in more limited replicative capacity of less than 20 PDs. 
However, the reduction of the oxidative tension increased the replicative lifespan of 
GM 17523 by 20% compared to that obtained when cultured in 20% oxygen. This is 
consistent with observations in both foetal and adult human lung fibroblasts and Wemer 
cells (Britt-Compton et al., 2009, Forsyth et al., 2003, Kashino et al., 2003) where 
culturing at low oxygen concentrations extended the lifespan of these cells. Comparing 
the exponential growth rate and telomere erosion rate at both oxygen concentrations, 
only the growth rate of GM 17523 at 3% oxygen is increased by 27%.
4.4.3 Short telomere distribution in DNA Ligase IV deficient cells GM17523
Another distinct aspect of telomere dynamics in the GM 17523 cell strain, derived from 
the more severely affected patient, was the apparent presence of a population of very 
short telomeres at the 17p telomere (Fig 4.7 b). This telomere length distribution was 
invariant, exhibiting no apparent telomere erosion despite the bulk of the telomere length 
distribution suffering erosion. The frequency (average 14.4%) of the short telomeres
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remained constant during the lifespan of the culture only disappearing in the final 2 PD. 
These short telomeres may be consistent with the observations of signal free ends (3%) 
by Cabuy et al in Ligase IV deficient cells. These telomere dynamics using STELA have 
not been seen in telomerase negative cells. Two possibilities present themselves: Firstly, 
cells that contain these short telomeres have activated some form of telomere 
maintenance system; however this does not appear to result in telomere lengthening and 
the frequency of these telomeres does not increase as be predicted if they were being 
maintained. Alternatively, the Ligase IV deficiency confers a telomere instability 
phenotype that results in constant rate of production of short telomeres. Cells that 
contain these telomeres either exit the cell cycle and do not contribute to the growth of 
the culture or the short telomeres are repaired through an Ligase IV independent DNA 
repair pathway resulting in fusions to another chromosome ends. The latter possibility 
appears more likely given the DNA repair deficiency of these cells.
Telomeres represent difficult loci to replicate and have recently been described as fragile 
sites (Sfeir et al., 2009). Furthermore G-rich telomeric DNA is considered to form G- 
quadruplex structures which are difficult to replicate and require specialised helicase 
activity to resolve. Thus, replication fork stalling and resolution as a double-strand DNA 
break may result in telomeric mutation. I speculate that Ligase IV deficient cells exhibit 
an enhanced telomere replication defect. Why this phenomena was only observed at the 
17p telomefe is also a matter of speculation, however one explanation could be the 
presence of telomere variant repeats within the proximal regions of the telomere repeat 
array. These distributions are hypervariable and each telomere of each individual will 
display a unique telomere variant repeat pattern (TVR) (Baird et al., 1995). Some repeat 
types exhibit differing levels of stability, for example CTAGGG is particular mutable 
(Mendez-Bermudez et al., 2009). It is conceivable that the TVR region at the 17p 
telomere in GM 17523 presents a particular problem during replication compared to the 
XpYp telomere. Consistent with this CTAGGG repeats have been detected within the 
17p telomere (Letsolo et al., 2009).
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These hypothesises could be tested by attempting to clone out this telomere phenotype, 
however despite multiple attempts it was not possible to obtain viable clones from these 
cell strains.
4.4.4 Fusions in DNA Ligase IV deficient fibroblast cultures
The purpose of these experiments was to produce Ligase IV deficient fibroblasts with 
short dysfunctional telomeres that are capable of fusion. Unfortunately the particular 
cell strains used here did not have very short telomeres at the particular telomeres 
analysed. Furthermore it was apparent that the introduction of HPV E6E7 did not confer 
a lifespan extension. It was thus not possible to obtain sufficiently short telomeres that 
would undergo fusion. Previous analysis of this type in normal fibroblasts (Capper et 
al., 2007) as well as in Ligase I deficient cells (chapter 3), have shown short 
dysfunctional telomere are subjected to fusion. Despite the severe difficulties in 
obtaining sufficient DNA for analysis, telomere fusion was detected in the Ligase IV 
deficient cells in the absence of HPV 16 E6E7. There was an apparent increase in fusion 
frequency in both Ligase IV deficient strains with ongoing cell division. Fusion 
frequencies were greater within the 21q family of telomeres, indicating that other 
telomeres could be shorter and undergo fusion compared to the here analysed 17p and 
XpYp telomeres. It would therefore be of interest to examine the telomere dynamics at 
these ends. The fusion frequency was low (GM 16088: 1.3 * 10-4, GM 17523: 6.7 * 10*5) 
but still significantly higher than in normal other fibroblast cell lines with similar 
average telomere length (Capper et al., 2007) where a fusion frequency of 4 x lO'6 was 
observed. These observations are consistent with the increased presence of anaphase 
bridges observed previously in 180BR (GM 16088) compared to normal fibroblasts 
(Cabuy et al., 2005). Similar to the here observed fusions, the frequency of anaphase 
bridges increased with ongoing cell division (Cabuy et al., 2005). The apparent increase 
in fusion frequencies compared to normal cells, may be consistent with the presence of 
the short telomeres observed in these Ligase IV deficient cells being subjected to fusion.
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The DNA Ligase IV activity in the GM 16088 cells is below 10% and in GM 17523 
below 1% of levels found in normal fibroblast. Both cells strains are radiation sensitive 
indicating a defect in DSB repair. Despite being compromised for NHEJ, these cells 
exhibit a 30 times higher fusion frequencies than that observed in normal cells. These 
observations are consistent with data from Ligase IV mutants in fission yeast (Baumann 
and Cech, 2000), telomerase negative mice (Maser et al., 2007) and Arabidopsis 
(Heacock et al., 2007). All these studies show that short dysfunctional telomeres can be 
subjected to fusion despite the absence of DNA ligase IV and consequently functional 
C-NHEJ. The observation of fusion in Ligase IV deficient cells is also consistent with 
the hypothesis that fusion of short dysfunctional telomeres is dependent on alternative 
NHEJ. This hypothesis is based upon the distinct mutational profile observed following 
the fusion of short telomeres in human cells, compromising of large sub-telomeric 
deletions and microhomology at the fusion point (Capper et al., 2007, Letsolo et al., 
2009). The profile is in contrast to telomeric fusion following the experimental 
abrogation of TRF2. These chromosomal fusion events display several kilo bases of 
telomeric repeats at the fusion point and are dependent on DNA Ligase IV, Ku70/80 and 
DNA-Pkcs (Smogorzewska et al., 2002, Stansel et al., 2001). Therefore classical NHEJ 
may not be the predominant mechanism underlying the fusion of short dysfunctional 
telomeres.
4.5 Conclusion
It appears that premature senescence of DNA Ligase IV syndrome cells is not a result of 
elevated telomere attrition as telomere erosion rates are in the range observed in normal 
human fibroblasts. However a distinct and constant distribution of short telomeres could 
trigger a DNA damage response inducing premature senescence. Telomere fusion events 
could be detected despite the lack of DNA Ligase IV activity. This is consistent with 
error-prone alternative end-joining processes operating to facilitate the fusion of short 
dysfunctional telomeres.
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Chapter 5: Nijmegen Breakage Syndrome
5.1 Abstract
NBSl is a part of the MRN complex and plays a critical role in the repair and processing 
of DNA double strand breaks. The primary human Nijmegen Breakage Syndrome 
fibroblast cells analysed in this study contain a hypomorphic 657del5 mutation found in 
90% of all NBS patients.
The telomere dynamics in NBSl deficient cells were investigated using STELA. It 
appears that in contrast to previous observations NBSl deficiency does not influence the 
rate of telomere attrition. Therefore the limited replicative capacity of NBS fibroblast is 
not a consequence of elevated telomere loss. In addition, the NBSl deficient primary 
fibroblasts display a significant paucity of sporadic telomere deletions events, thus 
indicating a possible role of NBSl in the process. In conclusion, sporadic telomere 
deletion events might be the result of the resolution of Holliday junctions at the bottom 
of t-loops and are accompanied by the formation of t-circles.
Another aspect of this study was to determine if NBSl participates in the fusion of short 
dysfuntional telomeres. However the expression of HPV 16 E6E7 in NBSl deficient 
cells failed to push average telomere length into the length range at which telomeres 
become unprotected and undergo fusion. The large scale analysis of the parental culture 
did not yield any fusion events. This was not surprising as average telomere is relatively 
long and no sporadic telomere deletions could be observed. Thus no conclusion could be 
reached regarding the role of NBSl in telomeric fusion events.
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5.2 Introduction
5.2.1 NBSl/nibrin
As a component of the MRN protein complex, NBS 1 plays a critical role in the repair 
and processing of DNA double strand breaks (DSB) (Carney et al., 1998, Varon et al., 
1998). NBSl is essential for the nuclear location of Mrel 1 and RAD50 (Carney et al., 
1998). In addition, NBSl binds to histone y-H2AX foci and initiates the rapid assembly 
of MRN at DSBs (Kobayashi et al., 2002). NBSl is involved in the initiation of the 
DNA damage response by mediating protein-protein interactions at DSBs (Lloyd et al., 
2009, Williams et al., 2009). Furthermore, the MRN complex is associated with 
telomeres through its interaction with telomere binding protein TRF2 which is a 
mediator in t-loop formation (Kass-Eisler and Greider, 2000, Zhu et al., 2000).
The NBSl gene contains 3 distinct domains. The N-terminal region includes a fork head 
associated domain (FHD) and two breast cancer C-terminal (BRCT) domains. The FHD 
domain binds to DNA damage proteins like Mdcl and Ctpl and most importantly acts as 
a tether to M rell. The BRCT domains are involved in the recruitment of repair and 
checkpoint proteins to DSBs (Lloyd et al., 2009, Williams et al., 2009). The central 
region comprises several conserved sequences for phosphorylation by ATM and 
ATM/RAD3 associated (ATR) kinases. The C-terminal region incorporates the M rell 
binding domain (MBD) and ATM recruitment motif (Becker et al., 2006, Williams et 
al., 2002).
5.2.2 Nijmegen breakage syndrome
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive disorder and belongs 
in the group of human chromosomal instability syndromes like Bloom’s Syndrome and 
ataxia-telangiectasia (AT) (Weemaes et al., 1981). Characteristic symptoms of NBS are 
microcephaly, immunodeficiency, distinct facial features, growth retardation, 
hypersensitivity to ionizing radiation (IR), chromosomal instability and a strong 
predisposition for lymphomas (Williams et al., 2009, Digweed and Sperling, 2004,
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Weemaes et al., 1981). NBS is caused by mutations in NBSl gene located at 
chromosome 8q21.3 (Carney et al., 1998, Varon et al., 1998). 90% of all NBS patients 
are homozygous for a hypomorphic 5 bp deletion event at position 657 in exon 6 of 
NBSl (Varon et al., 1998). The 657del5 germline mutation has the highest frequency in 
the Slavic population in central Europe, presenting a common founder mutation (Varon 
et al., 2000). The 657del5 missense mutation splits the NBSl directly in the BRCT 
linker region into two separate peptides of 26 kDa and 70 kDa. The smaller peptide 
contains the FHD and one of the BRCT domains and the larger peptide includes the 
Mrel 1 binding domain and ATM binding motif. The larger peptide retains the ability to 
interact with Mrel 1, suggesting that this interaction is essential for viability (Becker et 
al., 2006, Williams et al., 2002). Seven other mutations in NBSl result in the expression 
of a truncated protein and lead to NBS (Attwooll et al., 2009).
5.23 GM07166
GM07166 fibroblasts were derived from a NBS patient carrying the homozygous 
657del5 mutation. Like all NBS patient derived cells, GM07166 cells display an 
abrogated p53 function which results in an abnormal cell cycle arrest in Gl-S and a 
prolonged accumulation in G2 phase following ionizing radiation (Jongmans et al., 
1997). Furthermore, GM07166 is impaired in the intra S-phase checkpoint as cells 
continue to synthesize DNA despite the presence of radiation induced DNA damage 
(Girard et al., 2002, Shiloh, 1997). GM07166 cells show high sensitivity to ionizing 
radiation, chromosomal instability, decreased homologous recombination and 
accelerated telomere shortening (Ranganathan et al., 2001, Tauchi et al., 2002). The 
DNA-PK activity appears to be normal (Sullivan et al., 1997).
5.2.4 Animal models of NBS
NBSl-null phenotype in mice causes embryonic lethality (Zhu et al., 2001) whereas 
those expressing the C-terminal region of NBSl are viable and share many symptoms of 
NBS (Williams et al., 2002, Kang et al., 2002). The chicken cell line DT40 is disrupted
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in NBSl expression. As a consequence, cell cycle progression is slowed down due to a 
defect in the intra-S phase checkpoint regulation. DT40 is also hypersensitive to DNA 
damaging agents and chromosomal instability (Tauchi et al., 2002).
5.2.5 Stochastic Telomere Deletion Events
STELA analysis revealed that most telomeres erode gradually as a consequence of the 
end replication problem (Olovnikov, 1971). However superimposed on this telomere 
loss were sporadic large scale telomere deletion events (Baird et al., 2003). Similar 
telomere deletion events referred to as telomere rapid deletions (TRD) have been 
observed in yeast and are dependent on RAD52 and MRX complex (Bucholc et al., 
2001, Lustig, 2003). However the mechanism creating TRDs in yeast may be distinct 
from the mechanisms inducing sporadic telomere deletions in humans. The mechanistic 
basis of these human sporadic telomere deletion events is still unknown. Several 
mechanisms are to be considered: sister chromatid exchange (SCE) (Bailey et al., 2004, 
Rudd et al., 2007), replication fork stalling (Crabbe et al., 2004), oxidative damage 
(Petersen et al., 1998) and T-loop recombination, first characterized in yeast (Lustig, 
2003). High levels of sister chromatid exchange (SCE) have been observed at 
mammalian telomeres. Evidence in mouse cells indicates that SCE is 20 times higher at 
telomeres than at genomic loci (Bailey et al., 2004). Furthermore, human telomeres are 
subjected to a SCE rate which is 1600 times higher than the rest of the genome (Rudd et 
al., 2007). Moreover, SCE might lead to unequal sister chromatid exchange if the newly 
replicated chromatids are misaligned. The resulting long and short telomere product 
might give rise to dramatic changes in telomere length. Observations on telomere variant 
repeats are consistent with unequal SCE generating diversity (Baird et al., 1995, Baird et 
al., 2000, Britt-Compton and Baird, 2006). However, there is no data so far to suggest 
that SCE might lead to large scale telomere deletion events. Sporadic telomere deletion 
events do not accumulate with ongoing cell division, implying they are either repaired 
by an unknown DNA repair pathway, trigger a DNA damage response followed by the 
exit of the cell from the cell cycle or undergo fusion. Previous observations in our group 
have proven that these sporadic telomeric deletions can undergo fusion (Capper et al.,
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2007). Assuming that an estimated 2% of the each telomere population undergo sporadic 
telomere deletions, this may represent a significant contributor to genomic instability 
and therefore could aid cancer progression in normal fibroblasts.
5.2.6 Aims
The aim of this work was to determine if NBS 1 influences telomere dynamics and if 
NBSl participates in the fusion of short dysfuntional telomeres. Furthermore, this study 
tried to determine if NBSl deficiency abolishes the presence of sporadic telomere rapid 
deletion events in humans.
125
5.3 Results
5.3.1 Optim ising the replicative lifespan of NBSl deficient fibroblasts
Previous studies have shown that radical oxygen species (ROS) can give rise to varying 
levels of DNA damage in primary human fibroblasts inducing premature cell cycle 
arrest and consequently a significant reduction of the replicative capacity of the primary 
cells (Chen et al., 1995). Large quantities of non-proliferating cells in a culture can 
simulate an increase telomere erosion rate in particular near the end of the replicative 
lifespan of the cells (Forsyth et al., 2003). Moreover, another hypothesis suggests that 
the TTAGGG repeats of the telomere are sensitive to ROS induced DNA damage 
resulting in increased, end-replication independent telomere shortening (von Zglinicki,
2002). The NBSl deficient cells GM07166 are sensitive to DNA damaging agents 
(Nove et al., 1986). Oxidative stress may further aggravate the severely compromised 
cell phenotype of NBSl deficient cells and consequently attenuate the cultures 
replicative lifespan and influence the telomere dynamics observed in these cells.
In order to monitor the influence of oxidative stress on NBSl deficient cells GM07166 
the parental bulk population was split at PD 7.5 and was either cultured under normal 
oxygen concentrations of 20% O2 and physiological oxygen concentration of 3% O 2 . 
The cells were cultured by Mrs Rebecca Capper. The cells were passaged serially and 
the accumulated PDs were plotted as a function of time (Fig. 5.1).
Culturing NBSl deficient fibroblasts GM07166 at physiological oxygen levels of 3% 
did not extend o f the replicative capacity of the patient derived cells (Fig 5.1). The cells 
at 20% and 3% oxygen reached their replicative limit at PD 25 and 26.5 respectively. 
This represents a truncated replicative lifespan compared to normal fibroblast cultures 
(Hayflick, 1965) and is consistent with other DNA repair deficient cells strains analysed 
in this thesis. This data is also in line with previous observations in several model 
organisms (Kang et al., 2002, Tauchi et al., 2002), where the NBSl deficient cells 
presented a significantly slower cell cycle time and cell growth rates compared to 
normal cells. The cells were kept in culture for 217 days in the different oxygen
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concentrations and during that time 16.5 PD in 20% 0 2 and 18.0 PD in 3% O2  were 
achieved. The overall growth rates during the oxygen experiment were determined to be 
0.087 PD/day ± 0.092 PD/day at 20% 0 2 and 0.091 PD/day ± 0.062 PD/day at 3% 0 2 
(mean ± SD). However in both oxygen concentrations the growth rate varied during the 
course of the experiment slowing and speeding up in irregular intervals resulting in the 
step-like appearance of the growth curve (Fig. 5.1). It was not obvious if this is a result 
of the NBSl deficiency or experimental circumstances.
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Figure 5.1 Growth curves of NBS 1 deficient cells cultured in 3% and 20% oxygen. Plotting 
growth curves as function of population doublings (PD) verus time in days.Filled markers 
represent cells cultured at 20% oxygen and open markers represent those cultured in 3% 02.
5.3.2 Telomere dynamics of NBSl deficient fibroblasts
In order to determine if NBSl has a role in telomere dynamics, the XpYp and 17p 
telomere length distributions of GM07166 under 20% and 3% oxygen were investigated 
using single telomere length analysis (STELA) (Baird et al., 2003). In line with previous 
studies in the group (Baird and Farr, 2006, Baird et al., 2003, Britt-Compton et al.,
2006), only the XpYp and 17p telomere were analysed as both chromosome are 
representative for average chromosomal telomere length and average telomere erosion 
rates resulting from the end-replication problem. Multiple cell samples were taken 
during the course of the experiment and STELA was used to track the telomere
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dynamics with ongoing cell division. The STELA southern blots for the experiment are 
shown in figures 5.2 to 5.3.
In both oxygen concentrations, the telomere length distributions of GM07166 were 
bimodal at the XpYp telomere (Fig 5.2 a and Fig 5.3 a). At 20 % O2 , an apparent change 
in the distributions could be observed, the upper modal distribution disappeared as the 
cell reached the end of their replicative capacity. Albeit less obvious, the 17p telomere in 
both oxygen concentrations displayed a similar bimodal distribution, with evidence of 
the loss of the lower distribution after approximately 132 days in culture (Fig. 5.2 b and 
Fig 5.3 b). During the 6.5 PD between which telomere dynamics were analysed at 20% 
O2 , the lower XpYp distribution decreased by 0.9 kb whereas the upper distribution 
decreased by 0.7 kb disappearing after 3.5 PDs making it difficult to determine an 
accurate erosion rate. For the 17p telomere, the culture at 20% O2 , displayed a loss of 
1.7 kb at the upper modal distribution whereas the lower distribution was more difficult 
to define and disappeared after 3.5 PDs, therefore an accurate telomere erosion rates 
could not be determined. At 3% O2 , the upper XpYp length distribution lost 2.1 kb and 
the lower telomere length lost 1.05 kb over 10 PDs. The 17p telomere lost 0.3 kb at the 
upper distribution during this period and again the lower distribution disappeared after
3.5 PDs, hence an accurate erosion rate could not be determined. The telomere erosion 
rate data for NBSl deficient primary fibroblasts is summarised in Fig. 5.4. The telomere 
erosion rates were calculated separately for each chromosome. The overall erosion rate 
for the lower modal XpYp distribution and the upper modal 17p distribution was 
determined to be 229.4 bp/PD ± 73.2 bp/PD in 20% O2 and 95.6 bp/PD ± 46.7 bp/PD in 
3% O2 (mean ± SE).
Sporadic telomere deletion events have been observed in normal and diseased primary 
fibroblasts (Baird and Farr, 2006, Baird et al., 2003, Britt-Compton et al., 2006)(chapter 
3 and 4 in this thesis), these represent a significant mutational mechanism creating 
dysfunctional telomere that are capable of fusion (Capper et al., 2007). One of the 
objectives of this study was to determine if NBSl deficiency may play a role in the 
generation of telomeric deletion. This hypothesis was based on the genetic analysis that
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identified RAD50 and Mrel 1 in the process of telomere rapid deletion (TRD) observed 
in yeast (Bucholc et al., 2001, Lustig, 2003). The telomere length profiles observed in 
NBS cells (Fig 5.2 and 5.3) appeared to display a paucity of short telomeres compared to 
that observed in normal fibroblast cultures as well other DNA repair deficient cell strains 
analysed in this thesis. The XpYp telomere profiles of the different fibroblast cultures 
are presented as histograms depicting the observed telomere lengths distribution as a 
proportion (%) of the number of analysed molecules (Fig 5.5).
Stochastically shorter telomeres are defined as those which deviate from the normal 
(Gauss) distribution of expected telomere length. However bimodal distributions make it 
difficult to determine these deleted telomeres. Nevertheless an estimated 2% of all 
observed telomeres in different fibroblast cultures will be significantly shorter than the 
mean telomere length. In order to determine if NBSl deficient cells display no sporadic 
telomere deletion events, all telomere profiles were combined for analysis and a total of 
1051 and 1066 molecules were plotted in a histogram for 20% and 3% O2  respectively 
(Fig 5.5 bottom panel). There were no telomeres observed that are shorter than 0.9 kb 
and 1.1 kb in 20% and 3% O2  respectively. This differs from the expected 2% of 
telomeres which should be shorter than 500 bp. This difference is statistically highly 
significant for both oxygen concentrations (both p-value below 0.001, Chi-Square test).
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Figure 3.4 Summarising the telomere erosion rate data of NBSl deficient primary fibroblasts GM07166 
in 20 and 3% oxygen, a) Telomere erosion rate is calculated as the slope of the regression line after 
plotting the median telomere length against the corresponding PD. Individual telomere are detailed on 
the right, oxygen concentration is displayed above, error bars are ± standard error, y-axis presents 
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excluded from the overall mean and overall SE calculations.
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Figure 5.5 Statistically shorter telomeres (Outliers) in normal and diseased primary fibroblast cultures 
in 20 and 3% oxygen. The histograms display the observed telomere profiles for XpYp as a proportion 
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(5.3.3 Telomere dynamics of NBSl deficient fibroblasts expressing HPV E6E7 
oncoproteins
Another objective of this study was to investigate the role of nibrin/NBSl/p95 in 
telomere fusion events. In order to extend the lifespan of GM07166 and thus allow the 
telomeres to erode within the length range where to become de-protected and undergo 
fusion, cells were transfected with HPV 16 E6E7 oncoproteins. These oncoproteins 
abrogate the function of p53 and Rb, allowing the cells to bypass senescence and 
continue to divide through to crisis.
Initial experiments in NBSl deficient cells at both oxygen concentrations were carried 
out and the cells were transfected 3 PDs prior to end of the replicative lifespan of the 
cells. The transfection proved to be lethal to the cells, no clonal population could be 
obtained and with no extension of proliferative lifespan was observed in the bulk 
population. The transfection was therefore repeated at both oxygen concentrations at an 
earlier PD; PD 3 for 20% O2 and PD 11 for 3% O2 . Although 24 E6E7 clones and 12 
NEO clones were picked at each oxygen concentration, no viable clone could be 
established. At both oxygen conditions, the transfection efficiencies were low, cells 
grow poorly in low densities and no apparent lifespan extension could be achieved. 
After 100 days post transfection most clones contained less then 5 x 104 cells, with an 
average of 3 x 103 cells. STELA analysis was attempted however DNA content of all 
samples was not sufficient to obtain usable data (data not shown).
5.3.4 Fusion assay of NBSl deficient fibroblasts GM07166
The expression of HPV E6E7 in NBSl deficient cells GM07166 did not extend the 
proliferative capacity of the fibroblasts and consequently the average telomere length is 
likely to have remained above the threshold length at which telomeres become de­
protected and undergo fusion as observed in un-transfected cells (Capper et al., 2007). 
Furthermore because these cells failed to proliferate, the obtained DNA samples proved 
to be insufficient for fusion analysis and thus no data could be compiled. However a 
total of 25 samples from the parental population was analysed for fusions. Even though a
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total of 3.75 x 105 molecules were analysed, no fusion events were detected (data not 
shown).
5.4 Discussion
5.4.1 Cell proliferation and telomere erosion in NBSl deficient cells
In the study presented here, GM07166 displayed slow cell proliferation achieving less 
then 20 PDs in 217 days. The slow rates of proliferation could be a consequence of the 
prolonged cell cycle resulting from the NBS 1 deficiency in these cells (Jongmans et al., 
1997, Kang et al., 2002, Tauchi et al., 2002). Notable, a step-like growth curve of the 
NBS 1 deficient primary fibroblast in 20% O2 was observed; long stretches of slow 
growth alternate with short periods of faster cell proliferation (Fig 5.1). One explanation 
for the shape of the growth curve could be related to the kinetics of single cell growth in 
slowly growing cultures. In these cultures the main cell population displays little or no 
cell growth, only a minority of clonal populations are still proliferating. The faster cell 
growth of these populations could result in a clonal overtake of the parental culture; with 
stretches of slow growth corresponding to the time the clone needed to over take the 
culture. These type of cell kinetics are similar to those described in fibroblast cultures 
derived from Werner’s syndrome patients (Baird et al., 2004, Schonberg et al., 1984) 
and to some extent in normal human fibroblasts (Littlefield and Mailhes, 1975), where 
clonal succession, attenuation and expansion artificially increased the telomere loss of 
the bulk population. As described above, the cell growth of the bulk population is driven 
by a small minority of proliferating cells whereas the majority of the NBS cells exit the 
cell cycle. In later stages of the culture, these clonal populations overtake the culture. In 
this situation, the estimated PDs of the culture do not correspond with actual cell 
divisions (CD) of the individual fibroblasts. Subsequently the telomere erosion which is 
measured in bp/PD will appear to be increased as the estimated PDs are significantly 
lower than the actual CDs. This might suggest that the elevated telomere erosion rate of
229.4 bp/PD ± 73.2 bp/PD (mean ± SD) in 20% O2 is a product of this discrepancy. 
Moreover the erosion rate of 95.6 bp/PD ± 46.7 bp/PD in 3% O2 is well within in the 
range of telomere erosion rates observed in normal fibroblast cultures (Baird et al., 2003,
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Harley et al., 1990). Taken together with the step-like growth of NBS fibroblasts (Fig 
5.1), this could give an explanation for the accelerated telomere attrition of NBSl 
deficient cells at 20% O2 . However it was not immediately obvious why the phenomena 
can only be seen at 20% O2 . One argument could be that higher oxidative tension results 
in more cells exiting the cell cycle and therefore amplifying the clonal succession, 
attenuation and expansion phenotype. Attempts were made to examine this issue further 
by deriving clonal cultures in which the telomere dynamics and grow rates could be 
examined in isolation from the bulk populations where the complex replicative histories 
of the various cell lineages can confound the analysis (Smith et al., 1980). Unfortunately 
it was not possible to obtain viable clones from the parental culture or indeed the 
HPVE6E7 transfected culture, this may been due the cells inability to grow at low 
densities. Taken together, this argues against a previous observation that NBSl 
deficiency results in an accelerated telomere erosion rate (Ranganathan et al., 2001).
5.4.2 Replicative Lifespan and the Influence of Oxidative Stress on of NBSl 
deficient cells
In a previous study GM07166 reached senescence after ~ 10 PDs in culture 
(Ranganathan et al., 2001). The GM07166 in this study were obtained from the same 
source as used in this chapter (Cornel Institute) at passage 8 and were cultured for 50 
days in which they achieved approximately 10 PDs. They determined senescence using 
senescence-associated mammalian p-galactosidase activity (SAp-gal) assay (0.4) or 
(40%), however senescent cells have a SAp-gal activity of > 90% (Bond et al., 1999). 
This may imply that the replicative capacity of GM07166 was not completely utilised in 
the study by Ranganathan et al.
The NBSl deficient cells exhibited a limited proliferative capacity of approximately 26 
PDs. This is in line with previous observations in NBSl deficient primary fibroblast 
cultures (Girard et al., 2000). Furthermore, severe reduction in the replicative lifespan 
has been observed in other patient derived fibroblast cultures with mutations in DNA 
damage repair components; DNA ligase I deficient fibroblasts (chapter 3), DNA Ligase
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IV syndrome cells (chapter 4) and Werner Cells (Martin et al., 1970, Tollefsbol and 
Cohen, 1984). One explanation for this could again be related to the explanation 
articulated in the earlier chapters on Ligase I deficiency and Ligase IV syndrome. 
Another aspect of this study was to test if the replicative capacity of NBS 1 deficient 
fibroblast would be extended by lowering the oxidative tension. However the patient 
derived NBS culture displayed no increase in replicative lifespan at low oxygen 
concentrations.
5.4.3 Failed Replicative Lifespan Extension of NBSl deficient cells
Abrogation of p53 and Rb does not extend the replicative capacity of primary NBSl 
deficient fibroblast GM07166. A previous study on these fibroblast showed that NBS 
deficiency leads to reduction and delays in the p53 up-regulation (Jongmans et al., 1997) 
indicating that the p53 response pathway is defective in these cells. Thus experimentally 
interfering in this pathway may not have any effect on replicative lifespan.
5.4.4 NBSl Deficiency and Telomeric Fusion Events
The main aspect of this study was to extend the replicative lifespan of NBSl deficient 
fibroblast and consequently to produce cells with short dysfunctional telomeres that are 
capable to undergo fusion. Unfortunately the introduction of HPV 16 E6E7 did not result 
in the expected lifespan extension. Furthermore, no sporadic telomere deletions events 
could be detected in the NBS fibroblast cultures which in normal human fibroblasts can 
undergo fusion (Capper et al., 2007). Another approach to observe the influence of 
NBS 1 on telomeric fusion events would be to abrogate function of the complete MRN 
complex via a small molecule inhibitor, called mirin (Dupre et al., 2008, Gamer et al., 
2009). Mirin abolishes the Mrel 1-associated exonuclease function of the MRN complex 
and inhibits all homology mediated DNA repair in the treated cells. Similar to the 
experiment described in chapter 6, a clonal derivative of human fetal lung diploid MRC5 
fibroblasts expressing HPV 16 E6E7 (clone 1) could be treated with mirin. The inhibitor 
might create an effect on the mutational fusion profile of MRC5 HPV 16 E6E7.
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5.4.5 Sporadic Telomere Deletions in NBS
Sporadic telomere deletions are not consistent with gradual telomere loss resulting from 
the end replication problem (Olovnikov, 1971). Instead it appears these deletion events 
are generated by a currently unknown mechanism. One possible explanation could be a 
process previously described in S. cerevisiae termed telomere rapid deletion (TRD) (Li 
and Lustig, 1996). Initial observation in yeast showed that TRD results in the rapid 
reduction of artificially elongated yeast telomeres to wild-type telomere length. 
Following the observations that TRD increased in the absence of the hyper 
recombination gene HPR1 and decreased in the absence of the recombination protein 
RAD52 (Aguilera and Klein, 1989, Li and Lustig, 1996), it has been proposed that TRD 
occurs through intra-chromosomal recombination within the telomere array. Moreover, 
the MRX (homolog of human MRN complex) participates in TRD by initiating the 
branch invasion of the 3' chromosome termini into the proximal telomere repeat 
sequence. The strand invasion displaces the telomeric DNA forming a D-loop and 
therefore creating a structure which resembles a T-loop. The D-loop is nicked resulting 
in a Holliday junction like structure at the strand invasion point which is resolved into a 
truncated telomere and a TTAGGG rich circular DNA molecule referred to as telomeric 
circle (T-circle) (Bucholc et al., 2001, Lustig, 2003). Evidence for TRD has also been 
observed in mammalian cells with a mutated allele of TRF2, TRF2AB (Wang et al., 
2004). The abrogation of functional TRF2 led to the suppression of NHEJ and rapid loss 
of large segments of telomeric DNA which form circular loops. Further investigation 
showed that these deletion events were dependent on NBS1 and X-ray repair cross­
complementing 3 (XRCC3). The latter, together with its partner RAD51C, is thought to 
be involved in the resolution of Holliday junctions (Liu et al., 2004c). Following this 
observation, it has been proposed that t-circles are a result of t-loop deletion via 
homologous recombination (HR) and might contribute to rapid telomere deletion (Wang 
et al., 2004). T-circles have also been observed in cell with an alternative lengthening of 
telomeres (ALT) phenotype (Cesare and Griffith, 2004, Wang et al., 2004). In line with 
the previous hypothesis of T-circle formation, NBS1 and XRCC3 are required for the 
ALT phenotype and the formation of T-circles in these cells (Compton et al., 2007, 
Tomaska et al., 2009, Zhong et al., 2007).
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In the data presented here, NBS1 deficient fibroblasts display a paucity of sporadic 
telomere deletion events. Based on the model described above, this indicates that 
sporadic telomere deletions might be the result of resolution of Holliday junctions at the 
base of the t-loop by homologous recombination. One way to test this hypothesis would 
be to reintroduce functional NBS1 into the NBS fibroblast which might lead to the re­
appearance of sporadic telomere deletions.
5.5 Conclusion
In contrast to previous observations, the telomere erosion in NBS deficient fibroblasts is 
not elevated and consequently not the reason for premature senescence in these cells. 
Notable, the investigated primary fibroblasts display a significant paucity of sporadic 
telomere deletions events. This implies that sporadic telomere deletion events might be 
the result of the resolution of Holliday junctions at the bottom of t-loops and are 
accompanied by the formation of t-circles. No conclusion could be made regarding the 
role of NBS 1 in telomeric fusion events.
139
Chapter 6: PARP inhibitors
6.1 Abstract
Poly(ADP-ribose) polymerase 1 (PARP1) transfers ADP-ribose subunits from NAD+ to 
target proteins forming poly(ADP-ribose) (pADPr or PAR) polymers. Recent studies 
have described an alternative end-joining pathway in absence of classic members of non 
homologous end joining. This pathway is dependent on PARP1 and DNA ligase 
III/XRCC1 complex. The mutational profile of this alternative NHEJ pathway is 
reminiscent of the mutational profile observed in fusions between short dysfunctional 
telomeres. Furthermore, clinical trials with PARP1 inhibitors have shown that tumours 
with pre-existing defects in DSB repair are sensitive to PARP1 inhibition.
The telomere dynamics in MRC5 fibroblast expressing HPV16 E6E7 following PARP1 
inhibition were monitored using STELA. In line with previous studies, PARP1 
inhibition resulted in a rapid decline of average telomere length. The loss of telomere 
length may have been induced by PARP1 inhibition or by an earlier onset of crisis which 
is characterised by increase of telomere attrition. This latter explanation provides the 
intriguing possibility that PARP inhibition may sensitise cells to telomere dysfunction.
The main aspect of this study was to examine the role which PARP1 plays in fusion 
events between short dysfunctional human telomeres. However the limited data set from 
MRC5 E6E7 after PARP inhibition did not allow to draw any conclusions as to how 
PARP inhibition influences fusions between short dysfunctional telomeres.
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6.2 Introduction
6.2.1 Poly(ADP-ribose) polymerase 1 (PARP1)
Poly(ADP-ribosyl)ation through PARP1 transfers ADP-ribose subunits from 
nicotinamide adenine dinucleotide (NAD*) to target proteins forming poly(ADP-ribose) 
(pADPr or PAR) polymers (Kameshita et al., 1984, Rouleau et al., 2010). Poly(ADP- 
ribosyl)ation is a posttranslational protein modification and is an immediate response to 
DSBs. PARP1 is the founding member of poly(ADP-ribose) polymerase (PARP) family 
which all feature the same catalytic domain which implements poly(ADP-ribosyl)ation 
(Otto et al., 2005). In response to DNA damage, PARP1 is recruited to the site of single 
stranded and double stranded DNA breaks. It has been shown that poly(ADP- 
ribosyl)ation is involved in BER (Masson et al., 1998), HR (Hochegger et al., 2006) and 
NHEJ (Wang et al., 2004). In addition to recognising DNA damage, PARP1 rapidly 
recruits MRN and ATM to DSBs (Haince et al., 2007, Haince et al., 2008) and is 
involved in restarting of the replication fork (Bryant et al., 2009, Levy et al., 2009).
6.2.2 PARP inhibitors
Initial experiments with PARP inhibitors such as 3-aminobenzamide (3-AB) and 1,5- 
Isoquinolinediol (DIQ) indicated that cancer cell lines and human tumours that lack 
BRCA1 and BRCA2, both members of HR, are highly sensitive to PARP inhibition. 
The inhibition resulted in chromosomal instability, cell cycle arrest and consequently 
apoptosis of the treated cells (Bryant et al., 2009, Farmer et al., 2005). This gave the 
impulse to develop PARP1 inhibitors as an alternative to traditional chemotherapy for 
the treatment of tumours with pre-existing defects in DSB repair. However as 3-AB and 
DIQ are neither selective enough nor potent enough to result in a specific and complete 
inhibition of PARP 1 (>90%), a new generation of PARP inhibitors has been developed. 
These inhibitors are created to actively compete with NAD* and thus prevent the 
poly(ADP-ribosyl)ation through PARP1 and related proteins(Rouleau et al., 2010, 
Zaremba and Curtin, 2007).
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Several preliminary clinical trials have shown that PARP1 inhibition in BRCA-negative 
breast and ovarian cancer gives promising results (Fong et al., 2009, Rouleau et al., 
2010).
6.2J PARPs and Telomeres
Several members of the PARP family interact with telomere binding proteins. Human 
PARP5 (Tankyrase, TNK) interacts with TRF1 (Smith and de Lange, 2000, Smith et al., 
1998), PARP 1 and 2 with TRF2 (Dantzer et al., 2004, Gomez et al., 2006). In human, 
TNKS and TNKS2 both localise to human telomeres and both are involved in telomere 
length maintenance. They both interact with TRF1 and poly(ADP-ribosyl)ate TRF1 as 
well (Hsiao and Smith, 2008). Consequently inhibiting the binding of TRF1 to telomeres 
and therefore leaving the chromosome end accessible for telomerase to allow the gradual 
elongation of the telomere (Cook et al., 2002, Smith and de Lange, 2000). In mice, the 
abrogation of PARP1 gave controversial observation either having no impact on 
telomere erosion rates, telomere capping and the overall viability of the mice or resulting 
in shortened telomeres compared to wild type mice (d'Adda di Fagagna et al., 1999, 
Espejel et al., 2004). The individual deletions of TNKS 1 and TNKS 2 in mice produce 
viable and active animals. Furthermore, both deletions have no effect on telomere 
maintenance or telomere capping (Chiang et al., 2008, Chiang et al., 2006, Yeh et al.,
2006).
6.2.4 Alternative NHEJ (A-NHEJ)
Recent studies described an alternative non-homologous end-joining (NHEJ) pathway 
which is independent of DNA-PKcs and Ku70/80. Instead the pathway relies on 
poly(ADP-ribose) polymerase 1 (PARP-1) and XRCC1/DNA Ligase III complex 
(Audebert et al., 2004, Audebert et al., 2006, Wang et al., 2005). This slower back-up 
process (A-NHEJ) can be observed in wild-type cells and cells with defects in DNA-PK 
dependent NHEJ (C-NHEJ). The pathway utilizes microhomologies and is prone to 
missjoining (Roth and Wilson, 1986, Verkaik et al., 2002). In addition, the joining 
process is biased to a high G:C content at the joining point (Audebert et al., 2008).
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6.2.5 Fusion of short dysfunctional telomeres
Alternative NHEJ is reminiscent of the mutational profile of fusion events between short 
telomeres previously observed in our group. The profile comprises large deletion events, 
short patches of microhomology and a bias toward G:C at the fusion point between 
dysfunctional human telomeres (Capper et al., 2007, Letsolo et al., 2009). Furthermore, 
recent observations in telomerase negative mice have indicated that critically short 
telomeres undergo fusion in the absence of Lig4 and DNA-PKcs (Maser et al., 2007). 
This suggests that A-NHEJ could be the predominant mechanism to fuse short 
dysfunctional telomeres.
6.2.6 Aims
To test the hypothesis, a clonal derivative of human fetal lung diploid MRC5 fibroblasts 
expressing HPV16 E6E7 (clone 1) was treated with PARP-1 inhibitor, 1,5- 
Isoquinolinediol (DIQ). MRC5 E6E7 presents a well defined and reproducible model to 
investigate fusion events between short and dysfunctional telomeres. The inhibitor may 
disrupt the A-NHEJ pathway and create an effect on the mutational profile of MRC5 
HPV16E6E7.
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6.3 Results
6.3.1 Culture kinetics of MRC5 HPV16 E6E7 incubated with PARP inhibitor
The clonal derivative of human fetal lung diploid fibroblast MRC5 fibroblasts 
expressing HPV16 E6E7 (clone 1) was previously described (Baird et al., 2003, Capper 
et al., 2007, Letsolo et al., 2009). Briefly, the lifespan of the clone was extended by 
forcing the expression of the human papillomavirus (HPV)16 E6E7 oncoproteins, which 
abrogate the function of RB and p53. The cells bypassed senescence and reached crisis 
after further 26-28 PDs. The XpYp telomere presents two alleles. The longer allele 
erodes with an erosion rate of 86 bp/PD which was indistinguishable from the erosion 
rate of the parental culture before senescence. The short XpYp allele and the 17p 
telomere continued to erode beyond a threshold length were they were no longer 
detectable with STELA. No XpYp telomeres derived from the shorter allele were 
present in crisis cells. The 17p telomere was lost in 85% of analysed cells as cells 
approached crisis. The disappearance of the short XpYp telomere and the 17p telomere 
coincided with the increase of fusion events.
MRC5 cells expressing HPV16 E6E7 were cultured at PD 32.9 in the absence and 
presence of dimethyl-sulfoxide (DMSO), 10 pM DIQ and 100 pM DIQ in 20% oxygen. 
For the experiment, the inhibitor DIQ was dissolved in DMSO and was added to the cell 
culture medium at a concentration of lOpM and lOOpM. The cells were grown and 
treated by Mrs Rebecca Capper. Compared to the untreated cells, treatment with 10 pM 
and 100 pM DIQ reduced the replicative lifespan of MRC5 cells by 1.94% and 3.88% 
respectively (Fig. 6.1). Interestingly, the addition of 0.1% DMSO to the culture medium 
increased the lifespan of the cells by 1.94%. Investigating the growth rates during the 
exponential growth phase, the growth rate of all four cultures slowed from 1 PD per day 
to less than 1/5 of a PD per day, with an average value of 0.453 PD/day ± 0.284 PD/day 
for the untreated cells, 0.469 PD/day ±0.317 PD/day for the DMSO treated cells, 0.425 
PD/day ± 0.295 PD/day for the 10 pM DIQ treated cells and 0.399 PD/day ± 0.273 
PD/day for the 100 pM DIQ treated cells (mean ± SD). No significant difference in the 
average growth rate could be found between the four cultures (p-value 0.977, ANOVA:
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Single Factor). PARP inhibition at 10 pM and 100 pM DIQ concentration has no 
apparent effect on cell growth and cell viability.
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Figure 6.1 Growth curves of MRC5 HPV16 E6E7 cells in the presence and absence of 
PARP inhibitor DIQ.
6.3.2 Telomere dynamics of MRC5 HPVI6 E6E7 after PARP inhibition
In order to monitor the telomere dynamics following the inhibition of PARP, the XpYp 
and 17p telomere length distributions of the untreated, DMSO treated, 10 pM DIQ and 
100 pM DIQ treated cells were determined by using single telomere length analysis 
(STELA). Only the XpYp and 17p telomere were analysed as both chromosome are 
representative for average chromosomal telomere length and average telomere erosion 
rates resulting from the end-replication problem (Baird and Farr, 2006, Baird et al., 
2003, Britt-Compton et al., 2006). Multiple cell samples were taken and subjected to 
STELA in order to track telomere dynamics with ongoing cell division as the cells 
approached crisis. Only the STELA southern blots for the DMSO and the 100 pM DIQ 
treated cells are presented here (Fig 6.2 and 6.3).
Both the DMSO and lOOpM DIQ cells display the same bimodal distribution at the 
XpYp telomere. In both cultures, the shorter XpYp allele disappeared after
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approximately 52 PDs. The 17p telomere was gradually lost as cells reached the end of 
their replicative lifespan. Both cultures appear to be similar and no obvious differences 
to the previous study could be observed (Capper et al., 2007). The minimal telomere 
length was determined after 70 days before PD values decreased due to the onset of 
crisis (Fig. 6.1). Comparing both cultures at this time point, both cultures attain a similar 
telomere length at both analysed chromosome ends. For the XpYp telomere, the control 
culture reached a minimal telomere length of 3.8 kb whereas the DIQ treated culture 
obtained a minimal length of 3.4 kb (p-value: 0.354, two tailed t-test). The 17p telomere 
attained the minimal telomere length of 0.57 kb and 0.58 kb at the control and PARP 
inhibited culture respectively (p-value: 0.788, two tailed t-test).
During the 70 days of the experiment, the DMSO and lOOpM DIQ treated culture, lost
1.6 kb and 2.0 kb at the upper XpYp modal telomere length respectively. The 17p 
telomere decreased by 890 bp in the DMSO treated culture and by 650 bp in DIQ treated 
culture in this time period. During the exponential growth phase of the culture (47 days), 
the erosion rates for the XpYp and 17p telomere were calculated separately and are 
shown in Fig. 6.4. From the erosion rate diagrams it became apparent that treatment with 
a PARP inhibitor resulted in a rapid decrease in the XpYp telomere length in the later 
stages of the culture whereas the XpYp telomere in the control cells eroded more 
gradually. The same event could be observed at the 17p telomere in the DIQ treated 
cells. However it was not clear from these observations if the elevated telomere attrition 
was either a result of the influences of PARP inhibition on telomere dynamics or if 
PARP inhibition had induced an earlier onset of crisis which is characterised by an 
increase in the rate of telomere erosion (Britt-Compton et al., 2006, Capper et al., 2007).
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Figure 6.4 Summarising the telomere erosion rate data of MRC5 fibroblasts expressing HPV16 E6E7 
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149
6.3.3 Fusion assay of MRC5 HPV16 E6E7 after PARP inhibition
Previous studies with MRC5 expressing HPV16 E6E7 have shown that the non- 
detectable telomeres become de-protected and can undergo fusion (Capper et al., 2007, 
Letsolo et al., 2009). The presence and quantity of telomere-telomere fusion events was 
determined using long-range single-molecules PCR amplifications with 3 primers for 
17p, XpYp and 21q group telomeres (21q, lq, 2q, 5q, 6q, 6p, 8p, lOq, 13q, 17q, 19p, 
19q, 22q and the 2ql3 interstitial telomeric locus) (Letsolo et al., 2009) (Fig. 6.5).
Fusion events between all chromosome ends could be detected. The fusion frequency 
was calculated for the 17p telomere in order to avoid the clonal fusion event between 
XpYp and 21q group in later PDs in DIQ treated cells. In a previous study the fusion 
frequency for MRC5 E6E7 fibroblasts was estimated for the XpYp telomere which is 
not suitable for comparing fusion frequencies in this thesis (Letsolo et al., 2009). 
However comparing the fusion frequency for the XpYp telomere in the control cells at 
PD 52.5 (4 * lO'4) from this thesis to the frequency of the previous study (3.9 x 10"* at 
PD 52.8) no obvious difference was apparent. As expected, the fusion frequency 
increased near crisis in both the control and treated cells. This is consistent with previous 
studies (Capper et al., 2007, Letsolo et al., 2009). Notably, after 70 days of treatment, 
fusion frequency is approximately 2 times higher in the PARP inhibited fibroblasts than 
in the control cells. The decrease in fusion frequency at the end of the DIQ treated 
culture (93 days) maybe attributed to the smaller amount of viable cells and reduction of 
diversity in fusion events. In addition, it was evident that the DIQ treated culture was 
overtaken by a clonal fusion between the XpYp telomere and a member of the 21q 
group. These fusion events from in an earlier PD, are maintained throughout the cell 
cycle and can overtake a clonal culture (Artandi and DePinho, 2000a, Capper et al.,
2007).
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6.3.4 Internal Structure of Fusions in MRC5 HPV16 E6E7 after PARP 
inhibition
In order to examine the internal structure of telomere fusion events following PARP 
inhibition for 95 days, 30 fusion events in MRC5 cells expressing E6E7 were re- 
amplified and sequenced (Fig. 6.6). Unfortunately only 3 fusion points could be 
determined by direct sequencing. The nature of fusion events between members of the 
2 lq group made it difficult to obtain the fusion points, however in three fusion events 
the double sequence of the fusion could be separated due to the location of the fusion 
points (Fig 6.6). In addition six more fusions involving members of the 2 lq group were 
initiated though the fusion point could not be determined to a limit in the available 
DNA. All attempts to determine the sequence of prominent 21q-XpYp fusion event after 
93 days of PARP inhibition were in vain (Fig 6.5). Sequencing with an XpYp primer 
revealed a clear sequence of the XpYp telomere whereas the 21q group primer gives a 
double sequence which could not be allocated to a specific telomere (data not shown). 
The same phenomena could be observed in fusion events between 21 q group and the 
17p telomere. Reamplification for fusions between the XpYp and 17p telomere were 
attempted however no true fusion event could be identified.
Whilst this does not represent a significant sample set, it is notable that the mean sub- 
telomeric deletion size is 2706 bp. This is considerably larger than the deletion size 
observed in a large analysis of MRC5 E6E7 fibroblasts undergoing crisis in culture, 
where a mean of 1496 bp has been documented (Letsolo et al., 2009).
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6.3.5 Efficiency of PARP1 inhibition
Attempts have been made to confirm the efficiency o f PARP 1 inhibition by westem-blot 
analysis. Following a standard protocol, soluble protein was isolated and quantified, but 
both PARP inhibition samples presented negative protein quantities. It was not clear if  
this was either the result o f  PARP1 inhibition or just a technical problem. Furthermore, 
it was decided to measure PARP activity by using an antibody against poly(ADP-ribose) 
(PAR) polymers. Several antibody dilutions (ranging form 1:1000 (recommended) to 
1:100) were used, but not even a clear signal for the positive control samples could be 
achieved. Due to the time limit it was not possible to repeat the experiment (data not 
shown).
a)
\  AGGTG A  AACCCCGTCTCTACTAA AA AT AC A AAA A  AT I A < 7 f  '(  ( I t  t i n  l i  it A t  ( 1 4
21qA ^  ^  21 q group A
-2462 bp ^  -3186 bp
b)
..t g a g a c a g a g g c a o g a a t g  a . t  t r y <■ < < < g <
lq  A -----1 21 q group A
-1520 bp -3175 bp
C)
ATTTGCAGAACTGAi GGGGATTAATAAC I G ^ C  < < IV <
2q internal ^  | ^  21 q group A
telomere -3186 bp
Figure 6.6 DNA sequences data o f  fusion events in MRC5 lung fibroblasts expressing E6E7 
after PARP inhibition. Three fusion events between tw o members o f  the 2 1 q group are presented, 
a) 21 q :2 1 q group fusion; b) lq:21q group fusion; c) 2q (internal telomere):21q group fusion. 
Telomere-adjacent DNA is shown in multicolor. Fusion points, deletions size in bp, microhomoloy 
(bold and underlined) are displayed below the fusion event. The ream plideation primer is indicated 
in italics.
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6.4 Discussion
6.4.1 Effect of PARP inhibition on telomere length and lifespan of MRC5 
E6E7 fibroblasts
In contrast to the DMSO treated MRC5 cells, PARP1 inhibition resulted in a rapid 
decline in average telomere length at the XpYp and 17p telomere in the later stages of 
culture. The reason behind these phenomena was not immediately apparent. One 
explanation could be that the rapid decrease of telomere length is the result of population 
doublings (PDs) not matching cells divisions (CDs) as it has been seen in cultures 
approaching crisis. In cultures at the end of their replicative capacity, long periods of 
constant cell number though with still significant cell division present an elevated 
telomere erosion rate (Capper et al., 2007). This raises the intriguing possibility that 
PARP inhibition could sensitise cells to telomere dysfunction driving them to crisis. 
However, what counts against this is the observation that growth rates of the control 
culture and the DIQ treated culture are similar and no significant slow down could be 
observed. Furthermore, there was no obvious influence of PARP inhibitors on cell cycle 
and cell viability at the chosen concentrations. Therefore, it can be assumed all effects 
observed are a result of gradual inhibition of PARP activity since cell cycle progression 
and cell viability are not compromised by DIQ. This is in agreement with the fact that 
DIQ inhibits 100% PARP activity without significantly inhibiting mono-(ADP-ribosyl) 
transfereases at DIQ concentrations below 890 pM (Shah et al., 1996).
Rapid decrease in telomere length has been observed before in human and hamster cells 
(Beneke et al., 2008). However, observations in mice are more ambiguous. Whereas one 
group showed rapidly shortening telomeres (d'Adda di Fagagna et al., 1999, Tong et al., 
2001), others observed no impact after PARP inhibition (Espejel et al., 2004, Samper et 
al., 2001). Benke et al carried out a similar experiment in human and hamster cells 
observing similar rapid telomere erosion as seen in the MRC5 expressing E6E7. 
Furthermore, following the release from the PARP1 inhibitor, average telomere length 
reversed back to control levels in telomerase expressing cells. They speculated that 
PARP1 inhibition interferes with TRF2 activity. However it is not clear if PARP1
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interacts with TRF2 in a permanent or more transient way. Both models propose that 
PARP1 is required for TRF2 modification, t-loop opening and replication fork passage 
(Beneke et al., 2008).
DIQ treated cells attain the same minimal telomere length as control culture. It is not 
possible to determine if the telomere lenght at XpYp and 17p levels out as it has been 
observed in previous observations (Beneke et al., 2008) or continuous to decrease 
further. Following previous observations the short unprotected telomeres undergo 
fusion.
6.4.2 Effect of PARP inhibition on fusion frequency of MRC5 E6E7 
fibroblasts
The fusion frequency in the DMSO control cells was in the same range than observed in 
previous studies (Letsolo et al., 2009), whereas the fusion frequency of the DIQ treated 
MRC5 E6E7 fibroblasts is elevated (2x) compared to the control cells. Similar to the 
fusion events in DNA Ligase I deficient fibroblasts (chapter 3), the increase in fusion 
frequency could be an indicator that the fusion process is more efficient and therefore 
the unprotected chromosome termini undergo less processing prior to the final ligation 
step of end joining. However the few fusion events sequenced involved the 
chromosomes of the 21q group and indicated that most of the re-amplifiable fusion 
events are right at the limit of the fusion assay which detects deletion up to 3.5 kb 
(Letsolo et al., 2009). Interestingly, the mean deletion size was considerably larger in the 
three fusion events sequenced from the cells treated with the PARP inhibitor. Clearly 
more data are required to validate this result. However, if the assumption can be 
supported these data indicate that PARP inhibition may modulate the mechanism 
underlying telomere fusion, possibly by reducing the efficiency of ligation and thus 
facilitating continued 5' -  3' nucleolytic resection.
Fusions sequencing in MRC5 fibroblasts expressing E6E7 proved to be not as straight 
forward as expected. Recent observation of fusion events in ataxia telangiectasia-like
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disorder (ATLD) fibroblasts, resulting from a deficiency in M rell have shown that 
telomere fusion in these cells display a more erratic mutational profile (Maira 
Tankimanova, personal communications). The fusion events in ATLD cells contain a 
higher frequency of insertions events. Closer inspection of which indicated that they are 
derived from duplicated sequences adjacent to the fusion point. From these data it was 
concluded that Mrell is required to stabilise the end-joining complex to facilitate 
ligation. Furthermore, and consistent with its role in this process, fusion in ATLD cells 
exhibit more extensive sub-telomeric deletions. A similar pattern might be observed in 
MRC5 expressing E6E7 following the PARP1 inhibition. PARP1 is essential for the 
rapid recruitment of the MRN complex to end of DNA lesions (Haince et al., 2007). The 
structure of the MRN complex provides a stable DNA-chromatin bridging scaffold 
between two DNA ends in homologous recombination and NHEJ (Hopfher et al., 2002, 
Williams et al., 2008). This may account for the possible increase in sub-telomeric 
deletion size in presence of PARP inhibition. However it is clear that more sequencing 
analysis of fusion events is required before any firm conclusion can be drawn.
6.5 Conclusion
The limited data set from MRC5 E6E7 after PARP inhibition does not allow making any 
assumption how PARP inhibition influences fusions between short dysfunctional 
telomeres.
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Chapter 7: General Discussion and Further Investigations
7.1 Reduced Replicative Lifespan in DNA Repair Deficiency
Syndromes is not a Result of Elevated Telomere Erosion
All DNA repair deficient and patient derived human fibroblast strains observed in this 
thesis exhibit a similar limited replicative capacity of less than 30 PDs. This is in 
contrast to normal fibroblasts where 40 to 70 PDs at the point of replicative senescence 
are expected (Hayflick, 1965). The reduced replicative lifespan is in line with previous 
observations of these strains (DNA Ligase I deficiency: (Cabuy et al., 2005, Soza et al., 
2009); DNA Ligase IV syndrome: (Badie et al., 1997, Cabuy et al., 2005); NBS: (Girard 
et al., 2000, Ranganathan et al., 2001) and also other DNA repair deficient fibroblasts 
cultures such as Werner Syndrome (Martin et al., 1970, Tollefsbol and Cohen, 1984). 
Furthermore, previous studies have implied that elevated telomere erosion might be the 
cause of the attenuated lifespan in these DNA repair deficient fibroblasts (Cabuy et al., 
2005, Ranganathan et al., 2001). However, these studies were undertaken using TRF 
Southern Blots, Flow-Fish and Q-Fish. All these techniques are hybridisation based and 
suffer from a lower telomere length threshold below which telomeres cannot be 
detected. STELA does not suffer from this limitation as it is able to detect the length of 
the shortest telomere. In addition, the investigated DNA repair deficiency syndrome 
strains display a type of cell kinetics similar to those described in Werner’s syndrome 
patients (Baird et al., 2004, Schonberg et al., 1984) and to some extent in normal human 
fibroblasts (Littlefield and Mailhes, 1975), where clonal succession, attenuation and 
expansion artificially elevate the average telomere erosion rate of the bulk population. In 
this case, the estimated population doublings (PDs) of the bulk population do not 
correspond with the actual cell divisions (CDs) of the single fibroblasts. In order to 
further address this issue, normally clonal derivatives of the parental bulk population are 
isolated which allow the observation of growth rates and telomere dynamics of an 
individual cell lineage (Smith et al., 1980). However, it was not possible to obtain viable 
clones from either the parental bulk population or the HPV16 E6E7 transfected cultures
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of three of the DNA repair deficiency syndromes. Only the DNA Ligase I syndrome 
culture expressing HPV 16 E6E7 yielded viable clones. However due to the limited 
amount of samples and the cells reaching crisis, it was not possible to determine the 
average telomere erosion rate of these fibroblast cultures.
Telomere erosion is not the sole cause of replicative senescence. Also oxidative stress, 
DNA damaging agents and oncogene over expression can induce premature replicative 
senescence and thereby decrease the replicative lifespan of human fibroblast 
significantly (Dumont et al., 2000, Robles and Adami, 1998, Serrano et al., 1997). In 
order to determine the influence of oxidative stress on DNA repair deficient primary 
fibroblasts, all four fibroblast strains were cultured at 20% and 3% oxygen. Reducing 
oxidative stress increased the replicative capacity of the Ligase I deficient fibroblasts 
strain GM16096 and DNA Ligase IV syndrome strain GM 17523 (1% of remaining 
Ligase IV activity) by an average 22% compared to those cultured at 20% oxygen. 
However there was no significant increase in the growth rate in the exponential growth 
phase of these two DNA repair deficient strain. In contrast to these two, the second 
DNA Ligase IV Syndrome strain GM 16088 which retained less than 10% Ligase IV 
activity and the NBS 1 deficient strain, both displayed no increase in replicative capacity 
at low oxygen concentrations.
The average telomere erosion rate documented with STELA in all four DNA repair 
deficiency fibroblast strains at 3% O2 is within in the range of telomere erosion observed 
in normal human fibroblasts (40 to 120 bp per cell division) (DNA Ligase I deficiency: 
99.6 ± 47.5 bp/PD; DNA Ligase IV syndrome GM 16088: 112.4 ± 41.5 bp/PD; DNA 
Ligase IV syndrome GM 17523: 41.5 ± 14.1 bp/PD; NBS: 95.6 ± 46.7 bp/PD) (Baird et 
al., 2003, Harley et al., 1990). At 20% oxygen, only the erosion rates of DNA Ligase I 
and NBS1 deficient fibroblast strains are elevated by an average 110% (DNA Ligase I 
deficiency: 180.1 ± 27.5 bp/PD; DNA Ligase IV syndrome GM 16088: 115.4 ± 43.9 
bp/PD; DNA Ligase IV syndrome GM 17523: 43.9 ± 13.1 bp/PD; NBS: 229.4 ± 73.2 
bp/PD). Notably, the erosion rates for the two DNA Ligase IV syndrome strains are 
similar at both oxygen concentrations.
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The elevated telomere erosion rate and the even more truncated replicative capacity of 
DNA Ligase I deficient fibroblast at 20% oxygen indicates that the cells are sensitive to 
oxidative stress. This might be because oxidative tension can generate reactive oxygen 
species which in turn can cause cytotoxic lesions. These DNA lesions are repaired by 
base excision repair (BER) in normal human fibroblast (Laval et al., 1998). DNA Ligase 
I deficient fibroblasts are defective for long-patch BER and subsequently favour short- 
patch BER (Levin et al., 2000). It might be reasonable to assume that the defect in long- 
patch BER might promote a higher sensitivity to oxidative stress. This sensitivity might 
lead to more cells exiting the cell cycle and therefore no longer contributing to the 
overall growth of the culture. In consequence, the estimated PDs of the population 
would not correspond with the actual cell divisions and thereby increase the telomere 
erosion rate artificially.
In contrast to the DNA Ligase I deficient fibroblasts, NBS1 deficient fibroblast present 
elevated telomere erosion rate at 20% oxygen. However, this does not result in a further 
reduction in replicative lifespan of these cells. As described above, NBS cells at 20% 
oxygen displayed a type of cell kinetics in which clonal succession, attenuation and 
expansion artificially increase observed telomere erosion rates due to the estimated PDs 
not matching to the actual CDs.
Taking all of this together, this data supports the assumption that DNA repair deficiency 
does not result in accelerated telomere erosion and therefore the reduced replicative 
lifespan of these fibroblast cultures appears to be telomere independent.
The next step to further address this issue would be the forced ectopic expression of 
telomerase in these DNA repair deficient fibroblast cultures. In the case that the reduced 
replicative capacity of these patient derived strains is telomere dependent, the 
introduction of hTERT into these strains should result in telomere elongation, facilitate 
vigorous cell growth and consequently the cells should overcome replicative senescence 
extending the lifespan of the cells indefinitely (Bodnar et al., 1998, McSharry et al.,
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2001). However preliminary experiments (data not shown) have shown that this may not 
be the case. Following the transfection with hTERT, the growth rate stayed similar to the 
control cultures. Furthermore, no clonal population could be obtained and no replicative 
capacity extension was observed in the bulk population. Due to the time limit, no 
STELA analysis of these samples has been carried out. In line with the previous 
speculation, this might also indicate that the limited replicative capacity of DNA repair 
deficient fibroblast strains is telomere independent.
7.2 The Mechanistic Basis of Telomere Fusions in DNA Repair 
Deficient Human Fibroblasts Cultures
The expression of HPV E6E7 extended the lifespan of DNA Ligase I deficient 
fibroblasts GM 16096 resulting in short dysfunctional telomeres capable to undergo 
fusion. The observed fusion frequency was 10 fold higher than detected in normal 
MRC5 fibroblasts expressing HPV 16 E6E7 (Capper et al., 2007, Letsolo et al., 2009) 
analysed using the same fusion technology. This might be attributed to a more efficient 
fusion process which is devoid of extensive end-processing which creates large sub- 
telomeric deletion events. Furthermore, in conjunction with low levels of DNA Ligase 1 
activity, DNA Ligase I deficient cells display up-regulated levels of DNA Ligase III and 
are sensitive to PARP1 inhibition (Liang et al., 2008, Lonn et al., 1989, Moser et al., 
2007). As the survival of GM 16096 depends on DNA Ligase III and PARP1, this might 
suggest that the observed fusion events in GM 16096 are dependent on these two 
proteins.
In contrast to DNA Ligase I deficient cells, the introduction of HPV E6E7 did not confer 
a lifespan extension in the two Ligase IV syndrome and NBS1 deficient fibroblast 
cultures. Therefore it was not possible to obtain sufficiently short telomeres that would 
undergo fusion. However, analysis of the two parental DNA Ligase IV deficient 
fibroblast strains revealed an apparent increase in fusion frequency in both cultures with 
ongoing cell division. The elevated fusion frequency, compared to normal cells with a 
similar average telomere length, coincides with the presence of a population of short
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telomeres observed in both DNA Ligase IV syndrome strains. Several studies have 
shown (Baumann and Cech, 2000, Heacock et al., 2007, Maser et al., 2007) that short 
dysfunctional telomeres are subjected to fusion in the absence of functional NHEJ. 
Furthermore a previous study has shown that DSBs in human DNA Ligase IV deficient 
cells are joined by a microhomology driven, error-prone mechanism (Smith et al., 2003).
Similar to the fusion frequency in DNA Ligase I deficient fibroblast, the fusion 
frequency in MRC5 fibroblasts expressing E6E7 is elevated compared to the controls. 
Again this might indicate that the fusion process is more efficient and therefore the 
chromosome ends undergoes less processing prior the joining process. However, in 
contrast to previous observation, initial analysis revealed that all sub-telomeric deletion 
events of the analysed fusions are right at the limit of the fusion assay. Furthermore, the 
preliminary sequence analysis uncovered a large number of more complex fusion events. 
This resembles observations in ATLD cells, indicating that PARP1 inhibition might 
interfere with the recruitment of the MRN complex to DSBs.
Following these observations it might be safe to speculate that the fusion of short 
dysfunctional telomere is largely independent of DNA Ligase I and DNA Ligase IV. 
Furthermore, this leads to the final assumption that DNA Ligase III might be the 
predominant ligase involved in the fusion of short dysfunctional telomeres. From the 
here presented data, it was not possible to draw a conclusion about the involvement of 
NBS1 and PARP in the fusion of short telomeres.
The data presented here does not allow a definite statement about the mechanistic basis 
of fusions in short dysfunctional telomeres. Further sequence analysis and statistical 
analysis are necessary. For the fusion events detected in DNA Ligase I deficient 
fibroblasts, it could be interesting to determine if a paucity of large scale deletion events 
can be detected on the other chromosome ends from the 2 lq group (21q, lOq, 13q etc) 
similar to the 17p telomere. As it is not possible to carry out STELA on these telomeres 
to investigate the actual telomere length, it might be possible to determine if either all 
the observable fusion points are clustered in a specific range on the individual
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chromosomes or are spread through out the whole sub-telomeric region. Furthermore, it 
might be of interest to determine if the deletion size pattern of the individual 
chromosomes is different to previous observations in our group (Letsolo et al., 2009).
In order to determine the predominant DNA repair pathway involved in the fusion of 
short dysfunctional telomeres it might be necessary to inhibit more than one DNA repair 
pathway. However, it is not expected that cells will survive this procedure. Instead it 
might be interesting to observe the formation of fusions in a more isolated environment 
in regards to the preferred DNA repair pathway in the cells. A previous study has shown 
that high grade bladder tumours which are associated with a high levels of genomic 
instability (Bentley et al., 2004) favour a highly mutagenic, microhomology mediated 
alternative end joining pathway. This pathway is independent of Ku 70/80, DNA-PkcS 
and XRCC4, all prominent components of C-NHEJ (Bentley et al., 2004). As this 
alternative NHEJ pathway dominates the end joining of mismatched DSBs in these 
bladder tumours, it might be reasonable to assume that short dysfunctional telomeres in 
these tumours are joined favouring the same error-prone pathway. If this is the case the 
resulting fusion profile should be similar or even more distinct than the fusion profile 
previously observed in human MRC5 fibroblast expressing HPV E6E7 (Capper et al., 
2007, Letsolo et al., 2009).
Another possibility would be to approach the problem from another direction. As we 
have a good understanding how telomeres presents themselves in terms of TTAGGG 
repeat content, length of the TVR region and sub-telomeric region, it should be possible 
to create an artificial telomere template in a similar way like DSB templates are used to 
investigate end joining pathways (Bentley et al., 2004, Feldmann et al., 2000, Smith et 
al., 2001).
7.3 Sporadic Telomere Deletion Events in NBS1 Deficient Fibroblasts
The patient derived NBS1 deficient fibroblasts present a paucity of sporadic telomere 
deletion events. These deletion events do not conform to gradual telomere loss resulting
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from the end replication problem (Olovnikov, 1971). In line with observations in S. 
cerevisiae (Bucholc et al., 2001, Lustig, 2003), it has been speculated that loss of large 
segments of telomeric DNA (rapid telomere deletions) in mammalians are the result of 
the resolution of Holliday junctions at the base of the t-loop by homologous 
recombination. These events are dependent on NBS1 and XRCC3 (Liu et al., 2004c, 
Wang et al., 2004). The observations presented here are in line with this hypothesis. One 
way to further investigate the involvement of NBS1 in sporadic telomere deletions 
events would be to re-introduce functional NBS1 into NBS fibroblasts which might lead 
to the re-appearance of the deletion of large segments of telomeric DNA.
7.4 Short Telomere Distribution in DNA Ligase IV Syndrome cells
STELA analysis of DNA Ligase IV deficient fibroblasts GM 17523, which retained less 
than 1 % of DNA Ligase IV activity, revealed the presence of a distinct short telomere 
distribution on the 17p telomere. The distribution remained constant throughout the first 
23 PDs and represented an average 14.4% of the total numbers of telomeres. A similar 
short distribution was observed at the 17p telomere of the second DNA Ligase IV 
syndrome strain GM 16088. However, the result was ambiguous as the telomere adjacent 
probe for the 17p telomere yielded a number of recurring bands which could not be 
excluded to be a contamination. The consistent distribution in the more severely affected 
fibroblast culture appeared to be resistant against telomere erosion despite the average 
telomere length distribution declining with ongoing cell division. This lead to the 
speculation that DNA Ligase IV deficiency might facilitate a telomere replication defect 
which results in either premature exit from the cell cycle of the individual cell or an 
increased amount of telomeric fusion events through an DNA Ligase IV independent 
DNA repair pathway.
Interestingly, culturing the more severely effected DNA Ligase IV syndrome strain 
GM 17523 at lower oxygen concentration increased the replicative capacity of the cells 
by 20%. However, no notable difference could be observed between telomere erosion 
rates of the cultures at the different oxygen concentrations. Furthermore, STELA
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analysis revealed the distinct distribution of short telomeres being more prominent in the 
culture at 3% O2 . It has been speculated in this thesis that DNA Ligase IV deficiency 
confers an unknown telomere instability phenotype which results in a constant rate of 
production of short telomeres.
This phenotype may be related to the presence of specific TVR distributions that present 
a problem for telomeric replication. It may therefore be informative to examine the TVR 
distribution of the 17p telomere in these cell strains by TVR-PCR. It may also be 
informative to isolate and sequence the short 17p telomeric mutants observed in Ligase 
IV deficient cells. Little is known about the TVR composition of the 17p telomere, the 
only data coming from sequence analysis of fusion events that include the 17p TVR 
region. Some alleles contain CTAGGG repeats that have previously been documented 
to exhibit enhanced instability compared to the other TVR types (Mendez-Bermudez et 
al., 2009). CTAGGG repeats favour G-quadruplex formation (Lim et al., 2009), it is 
thus possible that the presence of CTAGGG repeats at the 17p telomere exacerbate 
replication fork stalling that may, in the absence of Ligase IV, preferentially lead to 17p 
specific mutation.
7.5 Increased Frequency of Single Nucleotide Mutations in DNA Ligase 
I Deficient Cells
While analysing the sequence of the observed fusion events in DNA Ligase I deficient 
human fibroblast expressing HPV E6E7, an increased frequency of single nucleotide 
mutations has been observed in the sub-telomeric sequence of the 17p telomere and the 
members of the 21q group (data not shown). Previous studies have shown that DNA 
Ligase I syndrome fibroblast have a defect in Okazaki fragment joining and single strand 
nick sealing during DNA damage repair (Prasad et al., 1996, Prigent et al., 1994). In 
contrast to unaffected fibroblasts, the ligation reaction in 46BR is stalled as a 
consequence of the accumulation of two normally transient intermediate products, 
Ligase I-AMP and nicked DNA-AMP (Henderson et al., 1985, Lonn et al., 1989, Prigent 
et al., 1994). The retarded ligation reaction could be the cause of the elevated single
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nucleotide mutations frequency and subsequently may explain the significantly 
increased level of genomic instability in DNA Ligase I deficiency mouse models 
(Harrison et al., 2002).
7.6 Effect of PARP Inhibition on Telomere Length and Lifespan
The inhibition of PARP 1 in MRC5 fibroblast expressing HPV E6E7 resulted in the rapid 
loss in average telomere length at the investigated XpYp and 17p telomere in the later 
stages of the culture. It was initially speculated that PARP1 inhibition could sensitise 
cells to telomere dysfunction and therefore drive cells to crisis. However this speculation 
was rejected as this and previous observations did not observe any changes in cell 
proliferation and cell viability during PARP1 inhibition (Beneke et al., 2008). Benke at 
al suggested that PARP1 inhibition interferes with TRF2 activity. However it is not clear 
yet, how PARP1 interacts with TRF2. One proposed model suggests PARP1 acts as a 
permanent “key” for the replication fork complex, modifying TRF2 and thereby opening 
the t-loop to facilitate the passage of the replication fork. The second model implies that 
PARP1 is transiently recruited to stalled or collapsed replication forks, where it modifies 
TRF2 and subsequently reactivates the progression of the replication fork. In both cases 
the replication fork stalling in the telomeric regions as a consequence of PARP1 
inhibition might be the cause of the rapid decline in average telomere length. It is 
apparent that speculation about the effect of PARP 1 inhibition are obsolete in this thesis 
as long as the actual PARP1 inhibition is not verified by western blotting.
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